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ABSTRACT 
Background 
Chronic musculoskeletal pain (CMSP) is a global healthcare concern, and is a major cause of 
disability and morbidity in sub-Saharan Africa. The implementation of high-quality, evidence-based 
clinical practice guidelines can enable quality healthcare for CMSP. Clinical guidelines for CMSP 
developed in developed nations may not be appropriate in developing countries with resource-
constrained environments, due to differences in socio-cultural, societal and policy contexts. The 
contextualisation of clinical guidelines may be an option to provide guidance in resource-
constrained environments. 
Aim 
The overall aim of the research project was to develop a contextualised evidence-based, multimodal 
clinical practice guideline for the primary health care of chronic musculoskeletal pain in adults in 
the Western Cape Province of South Africa (SA). 
Method 
The research was conducted in three parts: 
Part 1 comprised two qualitative descriptive studies to explore contextual factors that play a role in 
the health care of CMSP in three community centres. Three community health centres were 
strategically selected to represent a rural, a semi-urban and an urban-township setting. Study one 
used semi-structured interviews with patients to discover patients’ perspectives of CMSP and its 
healthcare management. In study two, semi-structured interviews were conducted with a diverse 
group of healthcare practitioners’ to explore their perspectives on the contextual barriers and 
facilitators regarding the healthcare of CMSP. Interviews were recorded, transcribed and analysed 
using inductive content analysis. 
Part 2 entailed study three, a systematic review conducted to identify current, high-quality clinical 
guidelines on the primary health care of CMSP. Guidelines that met the inclusion criteria were 
assessed using the Appraisal of Guidelines Research and Evaluation, Version II. Evidence-based 
recommendations were extracted from high-quality guidelines and synthesised for the 
contextualisation process. 
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Part 3 of the project entailed the validation and contextualisation of the clinical recommendations. 
In study four, a multi-disciplinary panel of experts validated the clinical recommendations for the 
South African context using a modified Delphi approach. The panel developed context points 
relevant to the recommendations during a consensus meeting. In study five, potential end-users 
reviewed the applicability and acceptability of the contextualised clinical practice guidelines 
through a survey. 
Results 
Twenty patients with CMSP and 21 practitioners participated in Part one. The findings indicated 
that CMSP influenced patients in multiple ways. Participants largely agreed on the context factors 
that influence CMSP care, namely the personal characteristics of the patient and practitioner, the 
social and environmental circumstances within which the patient lives, the healthcare interventions 
received and healthcare system factors. These contextual factors formed the foundation of the 
relevant facilitators and barriers to CMSP care in the context investigated.  
Twelve clinical guidelines on the primary healthcare management of CMSP were identified through 
the systematic review. Six of these clinical guidelines were of high quality, and 156 
recommendations were extracted from them. The recommendations were synthesised using a 
structured process. The end-result was a core set of 43 multimodal evidence-based, clinical 
recommendations.  
Seventeen multi-disciplinary panel members validated the recommendations for the South African 
context, nominated an extra recommendation and positioned the recommendations within the 
context of application for primary healthcare. The contextualized guideline was reviewed by a 
diverse group of 18 end-users who confirmed the clinical guideline to be largely applicable and 
acceptable for the intended context. 
Conclusion 
The end-product of the project was a contextualised, evidence-based and multimodal clinical 
guideline for the primary healthcare of CMSP in the Western Cape province of South Africa. The 
findings indicate that modifications in practice patterns, healthcare system organization and 
governance will contribute to the successful implementation of the guideline. A inter-/multi-
disciplinary approach, with the outcome of the patient as self-manager within a supportive 
environment, is underscored. Further research avenues include the development of a multilevel 
implementation plan and a pragmatic trial to investigate the feasibility of the contextualised clinical 
guideline in the South African context. 
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OPSOMMING  
Agtergrond 
Daar is wêreldwyd besorgdheid oor gesondheidsorg vir kroniese muskuloskeletale pyn (KMSP). 
Muskuloskeletale toestande is ŉ groot oorsaak van beperkte funksie en morbiditeit in sub-Sahara 
Afrika. Hoë-kwaliteit, bewysgesteunde kliniese praktyk riglyne is een manier om kwaliteit-
gesondheidsorg aan individue met KMSP te lewer. Kliniese riglyne vir KMSP wat in ontwikkelde 
lande ontwikkel is, is waarskynlik nie toepaslik vir omgewings met beperkte hulpbronne nie, 
vanweë verskille in die sosio-kulturele, samelewings- en politieke konteks. Die kontekstualisering 
van bestaande riglyne is dus ŉ opsie. 
Doel 
Die oorhoofse doelwit van hierdie navorsingsprojek was om ŉ gekontekstualiseerde, 
bewysgesteunde, multimodaliteit  kliniese praktyk riglyn vir die primêre gesondheidsorg van 
KMSP in volwassenes in die Wes-Kaap, ŉ provinsie van Suid Afrika, te ontwikkel.  
Metode 
Die navorsing het uit drie dele bestaan:  
Deel 1 het twee kwalitatiewe beskrywende studies behels om die konteks faktore wat 'n rol speel in 
die behandeling van KMSP te ondersoek, in ŉ steekproef van drie gesondheidsorgsentrums. Die 
drie gesondheidsentrums is strategies gekies om landelike, semi-stedelike en 'n stedelike-township 
te verteenwoordig. Studie een het semi-gestruktureerde onderhoude met pasiënte gebruik om hul 
perspektiewe rakende KMSP, en die behandeling daarvan te ondersoek. In studie twee is semi-
gestruktureerde onderhoude met 'n diverse groep gesondheidsorg praktisyns gevoer om hul 
perspektiewe rakende potensiële kontekstuele struikelblokke en fasiliteerders vir die behandeling 
van KMSP in primêre gesondheidsorg te bepaal. Die onderhoude is opgeneem, getranskribeer en 
ge-analiseer deur middel van induktiewe inhoud analise.  
Deel 2 het studie drie van die navorsing behels. 'n Sistematiese oorsig is gedoen om huidige, hoë-
kwaliteit kliniese praktyk riglyne ten opsigte van die primêre gesondheidsorg van KMSP te 
identifiseer. Die kliniese riglyne wat voldoen het aan die insluitingskriteria is geëvalueer met 
behulp van die Beoordeling van Kliniese Riglyne Navorsing en Evaluering, weergawe II. 
Bewysgebaseerde kliniese aanbevelings is vanuit die hoë-kwaliteit riglyne ontgin en verwerk vir die 
kontekstualiseringsproses. 
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Deel 3 van die projek het die bekragtiging en kontekstualisering van die kliniese aanbevelings 
behels. ŉ Multi-dissiplinêre groep kundiges het die kliniese aanbevelings vir die Suid-Afrikaanse 
primêre gesondheidsorg konteks bekragtig deur ŉ aangepaste Delphi-metode (studie vier). Die 
paneel het kontekspunte relevant tot die kliniese aanbevelings ontwikkel tydens ŉ konsensus 
vergadering. In studie vyf, het potensiële eindgebruikers die toepaslikheid en aanvaarbaarheid van 
die gekontekstualiseerde kliniese praktyk riglyn geëvalueer deur middel van ŉ vraelys. 
Resultate 
Twintig pasiënte met KMSP en 21 praktisyns het deelgeneem aan Deel een van die projek. Die 
bevindinge dui daarop dat KMSP pasiënte op verskeie maniere beïnvloed. Deelnemers het grootliks 
saamgestem oor die konteks faktore wat die behandeling van KMSP beïnvloed, naamlik die 
persoonlike eienskappe van pasiënte en praktisyns, die sosiale en die omgewings omstandighede 
waarbinne die pasiënt leef, die behandeling ontvang en faktore wat betrekking het op die 
gesondheidsorg stelsel.  
Twaalf kliniese praktyk riglyne rakende die primêre gesondheidsorg van KMSP is met die 
sistematiese oorsig geïdentifiseer. Ses kliniese riglyne was van 'n hoë gehalte, en 156 aanbevelings 
is uit die riglyne versamel. Die aanbevelings is met behulp van 'n gestruktureerde proses 
gesintetiseer. Die eindresultaat was 'n kern stel van 43 multimodale, bewysgesteunde kliniese 
aanbevelings. 
'n Multidissiplinêre groep van tot 17 kundiges het die lys van aanbevelings vir die behandeling van 
KMSP in die Suid-Afrikaanse konteks goedgekeur, ‘n ekstra aanbeveling genomineer en het die 
aanbevelings binne die konteks van implementering in die Suid-Afrikaanse konteks geposisioneer. 
Die gekontekstualiseerde riglyn is geëvalueer deur 'n diverse groep van 18 eind-verbruikers, wat 
bevestig het dat die riglyn grootliks toepaslik en uitvoerbaar is vir die bedoelde konteks. 
Gevolgtrekking  
Die eind-produk van die projek was 'n gekontekstualiseerde, bewysgesteunde en multimodale 
kliniese riglyn vir die primêre gesondheidsorg van KMSP in die Wes-Kaap provinsie van Suid-
Afrika. Die bevindinge dui daarop dat veranderinge in die praktykpatrone, organisasie en bestuur 
van die gesondheidsorg stelsel sal bydra tot die suksesvolle implementering van die kliniese riglyn. 
'n Inter-/multi-dissiplinere benadering, met die uitkoms 'n pasiënt as self-bestuurder binne 'n 
ondersteunende omgewing, word beklemtoon. Verdere navorsing behels die ontwikkeling van 'n 
multivlak implementeringsplan, asook 'n pragmatiese proefneming om die haalbaarheid van die 
gekontekstualiseerde kliniese riglyn in die Suid-Afrikaanse konteks te evalueer. 
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LIST OF DEFINITIONS 
Acceptability: The extent to which users are likely to accept a recommendation based on the 
following criteria: quality, comprehensiveness, logical reasoning, patient and provider attitudes and 
beliefs, ease of implementation into current system, patient needs, expectations and preferences 
(ADAPTE II Collaboration, 2009). 
Adapt a guideline: The use and/or modification of guideline(s) produced in one cultural or 
organisational setting for application in a different context. Adaptation can be used as an alternative 
to de novo guideline development or for customising existing guidelines(s) to suit the local context 
(ADAPTE II Collaboration, 2009). 
Adopt a guideline: The acceptance of a guideline as a whole after the assessment of its quality, 
currency and content. Healthcare providers (or other users of recommendations) who adopt a 
guideline, are committed to changing their practices in accordance with the recommendation in the 
guideline (ADAPTE II Collaboration, 2009). 
Applicability/Feasibility: The ability to which users can put a recommendation into practice. 
Applicability is influenced by a clearly defined eligible patient population and its congruence with 
the population in the intended setting. External factors such as knowledge, skill, staff, time frames, 
equipment and resources influence applicability (ADAPTE II Collaboration, 2009). 
Beliefs: These are the personally formed cognitions, often influenced by culture. Beliefs are 
informed by understanding of self and of the environment, and this influences behaviour (Daykin & 
Richardson, 2004). 
Biomedical model: This refers to the belief that pain symptoms are caused by physical structures, 
and thus the separation between body and mind (Daykin & Richardson, 2004).  
Biopsychosocial aspects: There is a complex and dynamic interaction between biological 
(physical), psychological and social aspects that influences the person’s experience of pain and 
clinical presentation (IASP, 2009a) 
Chronic non-malignant pain (WHO, 2007): Chronic non-malignant pain includes:  
i) Chronic musculoskeletal pain, including spinal pain or low back pain, chronic degenerative 
arthritis, osteoarthritis, rheumatoid arthritis, myofascial pain and rheumatic pain, chronic 
headache, migraine and bone pain; and 
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ii) Neuropathic pain including nerve compression pain, post-nerve injury and post-amputation 
pain, diabetic neuropathy, complex regional pain syndromes (type I and II), skeletal muscle 
spasm, post-herpetic neuralgia and chronic post-surgical pain; and 
iii) Visceral pain (distension of hollow viscera and colic pain); and  
iv) Chronic pain in sickle cell anaemia. 
Chronic (persistent) pain: This refers to pain that persists for longer than 12 weeks or beyond 
expected healing time (Blyth et al., 2001). 
Clinical practice guidelines: These guidelines are systematically developed recommendations that 
assist the practitioner and the patient in decision-making about health care for specific clinical 
circumstances (IOM, 2011). 
Conformability: This refers to the extent to which the findings are based on the study participants 
and settings
 
(Frambach et al., 2013). 
Consensus development: Formal consensus development methods are ways of obtaining and 
synthesising views of experts, opinion leaders and stakeholders. They involve the generation of 
group judgements based on explicit aggregation on individual participants’ judgements (Halcomb, 
et al., 2008). 
Contextual factors: Contextual factors include personal and environmental features of the 
individual. Personal factors are individualistic features such as gender, age, coping styles, social 
background, education, profession, past and current experience, overall behaviour pattern, and 
character, amongst other factors. The environmental factors comprise the physical, social, legal, 
external and attitudinal environment in which people live and conduct their lives. Contextual factors 
can act as facilitators of health care or barriers to such care (WHO, 2002, 2013). 
Contextualise a guideline: Contextualisation of a guideline for use in developing countries means 
retaining its current form, and using writing strategies that assist in its operationalisation in the local 
environment. The focus is on how to best translate existing evidence statements into local practice 
(Gonzalez-Suarez et al., 2012). 
Credibility (Trustworthiness): The extent to which a study’s findings are trustworthy (Frambach 
et al., 2013). 
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Dependability: The extent to which findings are consistent in relation to the context in which they 
were generated (Frambach et al., 2013). 
Disability: Problems in performing daily life tasks and activities, in the home as well as the 
workplace (Leeuw et al., 2007). 
Evidence-based practice: The conscientious explicit and judicious use of current best evidence in 
making decisions about the care of individual patients; the integration of best research evidence 
with clinical expertise and patient values (Sackett et al., 1996).  
Health systems strengthening: Improving the country’s health care system by identifying 
challenges and implementing changes in policy and practice in a country’s health system.  In this 
way, the country can respond better to its health and health system challenges (WHO, 2016). 
Interdisciplinary team: A group of health care professionals from different disciplines that 
integrate care as a team; who work in a coordinated fashion toward a common goal through 
frequent communication (IASP, 2009b; Medical Dictionary, 2016). Key features of an 
interdisciplinary approach are joint problem-solving, mutual responsibility and shared decision-
making (Turk et al., 2012).  
Knowledge synthesis: The contextualisation and integration of research findings of individual 
research studies within the larger body of knowledge on a topic (Canadian Institutes of Health 
Research, 2012). 
Knowledge translation research: The scientific study of the determinants of knowledge use and 
the methods to promote the uptake of research findings by healthcare providers, policy makers and 
patients (Eccles, Grimshaw, Walker, Johnston & Pitts, 2005). It is also known as implementation 
research and quality improvement research. 
Level of evidence: A hierarchical system that classifies evidence according to different individual 
study designs (Hillier et al., 2011). 
Multi-disciplinary team: A team of professionals including representatives of different disciplines 
who coordinate the contributions of each profession, which are not considered to overlap, in order 
to improve patient care (Medical Dictionary, 2016).  
Pain beliefs: A person’s conceptions of what pain is and what it means to the person (how the 
person makes sense of pain) (Daykin & Richardson, 2004). 
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Patient/-person-centred care: The patient as central within the professional relationship, with an 
understanding of the patient’s perspective, which underpins good practice in an equal therapeutic 
relationship (Kidd et al., 2011). 
Primary health care: Health care provided in the community by medical doctors, nursing and 
allied health professionals, which is often an individual’s first point of entry into the health system 
(Keleher, 2001). 
Quality of evidence: The body of evidence. The quality of evidence reflects the extent to which 
confidence in an estimate of the effect is adequate to support recommendations (Guyatt, Oxman, 
Vist, Kunz, Falck-Ytter & Schünemann, 2008b). The evidence base (i.e. number, level and risk of 
bias in included studies, which forms the body of evidence) (Hillier et al., 2011). 
Recommendations: Evidence-based statements that promote or advocate a particular course of 
action in clinical practice (Misso, Pitt, Jones, Barnes, Piterman & Green, 2008). 
Rehabilitation: A goal-orientated and time-limited process aimed at enabling impaired persons to 
reach an optimum mental, physical or social functional level (National Department of Health, 
2015). 
Strength of the recommendation: The extent to which one can be confident that the desirable 
effects of an intervention outweigh the undesirable effects (Guyatt, Oxman, Kunz, Falck-Ytter, 
Vist, Liberati & Schünemann, 2008a). 
Transferability: The extent to which the research findings can be applied to other, different 
settings (Frambach et al., 2013). 
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CHAPTER 1  
INTRODUCTION AND RATIONALE 
1.1 BACKGROUND 
Chronic musculoskeletal pain (CMSP) and its associated disability are worldwide concerns; and 
also a concern in the local South African (SA) context. The global prevalence of CMSP is high and 
rising (Schnitzer, 2006; Cimmino, Ferrone & Cutolo, 2011; Rauf, Meyer, Marcus & Becker, 2013). 
There are indications that the prevalence of CMSP is higher in African countries when compared to 
other countries (Demyttenaere, Bruffaerts, Lee, Posada-Villa, Kovess, Angermeyer, Levison, De 
Girolamo, Nakane, Mneimneh, Lara, De Graaf, Scott, Gureje, Stein, Haro, Bromet, Kessler, Alonso 
& Von Korff, 2007; Igumbor, Puoane, Gansky & Plesh, 2011; Rauf et al., 2013; Hoy, Geere, 
Davatchi, Meggit & Barrero, 2014). In SA, musculoskeletal conditions contribute significantly to 
the years lived with disability (YLDs) (Global Burden of Disease study 2015 Collaborators, 2016). 
However, the problem of CMSP is not prioritised in SA, due to the country’s quadruple burden of 
disease. Much health resources is spent on the prevention and management of HIV/AIDS (Human 
Immunodeficiency Virus/Acquired Immune Deficiency Syndrome) and tuberculosis, chronic (non-
communicable) diseases; maternal and child health and trauma and violence (Mayosi, Flisher, 
Lalloo, Sitas, Tollman & Bradshaw, 2009), therefore resources are not channelled towards the 
management of musculoskeletal conditions. 
There is a need for evidence-based, cost-effective and time-efficient management strategies to 
address CMSP and its consequences within the realities and constraints in the SA healthcare sector. 
The SA healthcare sector consists of a dual and separate public sector and private healthcare sector. 
The public sector suffers the consequences of SA’s historical apartheid system, and is currently a 
system in transition to reform (Coovadia, Jewkes, Barron, Sanders & McIntyre, 2009). This process 
of reform creates the opportunity for innovation and the hope of a uniquely African healthcare 
system that addresses the needs of African people (Coovadia, 2015). New and creative ways are 
needed to bring evidence-based practice for CMSP directly to the patients and the practitioners, 
where they interact within the current healthcare system. The implementation of clinical practice 
guidelines (CPGs) have been advocated to optimise health care by improving the quality, 
consistency, appropriateness and cost-effectiveness of care (Shekelle, Woolf, Grimshaw, 
Schünemann & Eccles, 2012; Graham, Harrison, Brouwers, Davies & Dunn, 2002; Vlayen, 
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Aertgeerts, Hannes, Sermeus & Ramaekers, 2005). CPGs may therefore play an important role in 
healthcare reform and the operationalisation of evidence-based practice.  
The focus of this study was on synthesising and organising evidence-based recommendations, using 
the novel approach of CPG contextualisation (Gonzalez-Suarez, Grimmer-Somers, Dizon, King, 
Lorenzo, Valdecanas, Gambito & Fidel, 2012). Contextualisation can be described as the process 
whereby clinical recommendations from existing high-quality CPGs are extracted, synthesised and 
used to create a new CPG. The recommendations sourced from original CPGs retain their form, but 
are re-written, using specific writing strategies. The reformed recommendations are accompanied 
by context points to facilitate the operationalisation of recommendations in the local context 
(Gonzalez-Suarez et al., 2012). The contextualisation process necessitated a thorough knowledge 
about contextual factors that impact the care of CMSP in SA. Therefore, contextual factors, such as 
personal and environmental factors that have an influence on the care of CMSP, as experienced by 
key informants consisting of patients and practitioners managing CMSP in the SA public sector 
primary healthcare (PHC) sector, were investigated. The knowledge about contextual factors was 
essential in informing the process of CPG contextualisation. 
1.2 SIGNIFICANCE OF THE STUDY 
CMSP, in SA and Africa, is a significant burden that should be addressed. In SA, chronic pain is 
reported to be often underdiagnosed, undertreated, or inappropriately treated (Narasimooloo, 
Naidoo & Gaede, 2011; Chetty, Baalbergen, Bhigjee, Kamerman, Ouma, Raath, Raff & Salduker, 
2012), which may lead to poor pain control. Additionally there is a dearth of research on CMSP 
impact and management in SA settings (Igumbor et al., 2011; Rauf, Meyer, Marcus & Becker, 
2014). The high prevalence of CMSP and its debilitating consequences necessitates effective 
strategies to prevent and manage the condition. An evidence-based CPG is thus ideally suited to 
enhance the implementation of strategies for the management of CMSP pain in the SA context. 
However, such a CPG that is applicable for a resource-constrained environment has not yet been 
developed. The research project focuses on the development of a CPG through the novel process of 
CPG contextualisation to address the burden of CMSP in the SA public health care sector. 
1.3 OVERALL AIM 
The overall aim of the research project was to develop a contextualised evidence-based, multi-
disciplinary clinical practice guideline for the primary health care of adults with CMSP in the 
Western Cape province of SA. To achieve the aim of the project, six research questions were asked: 
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 What are patients’ perspectives about their CMSP and its PHC in the SA context; in 
particular their pathway of care and the factors that have an impact on their pain experience 
and management?  
 What are healthcare practitioners’ perspectives about the PHC of patients with CMSP; in 
particular the pathway of care and the barriers and facilitators in implementing optimum 
pain management in PHC? 
 What are the evidence-based clinical recommendations contained in existing, current, high-
quality CPGs for the management of adults with CMSP in in PHC settings? 
 Which of the identified evidence-based clinical recommendations are valid, to be included 
in the CPG for the local (Western Cape, SA) context?  
 What are the context and practice points that represent standards for implementation of the 
recommendations contained in the CPGs? 
 Is the contextualised CPG for PHC of adults with CMSK pain applicable and acceptable for 
the intended setting? 
1.4 RESEARCH SETTING  
The research setting was primary health care, focusing on Community Health Centres/Clinics in the 
public health care sector of the Western Cape of SA.  
1.5 METHODS 
Five interlinked studies with different methods were implemented, drawing on the principles of 
knowledge translation research. Knowledge translation research is defined as the scientific study of 
the determinants of knowledge use and the methods to promote the uptake of research findings by 
healthcare practitioners, policy makers and patients (Curran, Grimshaw, Hayden & Campbell, 
2011). In the first part of the project, two corresponding qualitative studies were performed to 
investigate the context. In the second part, a systematic review was performed to source and 
synthesise the available evidence-based management options. In the third part, the context 
information and the evidence-based recommendations were integrated using consensus 
methodology and the feasibility of the integrated information was verified via an external review.  
1.6 STRUCTURE OF THE DISSERTATION 
The structure of the dissertation is illustrated in Figure 1.1. The dissertation begins with an 
overarching introduction and literature review (Chapters 1–2) and ends with a comprehensive 
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discussion chapter, which includes the limitations and recommendations derived from the study 
(Chapter 9), followed by a short conclusion (Chapter 10). The three phases of the research project 
are presented in three parts (Chapters 3–8) as follows: 
1.6.1 Part 1: The context 
Part 1 addresses the need for information about the authentic conditions within which CMSP is 
experienced and managed through the views of patients and practitioners as key stakeholders. 
Chapter 3 reports on the findings of a qualitative descriptive study about patients’ perspectives of 
CMSP and its PHC management; and Chapter 4 reports on a qualitative descriptive study about 
practitioners’ perspectives on the management of CMSP in the PHC context. The end-product of 
Part 1 is a framework of contextual factors that influence CMSP care. This framework was 
considered for contextualising CPGs for the management of CMSP in the Western Cape. 
1.6.2 Part 2: Evidence sourcing and synthesis 
Part 2 focuses on the identification and synthesis of evidence-based recommendations for use in the 
contextualisation process. Chapter 5 describes the procedures and outcome of a systematic review 
for the identification and appraisal of existing, up-to-date CPGs for the PHC management of 
CMSP. Chapter 6 describes the process whereby recommendations were extracted from high-
quality CPGs to be further analysed and synthesis. The process of synthesis involved transformation 
of recommendations into a context-friendly form, by merging and re-writing recommendations, 
using a specific writing guide. The end-product of Part 2 was a core set of multi-disciplinary 
evidence-based recommendations for inclusion in a CPG for CMSP. 
1.6.3 Part 3: Contextualisation 
In Part 3, the information from Parts 1 and 2 was brought together for the final stages of 
contextualisation. An expert multi-disciplinary panel evaluated and validated the recommendations 
produced for the applicability and feasibility of the recommendations for the intended setting, using 
the Delphi process (Chapter 7). During a consensus meeting (Chapter 7), the same panel generated 
context and practice points to accompany the recommendations, using the information obtained for 
Part 1. The validated recommendations with their context points were organised into an authentic 
patient pathway/journey, which was formed using the information from Part 1. Chapter 8 reports on 
the evaluation of the contextualised CPG and patient pathway via an external review, for further 
validation. 
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CHAPTER 2  
LITERATURE OVERVIEW  
2.1 CHRONIC MUSCULOSKELETAL PAIN  
2.1.1 Chronic musculoskeletal pain and its consequences 
Chronic musculoskeletal pain and its management present a challenge to patients, healthcare 
providers and communities. CMSP is pain associated with joints, muscles, tendons and nerves that 
persist for longer than 12 weeks, and thus beyond the expected healing time (Blyth, March, 
Brnabic, Jorm, Williamson & Cousins, 2001); Harstall & Ospina, 2003). The condition is classified 
as part of chronic non-malignant pain, which includes musculoskeletal, neuropathic and visceral 
pain and pain from sickle cell disease (WHO, 2007). Musculoskeletal pain can be a symptom from 
various conditions, for example osteoarthritis, rheumatoid arthritis, low back pain, tendinopathies 
and overuse injuries; however, in many cases, a clear diagnosis regarding CMSP cannot be made 
(Parsons, Harding, Breen, Foster, Pincus, Vogel & Underwood, 2007). CMSP is recognised as a 
global healthcare concern and it affects many societies, including those in sub-Saharan Africa, 
where CMSP is a major cause of disability and morbidity
 
(WHO, 2003; Furlan, Reardon & 
Weppler, 2010; Rauf et al., 2014). Work absenteeism, unemployment compensation and repeated 
treatments contribute to considerable socioeconomic burden of CMSP in developed and developing 
countries (Punnett & Wegman, 2004; Woolf & Pfleger, 2003). CMSP has a significant impact on 
physical and psychological health, function, participation in life roles and ultimately on quality of 
life (Foster, Pincus, Underwood, Vogel, Breen & Harding, 2003; Furlan et al., 2010); and reduces 
health-related quality of life. The condition is associated with high personal, financial, healthcare 
system and social system costs (Woolf & Pfleger, 2003). 
2.1.2 Prevalence of chronic musculoskeletal pain  
There is consensus that the prevalence of chronic pain and CMSP pain is high and may be 
increasing (Foster et al., 2003; Schnitzer 2006; Cimmino et al., 2011; Rauf et al., 2013; Hoy et al., 
2014). The increase is attributed to multiple factors which include an ageing population, obesity, 
urbanisation and lifestyles factors (Woolf & Pfleger, 2003; (Global Burden of Disease study 2013 
Collaborators, 2015). The prevalence of CMSP as an entity is unclear, as authors often do not 
differentiate between types of pain. The reported prevalence of chronic pain differs between 
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countries due to different definitions used, differences in population groups, cultures, comorbidities 
and lifestyles (McBeth & Jones, 2011; Rauf et al., 2013). While it is difficult to determine the 
precise global prevalence of chronic pain, Smith, Hopton and Chambers (1999) estimate it to be 
between 7.6% and 45%, and Harstall and Ospina (2003) estimate it to be between 10.1% and 
55.2%. In SA communities, a chronic pain prevalence of up to 41% was reported in the Eastern 
Cape (Igumbor et al., 2011) and Tshwane (Rauf et al., 2013) regions. Demyttenaere et al. (2007) 
found the SA prevalence for neck and back pain to be 26% (the fourth highest of the 17 countries 
surveyed). The findings are similar to the findings of Major-Helsloot, Crous, Grimmer-Somers and 
Louw (2014) who found a chronic low back pain (LBP) prevalence of 26% in Western Cape 
community settings. In a systematic review, Usenbo, Kramer, Young and Musekiwa (2015) report 
the prevalence of osteoarthritis in SA to be as high as 55.1%. Africa thus shares the high global 
burden of chronic pain.  
Chronic pain is one of the commonest complaints for consulting practitioners in PHC (Matthias, 
Parpart, Nyland, Huffman, Stubbs, Sargent & Bair, 2010; Patel, Peacock, McKinley, Clark Carter & 
Watson, 2008). Musculoskeletal conditions have likewise been found to be a significant reason for 
seeking PHC in SA (Mash, Fairall, Adejayan, Ikpefan & Kumari, 2012). Mash et al. (2012) report 
LBP as the sixth commonest complaint, while leg pain and joint pain ranked 13
th
 and 23
rd
 
respectively. The management of musculoskeletal pain and the prevention of chronicity should thus 
be prioritised to address the health burden that these conditions pose.  
2.1.3 Conceptual models for chronic musculoskeletal pain  
The conceptual models for chronic pain accentuate it as a complex condition, which is influenced 
by individual factors, personal beliefs, values, attitudes, expectations, cognitions, biological 
mechanisms, psychological factors, social and environment contexts and culture. Historically, pain 
was explained as a biological phenomenon by the pain gate theory (Melzack & Wall, 1965) and 
later the biopsychosocial model (Engel, 1977). A structural, biomechanical model often fails to 
sufficiently explain why pain persists, and it does not consider the impact of psychosocial and 
environmental influences on pain production and maintenance (Hayes & Hodson, 2011). The 
contemporary understanding of pain has evolved to conceptualise it as a multidimensional 
phenomenon which is governed by higher centres in the brain. The aforementioned concept is 
explained by the pain neuromatrix conceptual model (Melzack, 1999; Moseley, 2003). The pain 
neuromatrix model explains that widespread brain activity is initiated when the individual 
experiences pain. This brain activity is individual specific, denoting that there are individual 
differences as to which stimulus activates the pain neuromatrix and the areas of the brain that 
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respond to the stimulus, producing a perceptual and motor output (Moseley, 2003). This model 
transcends the biopsychosocial model to include the neurophysiological changes that takes place in 
the brain during the chronic pain experience. Consequently, effective management of pain requires 
a multimodal approach with the integration of pharmacological and non-pharmacological 
management approaches to address the multiple features that play a role in chronic pain 
construction. 
2.2 MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN 
2.2.1 Evidence-based practice 
The multiple features of CMSP, as well as its high prevalence and debilitating consequences, 
necessitate effective strategies to prevent and manage the condition. Evidence-based practice is 
imperative for the quality management of CMSP. Research about effective strategies to manage 
CMSP is fundamental to inform evidence-based practice. However, it is estimated that research 
findings can take up to two decades to be incorporated in practice (Sussman, Valente, Rohrbach, 
Skara & Pentz, 2006), implying that there may be complex barriers to evidence uptake. The uptake 
of evidence further requires knowledge translation, whereby research evidence is applied for 
decision-making in different contexts (Curran et al., 2011). Evidence-based practice is defined as 
the integration of best research evidence with clinical expertise and patient values (Sackett, 
Rosenberg, Gray, Haynes & Richardson, 1996), which indicates that, while it is imperative to 
consider the evidence base for interventions targeting CMSP, patient values and practitioners’ 
experience need to be considered during clinical decision-making. Knowledge translation requires 
understanding and attending to the multidimensional barriers and facilitators that influence 
decision-making within real world circumstances. Consequently, knowledge about the context 
factors that influence CMSP care may inform relevant prevention and management strategies. 
2.2.2 Interdisciplinary primary health care for chronic musculoskeletal pain  
The prevention and management of CMSP requires a holistic, multimodal and inter-/multi-
disciplinary approach to address the complex interaction between biological, psychological, social 
and environmental factors (Scascighini, Toma, Dober-Spielmann & Sprott, 2008). Turk, Stanos, 
Palermo, Paice, Jamison, Gordon, Cowan, Covington & Clark (2012) describe interdisciplinary care 
as an approach that involves a variety of healthcare practitioners, with complementary knowledge 
and skills and shared objectives. Key features of an interdisciplinary approach are joint problem-
solving, mutual responsibility and shared decision-making. In a multi-disciplinary approach, several 
practitioners are also involved; however, their approach is not integrated, but parallel, indicating 
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complementary goals (Turk et al., 2012). Schatman (2012) and Scascighini et al. (2008) conclude 
that an interdisciplinary team approach is more cost-effective and more effective to reach treatment 
goals, than treatment being given by a single practitioner. Schatman (2012) suggests that the core 
elements for an interdisciplinary approach to CMSP care include medication management, physical 
therapy, cognitive and behavioural therapy and stress management. The use of interdisciplinary care 
vs multi-disciplinary care in a healthcare system depends on organisational factors such as 
collaboration, healthcare system characteristics and resources available. For example, 
interdisciplinary care might not be possible in resource-constrained environments. The terms 
‘interdisciplinary’ and ‘multi-disciplinary’ seem to be used interchangeably in the literature. In this 
dissertation, I use both terms, staying true to which one authors have used in their study, ultimately 
indicating that multiple healthcare providers are involved in the patients’ care.  
A significant percentage of patients with CMSP are managed in PHC, as opposed to secondary and 
tertiary care (Gureje, Von Korff, Simon & Gater, 1998; Smith et al., 1999; Patel et al., 2008; 
Matthias et al., 2010), indicating the need for access to different professions in PHC to provide the 
core elements of pain management. PHC is provided in the community, addressing the health needs 
of the community within that community (WHO, 2008b). The components of PHC include 
community participation and empowerment while integrating preventative, promotive, curative and 
rehabilitation services. These components of PHC are congruent with the proposition that CMSP 
management should be multimodal and focus more on rehabilitative options, and less on curative 
management options as would be the case for acute pain (Smith et al., 1999; WHO 2007; Stein, 
Reinecke & Sorgatz, 2010). PHC appears to be ideally situated to deliver holistic care to prevent 
and manage CMSP. Consequently, PHC needs to be adequately resourced to deal with the service-
provision load associated with CMSP (Rauf et al., 2013).  
2.3 CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF 
CHRONIC MUSCULOSKELETAL PAIN  
The implementation of CPGs is one way of providing efficient, evidence-based options for the PHC 
management of CMSP. CPGs are defined as systematically developed recommendations that assist 
the practitioner and the patient in decision-making about health care for specific clinical 
circumstances (IOM, 2011). The recommendations in a good quality CPG is based on a systematic 
review of evidence and can provide information on the benefits and harms of interventions. CPGs 
summarise the extensive, published evidence for different interventions in a user-friendly form, 
making it easier for busy practitioners to apply evidence-based practice. The implementation of 
CPGs has been found to optimise patient care by improving the quality, consistency, 
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appropriateness and cost-effectiveness of care (Shaneyfelt, Mayo-Smith & Rothwangl, 1999; 
Graham et al., 2002; Vlayen et al., 2005). Furthermore, CPGs are important in influencing public 
healthcare policy and promoting equal healthcare distribution and quality healthcare for all (Woolf, 
Grol, Hutchinson, Eccles & Grimshaw, 1999; Qaseem, Forland, Macbeth, Ollenschlager, Philips & 
Van der Wees, 2012).  
2.3.1 The need for clinical practice guidelines on chronic musculoskeletal pain  
Contextually relevant, evidence-based and up-to-date CPGs for the primary care of CMSP may thus 
play an important role in translating research findings into clinical practice in order to optimise the 
health outcomes of patients with CMSP. The WHO (2007) has also prioritised the development of 
multimodal CPGs for the management of chronic non-malignant pain. In SA, two guidelines that 
focus on pain management in adults have recently been published.  The one guideline focuses on 
opioids for chronic non-malignant pain (Raff, Eppel, Meyer, Sarembock & Webb, 2014), and the 
other focuses on neuropathic pain (Chetty et al., 2012). However, these guidelines do not include 
the holistic management of CMSP in the SA context. Therefore, a CPG that focuses on inter-/multi-
disciplinary management of CMSP in the SA context is needed. Such a CPG would need to 
consider the uniquely SA needs, which may be coloured by socio-cultural, societal and policy 
factors that influence the experience and healthcare management of pain in this context. Grimmer-
Somers, Vipond, Kumar and Hall (2009) emphasise the importance of understanding the social-
cultural implications of interpreting pain experiences. Systematically integrating evidence-based 
practice with patient-centred care is an important consideration in resource-constrained 
environments such as those that are evident in Africa. 
2.3.2 Stakeholder values in clinical practice guideline development 
A patient-centred approach in the management of CMSP is essential, since individuals with chronic 
pain often perceive their condition to be neglected and not understood by medical practitioners 
(Upshur, Bacigalupe & Luckmann, 2010). A CPG that considers patients’ perspectives on CMSP 
may be the key to advancing patient-centred, relevant and holistic management of CMSP in PHC. 
Such an approach which takes cognisance of patient needs may contribute to patient satisfaction and 
improved clinical outcomes (Mead & Bower, 2000; Kidd, Bond & Bell, 2011). The consideration 
of patient values and preferences in CPG recommendations stems from the acknowledgement of 
patient autonomy and the patient-centred paradigm (Woolf, Schünemann, Eccles, Grimshaw & 
Shekelle, 2012). It is advocated that patient perspectives be considered when developing CPGs to 
ensure contextually relevant CPGs (Kredo, Gerritsen, Van Heerden, Conway & Siegfried, 2012). 
Several authors advocate the inclusion of patient values and preferences as part of CPG 
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development; however, this strategy has not been adopted by many guideline developers (Krahn & 
Naglie, 2008; Van der Weijden, Légaré, Boivin, Burgers, Van Veenendaal, Stiggelbout, Faber & 
Elwyn, 2010). Schünemann, Fretheim and Oxman (2006) and Hooten, Timming, Belgrade, Gaul 
and Goertz (2013) suggest the following ways to incorporate patient preferences in CPG 
development: 
 A literature search of patients’ preferences or patient preference-related evidence;  
 Patient or patient advocate participation in the guideline development group; 
 Key informant interviews and focus groups; 
 Environmental scanning through surveys; 
 Comments about CPG drafts and recommendations provided by patients or patient groups.  
In addition to patient involvement, policy makers and clinicians should also be involved in the 
process of CPG development to ensure that CPGs consider the needs of the target practitioners and 
patients (Kredo et al., 2012). Practitioner values play an important role in the healthcare decision-
making process. Involving target practitioners early in guideline development may assist in the 
identification of training needs, barriers to uptake, the relevant facilitators to uptake and it may 
instil a sense of ownership, which could facilitate the uptake of the CPG in the intended setting. 
However, as is the case with patient involvement, there is a dearth of literature on how practitioner 
values and preferences are incorporated in the guideline development process. In this study, the 
inclusion of patient and practitioner values and perspectives were regarded as important, as research 
about CPG development and implementation in this context is new.  
2.3.3 Development of clinical practice guidelines – De novo, adopt, adapt and contextualise 
Different options exist regarding development of CPGs, namely developing a new CPG (de novo), 
or adopting, adapting or contextualising existing CPGs. De novo development entails the sourcing 
and synthesising of primary and secondary evidence to create clinical recommendations. Adoption 
of a CPG is the acceptance of a guideline and its recommendations as a whole after the assessment 
of its quality, currency and content (ADAPTE II Collaboration, 2009). Adaptation of CPGs has 
been described as the modification of recommendations from one or more guideline(s) produced in 
one cultural or organisational setting and applying it in a different context (customising a 
guideline(s) to suit the local context) (ADAPTE II Collaboration, 2009). During contextualisation 
of a CPG(s), guideline recommendation(s) retains its form, and specific writing strategies are 
applied to facilitate the operationalisation of recommendations in the local environment (Gonzalez-
Suarez et al., 2012). Contextualisation is focused on ways to transform evidence recommendations 
into local practice by placing the recommendation within a suitable context (Gonzalez-Suarez et al., 
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2012). Contextualisation closely follows the adaptation process (see Appendix 4 for a comparison); 
and contextualisation may indeed be seen as a form of adaptation (Dizon, Machingaidze & 
Grimmer, 2016). However, with contextualisation, the intent is not to update or revise existing CPG 
recommendations (as is the case with adaptation). With contextualisation, congruent evidence-based 
recommendations from different high-quality CPGs are merged, and they are transformed into a 
representative version of the original recommendations. Contextualising CPGs has the advantage 
that it considers context-specific factors, local practice patterns and an authentic care pathway when 
writing the guideline recommendations. The process of contextualisation of CPGs arose from the 
realisation that guideline adaptation has been undertaken primarily in Western countries; and no 
framework existed to guide the use of Western guidelines in resource-limited low- and middle-
income countries with different healthcare systems, healthcare provider relationships, education, 
and patient needs.  
The decision to adopt, adapt or contextualise CPG recommendations is dependent on the local 
context and resources. The de novo development of CPGs is expensive, time-consuming and skill-
intensive. In resource-constrained environments, such as Africa, de novo CPG development may 
not be feasible. A viable option would be to adopt, adapt or contextualise existing CPGs for use in 
that context (ADAPTE II Collaboration, 2009; Gonzalez-Suarez et al., 2012). Considering the need 
for a CPG on CMSP in SA and the array of contextual factors that may influence optimum 
management of pain in the SA healthcare system, the contextualising process was indicated.  
2.3.4 The implementation of clinical practice guidelines  
The effectiveness of implementation and uptake of CPGs for CMSP are often questioned regarding 
their ability to influence behaviour change (change in practice patterns), patient outcomes and cost 
effectiveness of care. Three systematic reviews that investigated the impact of implementation 
strategies for LBP, neck pain and CMSP found variable results for the effectiveness of the 
implementation strategies (Ospina, Taenzer, Rashiq, MacDermid, Carr, Chojecki, Harstall & Henry, 
2013; Mesner, Foster & French, 2016; Suman, Dikkers, Schaafsma, Van Tulder & Anema, 2016). 
These authors made several suggestions to improve the effectiveness of complex interventions such 
as CPGs. The suggestions include: to make use of underpinning theory to support intervention 
strategies, to identify specific barriers and facilitators for implementation and address those in the 
implementation plan, to include patient mediated interventions, to follow best practice in design, 
conduct and reporting of implementation studies and to offer implementation strategies of long 
duration and increased frequency (Ospina et al., 2013; Mesner et al., 2016; Suman et al., 2016). 
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Implementation research is a new field of science, and development of this concept can influence 
the effectiveness of implementations strategies designed for CPGs. 
The concept of developing and implementing CPGs in the SA healthcare context is in its infancy.  
Two guidance initiatives, that concerns CMSP, has been successfully implemented in the SA public 
healthcare sector, namely the Standard Treatment Guidelines (STG) and Essential Medicines List 
(EML) for primary healthcare (developed by the National Department of Health, 2014); and the 
PACK (Practical Approach to Care Kit), developed by The Knowledge Translation Unit (2016) of 
the University of Cape Town, SA. 
The purpose of the primary care EML is to facilitate access to safe, efficacious and quality 
medicines, to facilitate equitable healthcare access in SA and to bring health care to communities 
(National Department of Health, 2014). The EML is a WHO concept whereby the list of medicines 
contained in the EML is selected according to the healthcare needs of a country, together with 
public health relevance, evidence on efficacy and safety and cost-effectiveness of the medication. 
The medicines in the EML are anticipated to be available in adequate amounts, in the appropriate 
dosage forms and at an affordable price (WHO, 2016). A range of conditions is covered in the 21 
chapters of the EML. Chapter 20.2 focuses on chronic non-cancer pain where guidance for essential 
medicines, dosages and treatment information for CMSP is provided. The EML recommends 
Paracetamol and/or NSAIDs (Non-steroidal anti-inflammatory drugs) for the management of 
CMSP.  Tramadol is the only opioid listed for the management of CMSP; and Amitriptyline can be 
used as an adjuvant (National Department of Health, 2014).  The EML is advocated to be the 
standard practice for the public sector but it is emphasised that this guidance should not replace 
sound clinical judgement.   
The Knowledge Translation Unit (2016) provides another guidance initiative for PHC in SA. This 
Unit uses the PACK to provide guidance to healthcare practitioners (particularly nurses and 
community care workers). PACK is described as a collection of policy-based and evidence-
informed guidelines on priority conditions seen in the SA PHC context (Fairall, Bateman, Cornick, 
Faris, Timmerman, Folb, Bachmann, Zwarenstein & Smith, 2015). PACK Adult covers 40 
symptoms and 20 chronic diseases through an algorithm and checklist approach, and there is 
evidence for its effectiveness to improve health outcomes and health systems strengthening (Fairall 
et al., 2015). Despite evidence of the high prevalence and associated morbidity of musculoskeletal 
conditions in PHC in SA (Mash et al., 2012; Global Burden of Disease 2015 Disease and Injury 
Incidence and Prevalence Collaborators, 2016), PACK Adult only contains information of arthritis, 
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gout, fibromyalgia and back pain. It would thus be ideal to include aspects of the CPG for CMSP in 
PACK Adult, since it is widely distributed in the public healthcare sector. 
Despite the uncertainties about the effectiveness of implementing CPGs, they have the potential to 
play an important role in providing guidance about management options. The section above 
discusses guidance initiatives that were successfully implemented in the SA context. However, as 
mentioned in section 2.3.1, two SA CPGs concerning chronic pain management exist, however no 
formal implementation strategy for its use in the public or private sector could be found.  It is 
hypothesised that a contextualised CPG for CMSP, with a relevant implementation plan, can be 
useful to influence evidence-based practice and enable effective decision-making towards providing 
person-centred care in busy clinics, such as in the SA PHC sector. 
 
2.4 HEALTH CARE IN SOUTH AFRICA 
2.4.1 The healthcare system 
The healthcare system is SA consists of a dual system of public and private health care. The public 
health system has undergone many changes since the demise of apartheid, and is currently in the 
process of healthcare reform to address inequities in the system and to provide quality care to all. 
Sixty-eight per cent of the SA population depends entirely on public sector health care which is 
funded by government tax; while 16% of the SA population makes exclusive use of the private 
sector; and 16% uses a dual system of state-provided specialist and in-patient services (Ataguba & 
Akazili, 2010). The transitioning public healthcare system in SA carries a high service load to 
provide health care to the population without health insurance.  
The public healthcare system in SA is organised in different parts. The emphasis of the public 
healthcare sector is on PHC and the district health system (Western Cape Government: Health, 
2014). PHC is an important point of access where a client makes first contact in seeking health care. 
In policy, there is an emphasis on disease prevention, health promotion and quality of healthcare in 
a re-engineered PHC system. The district health system is based on the principles of PHC, which 
consists of services rendered through home- and community-based care, in community health 
centres and clinics, and intermediate care (see Figure 2.1). Home and community based care 
provides care in living, working and recreational spaces, with a focus on prevention and health 
promotion. Community health clinics are clinics situated in a community, staffed by nurses, with 
support services from community health centres, such as visiting doctors and rehabilitation staff; 
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while community health centres are located in towns and are staffed by a team of doctors, 
pharmacists, radiographers and physiotherapists (Mash et al., 2012). In the SA context, the public 
sector primary care services are nurse-led; with nurses being the first line practitioners, supported 
by medical doctors and family physicians. Nurses therefore assess patients and refer patients to the 
doctor when necessary (Mash et al., 2012). Intermediate care entails transitional care to facilitate 
seamless transition between acute care and home care; and therefore focusses on supported 
discharge (Western Cape Government: Health, 2014). The re-engineering of PHC is strengthened 
by the Healthcare 2030 framework of the Western Cape Government. The Healthcare 2030 
framework builds on several other policies and frameworks within the national and international 
context (Western Cape Government: Health, 2014). This framework indicates the vision, values and 
principles that guide the Department of Health (Box 1). The focus of Healthcare 2030 is on 
wellness as opposed to illness, including the patient experience (patient-centredness), staff wellness 
and the impact of the social determinants of health. 
 
 
 
Figure 2.1: Service delivery platform for Healthcare 2030 (figure used with permission) 
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Box 1: The vision, values and principles for Healthcare 2030 (Western Cape Government: 
Health, 2014) 
Healthcare 2030 
Strategic framework 
 
Vision: Access to person-centred, quality care  
Values: Caring, Competence, Accountability, Integrity, Responsiveness and respect (C
2
AIR
2
) 
Principles: 
1. Striving for person-centred care 
2. Adopting an outcomes-based approach 
3. Commitment to the PHC philosophy 
4. Strengthening the district health system model 
5. Promoting equity 
6. Operating with efficiency 
7. Developing strategic partnerships 
2.4.2 Challenges of health care provision in South Africa 
The PHC sector is fundamental in providing accessible and affordable health care to all (WHO, 
2008b). As a transitioning system, the PHC sector in SA is faced with several challenges such as a 
lack of resources, infrastructure and staff shortages. Coovadia et al. (2009) contend that health 
reform in SA has not yet reached adequate levels of implementation, despite good healthcare 
policies. The lack of implementation of aspects of key healthcare policies has been attributed to 
human resource challenges and management inadequacies (Coovadia et al., 2009). The 
implementation of key healthcare policies is essential to provide quality health care. 
The Western Cape Department of Health faces several challenges to deliver quality PHC. The 
increasing volume of people who require healthcare pose a major challenge to providing healthcare 
(Western Cape Government, 2014). Data from the Statistics South Africa National census (2011) 
reports the migration pattern of an influx of people to the Western Cape since 2001, whereby people 
migrate from other provinces to seek employment and health care in the Western Cape. The 
increasing numbers are believed to lead to increased financial costs, staff shortages and an 
overloaded PHC system with increased waiting times to receive health care.  
SA’s quadruple burden of disease (discussed in Chapter 1), poses another challenge for the 
provision of quality health care. The increase in the prevalence of chronic diseases in SA can be 
attributed to the increased life expectancy with HIV/AIDs and to ageing (Mash et al., 2012; Ortblad 
Lozano & Murray, 2013). This phenomenon is likely to increase the pressure on PHC services, to 
cope with the growing burden of chronic diseases (Mayosi et al., 2009; Kautzy & Tollman, 2008). 
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Kautzy and Tollman (2008) propose that new models and approaches to PHC delivery are 
warranted to accommodate the changing disease profile; which necessitates a change in focus from 
acute to chronic care provision. The Healthcare 2030 framework (Western Cape Government: 
Health, 2014) acknowledges this challenge to change and proposes the renewed focus on PHC and 
promotion of wellness as solutions. The Global Burden of Disease study 2013 Collaborators (2015) 
support the notion of a rise in the burden of chronic diseases and the need for changed healthcare 
systems to accommodate the non-fatal dimensions of disease and injury. 
The recent global burden of disease study (Global Burden of Disease 2015 Disease and Injury 
Incidence and Prevalence Collaborators, 2016) highlight disability resulting from musculoskeletal 
disorders and mental disorders, substance abuse disorders and other non-communicable diseases 
and HIV/AIDs in sub-Saharan Africa. LBP, neck pain and major depressive disorder were found to 
be the leading causes of YLD. In the global ranks for top 25 causes of YLD, LBP was ranked as 
first, neck pain was fourth, other musculoskeletal was tenth, and osteoarthritis thirteenth (Global 
Burden of Disease study 2013 Collaborators, 2015). Additionally, the burden of musculoskeletal 
disability in developing countries was estimated to be 2.5 higher than in developed countries 
(Adebajo & Gabriel, 2010). The Global Burden of Disease study 2013 Collaborators (2015) point 
out that the burden of musculoskeletal disorders is much more that what was previously estimated. 
However, despite the clear message contained in the YDLs, musculoskeletal conditions are not 
priority non-communicable disease in SA, which indicates that a change in healthcare focus and 
planning is pertinent to address the burden associated with it. The knowledge about the burden of 
disease should drive healthcare policy to equip healthcare systems to address CMSP as a key 
healthcare issue. The challenge in the SA context is to provide quality evidence-based care for 
CMSP amidst the current health care challenges. 
2.5 CHAPTER SUMMARY 
The information contained in this chapter illustrates the need for cost-effective and evidence-based 
management options to address the burden of CMSP in SA primary care settings. The use of 
guidelines to support efficient, best practice was discussed. The use of contextualisation of existing 
international guidelines in this regard was explored. Additionally, the need to include stakeholder 
perspectives in the development of guidelines was emphasized.  
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PART 1: UNDERSTANDING THE CONTEXT  
INTRODUCTION 
This first part of the dissertation describes two qualitative studies that investigated contextual 
factors influencing the PHC of CMSP as experienced by a sample of patients suffering from CMSP 
(Chapter 3) and healthcare practitioners caring for patients with CMSP (Chapter 4). The 
International Classification of Function (ICF) (WHO, 2002, 2013) describes functioning and 
disability as outcomes of interactions between the health condition and contextual factors 
influencing a person. Contextual factors comprise personal and environmental factors. Personal 
factors include individualistic features, e.g. gender, age, coping styles, social background, 
education, profession, past and current experience, overall behaviour patterns and character. The 
environmental factors are described as the physical, social, legal, external and attitudinal 
environment in which people live and conduct their lives. In this study, knowledge about the 
contextual factors was important in attempting to discover the interaction between the individual, 
the practitioner, the healthcare sector and the societal environment that could influence the 
provision of chronic pain care (Kagee, 2004). Kagee (2004) advocates gaining a rich understanding 
of the contextual realities of persons living with chronic illness to understand barriers to, and the 
facilitators of health care. 
An understanding of patients’ perspectives can inform the content of management programmes to 
be person-centred, holistic, innovative, contextually relevant and culturally acceptable. There is a 
scarcity of research on patients’ perspectives on CMSP in Africa. Five recent systematic reviews on 
qualitative studies about patient perspectives of CMSP highlight the scarcity of research regarding 
CMSP and its management in the African context (Parsons et al., 2007; Bunzli, Watkins, Smith, 
Schütze & O’Sullivan, 2013; Snelgrove & Liossi, 2013; Toye, Seers, Allcock, Briggs, Carr, 
Andrews & Barker, 2013; MacNeela, Doyle, O’Gorman, Ruane & McGuire, 2015). Only one SA 
study was included (Snelgrove & Liossi, 2013). However, four other African qualitative studies 
focusing on chronic pain was identified during the literature search. Parker, Burgess, Dubaniewicz, 
Gouws, Krone, Madden, Nortje & Parsons (2009) investigated patient satisfaction with a chronic 
pain management programme in SA tertiary care; Wade & Shantall (2004) and Ernstzen, Louw & 
Hillier (2016) studied the lived experiences of a small group of SA patients with chronic 
pain/CMSP; Igwesi-Chidobe, Kitchen, Sorinola & Godfrey (2016) studied the experiences of 30 
individuals with chronic LBP in rural contexts in Nigeria. Therefore, there is a need for more 
Stellenbosch University  https://scholar.sun.ac.za
 19 
qualitative research regarding CMSP in the African context, to discover the impact of chronic pain, 
its management and the contextual factors that influence it.  
Healthcare practitioners are at the forefront of assessing and making decisions about the 
management of musculoskeletal conditions. There is an increasing need to include practitioners in 
the CPG development process, to represent the needs of the practitioners (Kredo et al., 2012). It is 
common practice for healthcare practitioners to be represented in CPG development teams. 
However, in Chapter 4 a different approach is taken, by studying their practitioners’ perspectives at 
the commencement of CPG development. This approach was needed to obtain a portrayal of the 
authentic circumstances within which practitioners provide care. Furthermore, several authors agree 
that practitioners’ perspectives influence their clinical reasoning and treatment choices (Daykin & 
Richardson, 2004; Matthias et al., 2010; Allegrettia, Borkana, Reisa & Griffiths, 2010; Jeffrey & 
Foster, 2012). Exploring practitioners’ perspectives may assist in identifying contextual factors that 
play a role in pain care, including requirements regarding guideline content, lay-out, educational 
needs and potential barriers to the CPG development and facilitators in this process.  
The findings of the studies referred to in Part 1 (Figure Part1a) were combined in a contextual 
framework shown at the end of Part 1 (Figure Part1b), to triangulate the information and to provide 
a comprehensive outline of contextual factors that were nominated by participating patients and 
practitioners.  
 
 
 
 
 
 
 
 
 
Figure Part1a: Outline of part A: Understanding the context 
 
PART A 
The context  
 
Chapter 3: 
Patient perspectives 
Chapter 4: 
Practitioner 
perspectives 
Framework of 
contextual factors 
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CHAPTER 3  
PATIENTS’ PERSPECTIVES ABOUT CHRONIC 
MUSCULOSKELETAL PAIN AND ITS PRIMARY 
HEALTHCARE MANAGEMENT  
3.1 RESEARCH QUESTION  
The research question for this part of the research project was formulated as follows: 
What are patients’ perspectives about their chronic musculoskeletal pain and its primary healthcare 
management in the South African context, in particular their pathway of care and the factors that 
have an impact on their pain experience and management?  
3.1.1 Objectives 
The objectives were to discover the experiences and perspectives of patients with CMSP about PHC 
management. The focus was on the following:  
 To provide a demographic profile of the participants, to aid understanding of their views. 
 The reported pathway of care (patient journey) and practitioners involved.  
 The impact of pain on the individual. 
 Patients’ views on management interventions. 
 The contextual factors that can be barriers to pain management and the facilitators in the 
PHC of CMSP. 
3.2 METHODS  
3.2.1 Study design 
An exploratory, descriptive, qualitative study was conducted, using an interpretive research 
paradigm and phenomenological approach, to study the lived experiences of patients with CMSP 
(Pope & Mays, 2006). This approach was chosen to develop an understanding of how participants 
conceptualise their pain and to explore participants’ personal contexts and how these influence 
CMSP and its PHC management.  
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3.2.2 Study setting 
The study was conducted in the Western Cape, which is one of the nine provinces in SA. The 
Western Cape is situated at the most southern part of the African continent, and houses about 11% 
of the SA population (Figure 3.1). Three community health centers/clinics in the public healthcare 
sector in the Western Cape were strategically chosen as study sites, based on their geographical 
location according to Cape Town Census (2011), the City of Cape Town, Strategic Development 
Information and Geographic Information System Department (SDI&GIS) (City Statistics and 
Population Census, 2013) and the Western Cape Profile (Western Cape Government, 2012). Clinics 
that offer rehabilitation services were included to offer a multi-professional perspective. The three 
clinics represented different settings namely a rural, a semi-urban and a township setting which 
allowed for diversity in language and culture of the potential sample. The three dominant languages 
spoken in the Western Cape is Afrikaans (50%), isiXhosa (25%) and English (20%). All three 
locations were resource-constrained (low socio-economic settings), and the dominant occupations 
practiced were of physical nature, for example agriculture, production (factories) and domestic 
assistance. Appendix 5 provides more information on the population characteristics of the 
communities served by the three selected clinics. 
 
Figure 3.1: Map of South Africa (http://www.southafrica.to/provinces/provinces.htm) 
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3.2.3 Population and sample 
Inclusion and exclusion criteria 
The population was comprised of adults with CMSP who presented for PHC management at the 
clinics. Purposive (strategic) sampling in the form of criterion sampling was used to ensure 
maximum exposure to key variables (Palys, 2008). These key criteria linked to the study objectives 
and included: 
 Musculoskeletal pain;  
 Persistent pain for longer than three months in duration;  
 Language: any of the three prevalent languages in the Western Cape, namely Afrikaans, 
English and isiXhosa (Western Cape Government, 2012); 
 Gender: males and females, taking into consideration that chronic pain is reported to be 
more prevalent in females (Demyttenaere et al., 2007); 
 Age: adults between 18 and 85 years, based on the age range of patients that have already 
participated in SA chronic pain prevalence studies (Igumbor et al., 2011; Rauf et al., 2013; 
Major-Helsloot et al., 2014); 
 Diverse cultural grouping: research on ethno-cultural influences on pain is in its infancy. 
Insufficient evidence exists to confirm that culture alone influences pain experience. 
Gender, education, religion, communication and locus of control play a role (Mailis-
Gagnon, 2010); 
 Received PHC in the SA public health sector.  
Persons with chronic pain from non-musculoskeletal origin were not eligible to participate, for 
example, cancer pain, neuropathic pain or sickle cell anemia. This exclusion criterion was set as 
these types of chronic pain have different pathological processes, clinical symptoms and 
management processes, which could lead to different patient perspectives. Another exclusion 
criterion was inability to participate in interviews, e.g. as a result of aphasia or dementia. 
Sample size 
Starks and Trinidad (2007) advise that a typical sample size for a phenomenological study can 
range between one and ten participants to identify the core elements of the phenomenon. However, 
sample size is tied to the objectives of the study and may depend on resources and time available 
(Ritchie, Lewis & Elam 2003; Palys, 2008). Six to ten participants per clinic were recruited. This 
number was thought to be adequate to provide sufficient diversity, identify core elements of the 
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phenomenon and to provide adequate answers for the research question. The intention was to recruit 
more participants if data saturation were not achieved. This is similar to studies that used individual 
interviews with 20 to 25 patients with chronic pain (Morden, Jinks & Ong, 2014; Cooper, Blair, 
Smith & Hancock, 2009, Allegrettia et al., 2010; Kenny, 2004).  
3.2.4 Instrumentation  
Semi-structured individual interviews 
Semi-structured individual interviews were conducted, due to the possibly sensitive nature of the 
information. An interview schedule was developed (Appendix 6), based on the study objectives and 
the literature reviewed (Harding, Parsons, Rahman & Underwood, 2005; Cooper et al., 2009; 
Allegrettia et al., 2010; Crowe, Whitehead, Gagan, Baxter & Panckhurst, 2010; Upshur et al., 2010; 
Matthias et al., 2010; Igwesi-Chidobe et al., 2016). The topics in the interview schedule were 
participants’ narrative (story) about pain, the influence of pain on life, their healthcare pathway, and 
their perspectives on health care and further suggestions for health care. A pilot study was 
conducted, to refine the interview schedule and methodological aspects of recruitment and 
interviewing. The interview schedule was adapted to include more specific probing questions 
regarding contextual factors as well as coping strategies. The principal investigator (PI) conducted 
the interviews in Afrikaans and English, as she is proficient in both languages. A research assistant, 
a trained interviewer proficient in isiXhosa, was sourced from the Centre for Research on Health 
and Society, Stellenbosch University, to conduct the interviews with first-language isiXhosa 
participants. The PI orientated the assistant to the study and the aims of the interview, and the 
assistant attended one interview as an observer.  
Questionnaires 
Participants were requested to complete three short questionnaires after the interviews. The 
questionnaires as well as more information on their psychometric properties are presented in 
Appendices 7-9). The information obtained from the questionnaires was used to profile the 
participants and to triangulate with qualitative data.  
- General information questionnaire 
This form was developed by the PI based on previous SA studies on chronic pain (Morris, 2013; 
Igumbor et al., 2011), and had three parts: socio-demographic information, pain information and 
healthcare-related information (Appendix 7). Questions included, age, gender, family, work status, 
pain area, pain intensity, health providers consulted, medications used and general health. Current 
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pain intensity and average pain intensity for three months were measured using the numeric pain 
rating scale (NPRS). The NPRS is a simple, validated, self-report/practitioner-administered 
measurement tool for pain intensity. It consists of a line with a numerical point scale with two 
anchors, with 0 representing no pain and 10 representing extreme pain (Kahl & Cleland, 2005). The 
respondent is asked to rate his/her pain intensity on the scale.  
- The Kessler psychological distress scale  
The Kessler psychological distress scale (K10) is a simple, brief, valid and reliable mental health 
scale designed to screen for psychological distress; primarily mood, anxiety and depression that a 
person has experienced in the last four-week period (Kessler, Andrews, Colpe, Hiripi, Mroczek, 
Normand, Walters & Zaslavsky, 2002; Andrews & Slade, 2001; Cornelius, Groothoff, Van der 
Klink & Brouwer, 2013) (Appendix 8). The wording is appropriate for moderately literate 
individuals. The 10-item scale has five response categories, from 1 (none of the time) to 5 (all of the 
time). The score is calculated as the sum of the responses to the 10 items (out of 50). The K10 has 
been proposed as the standard screening tool for mental illness at primary care level in the SA 
setting (Spies, Stein, Roos, Faure, Mostert, Seedat &Vythilingum, 2009). The K10 was widely used 
and studied in the SA context (Myer, Stein, Grimsrud, Seedat & Williams, 2008; Kuo & Operario 
2011; Spies et al., 2009; Anderson, Grimsrud, Myer, Williams, Stein & Seedat, 2011). Anderson et 
al. (2011) evaluated the performance of the K10 in screening for depression and anxiety in a multi-
cultural SA population, using the translated versions of the K10 in English, Afrikaans, isiZulu, 
isiXhosa, Northern Sotho and Tswana. For the purposes of the current study, the Afrikaans and 
isiXhosa K10 versions were sourced from Anderson et al. (2011).  
The interpretation of the K10 is guided by its cut-off scores. Cornelius et al. (2013) found the cut-
off score to be 24 in Dutch disability claimants, while Andrews and Slade (2001) developed the 
following cut-off scores from an Australian population health survey for PHC:  
 Scores under 20 are likely to be well.  
 Scores 20-24 are likely to have a mild mental disorder.  
 Scores 25-29 are likely to have moderate mental disorder.  
 Scores 30 and over are likely to have a severe mental disorder. 
Scores usually decline with effective treatment. Patients whose scores remain above 24 after 
treatment should be reviewed and specialist referral considered.  
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- The Pain Disability Index 
The Pain Disability Index (PDI) is a self-report instrument to assess the degree to which chronic 
pain interferes in a person's ability to engage in various life activities (Pollard, 1984; Chibnall & 
Tait, 1994) (Appendix 9). It consists of seven categories of life activity in two factors:  
 Factor 1 measures voluntary activities (items 1-5, family/home responsibilities, recreation, 
social activity, occupation, and sexual behaviour).  
 Factor 2 measures obligatory activities (items 6 and 7; self-care and life support activity). 
Participants rate their level of disability on a graphic rating scale ranging from 0 (no disability) to 
10 (total disability). This questionnaire is a simple, easy to comprehend, rapid (1-2 minutes), valid 
and reliable instrument (Tait & Chibnal, 2005; Soer, Reneman, Vroomen, Stegeman & Coppes, 
2012). An overall disability score is determined by summing the numerical ratings of the seven 
categories (out of 70). The higher the index out of 70, the greater the person’s disability due to pain. 
No cut-off scores apply.  
The PDI was used in this study as it is not restricted to a condition or body area and can be used to 
evaluate pain-related disability in multiple pain conditions (Tait & Chibnal, 2005). Furthermore, 
assessment of functional ability is a crucial element of chronic pain assessment (Cieza, Stucki, 
Weigl, Kullmann, Stoll, Kamen, Kosrtanjsek & Walsh, 2004).  
Translation of the interview schedule and questionnaires 
The interview schedule and questionnaires were available in English, Afrikaans and isiXhosa and 
were translated from English to Afrikaans and isiXhosa by the SU Language Centre. The translation 
in Afrikaans was verified by the PI, while the translation in isiXhosa was further checked and 
refined by the research assistant. 
3.2.5 Procedures 
The PI contacted the clinic manager and requested permission to visit the clinic and recruit patients. 
Clinical nurse practitioners and/or rehabilitation professionals at clinics were requested to identify 
eligible patients from their register who had visited the clinic in the prior six months (Ritchie et al., 
2003). A list of the inclusion and exclusion criteria was provided. The clinicians informed eligible 
patients about the study and asked permission to be referred to the PI. The clinicians provided the 
researcher with the names and contact details of patients who agreed. The PI contacted the eligible 
patients, informed them about the study aim and procedures, and invited them to participate in the 
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interviews. The PI/assistant gained permission to access the patients’ medical records at the clinic, 
to apply the inclusion and exclusion criteria. Interviews were conducted at a time and place 
convenient for the interviewees. Interviews took place in a private room in participants’ homes, 
places of work and where indicated at the clinics, to allow for a natural setting considering factors 
such as patient preference, interviewer safety, presence of family members and physical space 
(Britten, 2006).  
Prior to the interview, the PI/assistant gained written informed consent for participation (Appendix 
10). Each interview lasted approximately 20-40 minutes and was recorded on a digital voice 
recorder. After the interview, the participants completed the three short questionnaires. Participants 
who were unable to read and/or write were assisted by the PI/assistant to complete the 
questionnaires. The researcher documented field notes on general aspects such as atmosphere, 
comfort and additional information that could inform/shape further data collection (Pope, Ziebland 
& Mays, 2006). Participants were reimbursed for their time and/or travel expenses (R100). 
3.2.6 Data management  
The digital voice recordings were downloaded to the PI’s personal computer and allocated a unique 
serial number. IsiXhosa interviews were translated into English by the assistant who conducted the 
interviews, to provide in-context translation and to remain true to the personal nuances that were 
communicated. Translations were done shortly after the interview, and involved the research 
assistant listening to the original interview recording, and typing a translated version. An 
independent, professional transcription company transcribed the English and Afrikaans interviews. 
The PI authenticated each transcription by verifying it with the recording and correcting any 
discrepancies. An external audit of one of the isiXhosa translated interviews was done, to confirm 
authenticity. Selected member checking was done to assist with validation, by presenting data to 
individual participants (three participants) and a representative group at the relevant health care 
centres. The representative groups were current chronic pain rehabilitation groups.  This approach 
was taken due to the inability to secure appointments with participants. A summary of the data was 
presented to provide a holistic overview of all themes.  Members could confirm or refute relevant 
themes. 
The data from the questionnaires were scored by the PI, captured on Excel for analysis and verified 
by a research assistant.  
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3.2.7 The role of the researcher in the research process 
The positionality of the researcher forms an integral part of the research process. Data collection 
and analysis are influenced by the personal characteristics of the interviewer (age, occupation, 
gender and social distance) (Britten, in Pope & Mays, 2006; Karnieli-Miller, Strier & Pessach, 
2009). The PI introduced herself as a researcher and student. Some participants enquired about her 
profession and thus knew that she was a physiotherapist. This knowledge could have influenced the 
participants’ responses. The researcher has worked in private and public healthcare settings, at both 
primary and tertiary healthcare level, and has experience in the academic setting, which could have 
influenced her interpretation of the data. The researcher has experience in qualitative research, and 
underwent training in qualitative methods, including interviewing skills, to prepare for data 
collection and analysis.  
The isiXhosa research assistant was a male, who was trained as a qualitative research assistant and 
had been involved in numerous qualitative health studies. He interviewed one male and four female 
first language isiXhosa-speaking patients. It is acknowledged that the gender difference might have 
influenced the level of disclosure. 
Qualitative research involves power relations (Karnieli-Miller et al., 2009). In the case of 
interviews, the interviewer and interviewee are involved in the process of power interchange, which 
entails continuous establishing of boundaries and negotiation of power. Power interchange included 
the researcher requesting the participants’ consent to participate. The interviews were done in the 
participants’ preferred setting, which were unfamiliar settings for the researcher. The researcher 
built rapport and trust at the start of the interview, emphasising the contribution of the participant 
and communicating the researcher’s wish to hear the participant’s story. It was envisaged that a 
trusting relationship would ease communication, leading to open communication and 
approachability. 
3.2.8 Data analysis 
Inductive, thematic, content analysis of the interview transcripts using the framework method was 
undertaken (Gale, Heath, Cameron, Rashid & Redwood, 2013; Pope & Mays, 2006; Hsieh & 
Shannon, 2005). Qualitative content analysis focuses on the characteristics of language as 
communication with attention to the content and contextual meaning of the text (Hsieh & Shannon, 
2005). Content analysis aims to explore and understand a phenomenon. Knowledge is generated 
based on the participants’ unique perspectives and is grounded in the actual data. The framework 
method was used as a rigorous, transparent and systematic way to explore data, and draw 
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descriptive or explanatory conclusions (Gale et al., 2013; Spencer, Ritchie, & O’Connor, 2003). 
Using this approach, a framework is used to organise data into themes, concepts and categories, 
while being embedded in the actual data (Spencer et al., 2003). 
The data were analysed using Computer Assisted Qualitative Data Analysis Software (Atlas.ti, 
version 7) (http://atlasti.com/). Data analysis involved an iterative process of immersion in the data; 
familiarising self with the data; highlighting significant statement (quotes); creating a codebook; 
coding the data; developing clusters of meaning (categories); sorting categories based on their 
relations and linkages; and establishing themes (Pope et al., 2006). This process was followed by 
interpretation and additional validation of data. The PI and a second research assistant (a medical 
anthropologist), studied a selection of six of the transcripts and independently coded them. These 
codes were compared, discussed and merged to create a codebook. Thereafter, the PI independently 
coded the data according to the codebook, created new codes where necessary and revisited the data 
to check accuracy as part of validity checking. Analytical memos were made in Atlas.ti to track 
decisions made during data analysis process. Categories were formed by using patterns within the 
data. These categories were explored for their possible relationships. Categories were reorganised 
into themes, and relationships between categories and between themes were explored (Pope et al., 
2006). This analysis was done in the language in which the transcript was presented (English or 
Afrikaans). The Afrikaans quotes were subsequently translated by the PI for this dissertation and to 
enable auditing by the research supervisors and research assistant. Appendix 11 and 12 provide the 
codebook and examples of translated quotes. 
The questionnaire data were recorded and analysed in a purpose-built data collection sheet in MS 
Excel and were conveyed as frequencies, proportions and percentages. Ordinal data was 
summarised using the median and interquartile range (IQR); while interval data was summarised 
using the mean and standard deviation (SD), to indicate the central tendency and level of dispersion 
(Kirkwood & Sterne, 2003). 
3.2.9 Qualitative quality criteria 
The research adhered to the applicable quality criteria for qualitative research, highlighted by 
Frambach, Van der Vleuten & Durning (2013). Credibility was ensured using multi-level 
triangulation consisting of multiple data sources: three different community health clinics, multiple 
methods (interviews and questionnaires) and theory triangulation (different underpinning theories). 
Data were collected from October 2014 to April 2015, which indicates prolonged engagement. 
Member checking was done by presenting analysed data to individual participants and 
representative groups. Transferability was attended to through the sample strategy and the 
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description of context. Attention was given to dependability through iterative data collection and the 
analysis strategy. Theoretical data saturation was reached on the features of the research question; 
however, full data saturation was not reached on all characteristics identified by participants. To 
obtain full data saturation on all topics discussed by patients would require theoretical sampling for 
different groups or cases and additional data would have to be collected. However, this was not 
indicated due to the focus of this study, and also not possible due to time and resource constraints. 
Conformability was attended to by discussing the findings within the context of current literature, 
by peer debriefing, by acknowledging the researcher’s role and through the documentation of 
decisions in Atlas.ti. Additionally, data and findings were audited to ensure accuracy of data and 
valid interpretation of findings. Data was audited by member checking, external auditing by the 
supervisors, research assistants and external audiences (conferences and peer group discussions). 
3.3 RESULTS 
Twenty persons with CMSP participated in the study. The results section presents the quantitative 
data, followed by the qualitative data. All patients who were invited agreed to participate. However, 
several listed patients was not contactable due to invalid telephone numbers. All except one 
participant gave informed consent for the conversation to be recorded. However, this participant 
wanted to tell his story. The PI thus made notes during the interview (Participant 12). The same 
participant also declined to complete the outcome measure questionnaires. 
3.3.1 Quantitative results 
The data derived from the questionnaires are presented to profile the participants. The participants’ 
demographic information, pain information, scores for psychological distress (K10) and disability 
(PDI) are included in Table 3.1. Table 3.2 summarises information on diagnosis and health care 
received. Figures 3.2 report on the body locations of pain and Figure 3.3 provides information on 
participants’ on self-reported comorbidities.  
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Table 3.1: Profile of the participating patients with chronic musculoskeletal pain 
Variable  
Number 
(n=20) 
% Mean (SD) 
Geographical location 
Urban  
Rural 
Urban township 
 
8  
6  
6  
 
40 
30 
30 
 
Gender 
Female  
Male  
 
15  
5  
 
75 
25 
 
Language  
Afrikaans 
isiXhosa  
English 
 
13  
6  
1  
 
65 
30 
5 
 
Age (years) 
<20 
20 – 30 
31 – 40 
41 – 50 
51 – 60 
61 – 70 
71 >  
 
0 
0 
0 
6  
8  
5  
1  
 
0 
0 
0 
30 
40 
25 
5 
57 (9.6) 
Ethnicity 
Coloured 
Black 
White  
 
9  
7  
4  
 
45 
35 
20 
 
Marital status 
Married 
Widowed  
Single 
Divorced  
In relationship 
 
11 
3  
3  
2  
1  
 
55 
15 
15 
10 
5 
 
Number of children 
0 
1 – 3 
4 – 6 
>6 
 
3  
13 
4  
0 
 
15 
65 
20 
0 
 
Employment 
Full-time employment  
Retired/Pensioner 
Unemployed 
Disability grant 
Home executive 
 
7 
6  
5  
1 
1 
 
35 
30 
25 
5 
5 
 
Occupation (past/present) 
Domestic worker  
Industry 
Office worker  
Homemaker  
Production  
Baker  
Farm worker  
 
6 
4 
3 
2 
2 
1 
1 
 
30 
20 
15 
11 
11 
5 
5 
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Variable  
Number 
(n=20) 
% Mean (SD) 
Petrol attendant 1 5 
Highest educational level 
Primary school 
Secondary school 
Tertiary education 
 
11 
8  
1 
 
55 
40 
5 
 
K10
a 
< 10 
10 – 19  
20 – 24 (mild) 
25 – 29 (moderate) 
30 – 50 (severe) 
 
0 
11  
2  
3  
3  
 
0 
58 
11 
16 
16 
20 (8.22) 
PDI
a 
0 – 20 
21 – 40 
41 – 60 
61 – 70  
 
6  
10  
3  
0 
 
31 
53 
16 
0 
27 (11.7) 
 
Pain duration
a 
< 1 year 
1 – 5 years 
6 – 10 years 
>10 years 
 
1 
11 
2  
6  
 
5 
58 
11 
31 
 
 
Pain intensity today (NPRS)
a,b 
Mild pain: 0 – 3 
Moderate pain: 4 – 6 
Severe pain: 7 – 10 
 
9 
3 
7 
 
47 
15 
38 
Median (IQR): 5 (6.5)  
Pain intensity average (NPRS)
a,b 
Mild pain: 0 – 3 
Moderate pain: 4 – 6 
Severe pain: 7 – 10 
 
2 
6 
11 
 
10.5 
32.5 
58 
Median (IQR): 8 (4) 
Worst pain
a,b   Median (IQR): 10 (2) 
Least pain
a,b   Median (IQR): (3) (4) 
a
One missing data score) 
b
NPRS = Numeric Pain Rating Scale out of 10 
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Figure 3.2: Reported prevalence of pain in different body locations (n = 20) 
 
Figure 3.3: Self-reported prevalence of comorbidities (n =20) 
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Table 3.2: Patient-reported healthcare management  
Pain information Number (n=20) % 
Pain diagnosis provided 
Osteoarthritis 
Disc lesion 
No diagnosis 
Rheumatoid Arthritis 
Other  
(More than one option possible) 
 
6  
5  
4  
3  
3  
 
30 
20 
20 
15 
15 
Pain medication 
Paracetamol 
NSAIDs 
Opioid (Tramadol) 
Tricyclic antidepressants 
Muscle relaxant 
 
12  
8  
8  
2  
2  
 
60 
40 
40 
10 
10 
Healthcare providers in journey 
Medical doctor 
Nurse 
Physiotherapist 
Occupational therapy 
Orthopedic doctor 
Neurosurgeon  
Occupational health doctor 
Psychologist  
Psychiatrist 
Rheumatologist 
 
20  
18  
18  
5  
4  
3  
3  
2  
1  
1  
 
100 
90 
90 
25 
20 
15 
15 
10 
5 
5 
 
3.3.2 Qualitative results 
The interviews provided a rich and extensive data set as participants shared their stories.  
Table 3.3 provides an overview of the major themes and categories that emerged. The participants 
highlighted several factors that influenced their pain experience, namely individual factors, 
healthcare management factors, the healthcare system and socio-environmental factors. The 
relevant strongest themes and categories are discussed in the sections below. Verbatim quotes are 
provided and referenced by indicating the participant number, age and description of condition (e.g. 
P1, 47y, LBP Sciatica). Where indicated, quotes were translated form Afrikaans to English for the 
purpose of the report. Examples of translated quotes are as available in Appendix 12. 
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Table 3.3: Major themes and categories that emerged from the interviews 
Theme 1:  
Individual factors 
Theme 3:  
Healthcare system factors  
Beliefs about chronic musculoskeletal pain 
 Knowledge and understanding of pain 
 Biomedical beliefs 
Impact of chronic pain  
 Movement and function 
 Emotions 
 Relationships  
 Participation  
Coping with chronic pain  
 Active or passive coping strategy 
 Spirituality 
 Resilience  
 Acceptance  
Stress response 
Pathway of care (patient journey) 
 Private and/or public sector usage 
Waiting time/Waiting lists 
Continuity of care 
Regularity of care 
Patient interaction with healthcare system 
 Satisfaction with care  
 Understanding the system 
Access to care/Access to rehabilitation 
System load 
Theme 2:  
Healthcare management/intervention factors 
Theme 4:  
Societal and occupational factors 
Practitioner messages 
Access to inter-/multi-disciplinary care 
Pharmacological management 
 Effectiveness of analgesia 
 Beliefs about analgesia 
 Adherence to prescribed medication 
Self-medication/use of traditional medicines 
Non-pharmacological management 
 Effectiveness of exercise/other therapies  
 Beliefs about exercise and other therapies 
Advice and education 
Treatment goals 
Family 
 Family support 
 Concerns about family 
Financial circumstances 
Occupational influences 
Personal loss/stress 
Community influence 
 E.g. drug abuse, violence, gangsterism 
 
3.3.2.1 THEME 1: Individual factors 
- Beliefs about pain 
The participants’ understood their pain through a biomedical (structural) model that appeared to 
strengthen their belief for further investigations. Events related to the start of pain were thought to 
be linked to type of occupation and ergonomic factors. Participants indicated a partial understanding 
of their condition and had many unanswered questions. It was reported that these knowledge gaps 
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created anxiety and uncertainty while the acquisition of knowledge created a sense of control over 
the condition. 
They say it is because I am a machinist. They say it is a general problem. Your lower back will 
be painful, because you are sitting bent forward the whole day. You are not sitting correctly. 
You sit as it is comfortable for you to sit behind the machine and do your work. (P1, 47y, LBP 
leg pain) 
And the X-rays showed that there are cushions in my back. They told me that those cushions 
were damaged. I don’t know what is pressing on my nerve, so they say. That is why my back 
pain is so severe. I know about the cushions, and some of the joints were also displaced. Now 
they can’t fix that displacement, and that is why my back pain is so severe. (P18, 51y, LBP 
osteoarthritis) 
I don’t know, it is just that I cannot understand why it is like this, after all these years. That is 
why I am telling you, something is not right with me. I’ve got a problem. … It makes me worry; 
it makes me worry a lot. (P15, 50y, shoulder pain) 
- Impact of pain 
The multiple impact of CMSP was one of the main messages that participants wanted to 
communicate. CMSP influenced the individual’s ability to move, to do their daily activities 
(function), to sleep and to participate in meaningful life activities (specifically occupational/work 
performance). The pain influenced participants emotions/feelings and their relationships with 
others. The participants identified a whirlpool of dominant emotions that they endured on their life 
journey with CMSP, namely emotions of despair (hopelessness), helplessness (destitution) and fear 
and worry (anxiety). 
I noticed that this arm is not functioning like it used to. I use to work before but now it’s 
difficult. Even if I am carrying a 5 litre (bottle) I would feel the pain. I then decided to visit the 
clinic and find out (what is causing the pain) because I use to do everything. But this arm did 
not want to move like the other one. (P5, 59y, wrist and arm pain) 
It is difficult to sleep. If I am walking I would be in pain as if I am going to fall. If I am standing 
I must make sure that I hold on something very tight because I may fall. (P3, 57y, multiple joint 
pain) 
When I felt the pain I felt that I cannot take it anymore so much that I did not even care that I 
am not working, I decided to just sit at home and do nothing. (P19, 70y, multiple joint pain) 
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You know, a person feels like going into depression because of the pain. I have been there; I 
have used medication for it. … But the pain lets you go in depression if you are not careful. 
(P10, 69y, LBP leg pain) 
Then I am so tired. So terribly tired from inside myself and the pain is dreadful. But then I lie 
down and relax, and later I get up again. (P14, 43y, multiple joint pain) 
You are moody, because you are in pain, because you can’t do the things that you enjoy doing. 
So yes, it definitely influences my relationship with my people at home. You are abrupt when 
you are really in pain. Yes it influences your work also, the things that you have to do. It 
definitely has an influence, it influences many things. (P11, 53y, neck and shoulder pain) 
- Coping with pain 
The participants reported on different active and passive strategies they used to deal with the impact 
of pain on their lives. Participants depended regularly on the passive strategies, although these 
strategies had varying effects on pain. Active coping/management strategies were interconnected 
with the individuals’ perseverance and tenacity to continue with life activities. Participants 
described their journey towards acceptance of pain consisting of several interrelated steps. These 
steps included a perseverance that pain would not win; the skills of tenacity (holding on to 
something firmly) and resilience (adapting to a life with pain). Spirituality was also commonly 
reported as a coping mechanism. 
Then I go through my daily routine, my stuff that I do, I pay attention to it. But I have to tell you, 
if there are people with a lot of pain, tell them: Keep yourselves busy. We cannot sit and cry 
about it. We need to keep ourselves busy. Invite somebody for a cup of tea, chat and laugh a bit, 
even if you laugh through the pain. (P10, 69y, LBP leg pain) 
But I use the pills, I rub with the strong ointment, and many times I go lay down. It pains day 
and night. Then I rub some ointment on it, sometimes it helps, sometimes it does not. (P6, 66y, 
LBP, leg pain)  
I ask the Lord to make it more bearable so that I can handle it because I am … I have a task to 
do. Yes, I give it to the Lord. (P6, 66y, LBP, leg pain) 
In the beginning, after therapy, I had more pain, but I did not give up hope, I came back every 
time. No, I did not give up hope. (P1, 47y, LBP leg pain) 
I would like to be pain free, but I don’t know … Maybe an operation in future, I don’t know. But 
in five years I would like to see myself pain free. To always live in pain is not pleasant. (P11, 
53y, neck and shoulder pain) 
Stellenbosch University  https://scholar.sun.ac.za
 37 
I so hoped that that they can heal me, so that I can be normal again, but I realised that it is not 
going to happen. I will have to learn to live with the pain. But I told him, luckily I adapted 
already. I adapted. Adapted and accepted. It will go with me into my grave. (P6, 66y, LBP, leg 
pain) 
3.3.2.2 THEME 2: Healthcare management 
Participants reported that they had received a wide array of management options as summarised in 
Table 3.4. The prevailing management option received was pharmacological.  
Table 3.4: Management received for pain as reported by patient participants 
Management received Self-management 
Advice and education  
Analgesic medication  
Exercise  
Breathing techniques  
Group therapy  
Electrotherapy  
Heat application  
Cognitive therapy  
Surgery 
Rest  
Rubbing ointments  
Heat application  
Exercise  
Self-medication  
Medicinal plants  
Pacing 
Attention to posture and ergonomics 
- Pharmacological management 
Participants communicated a belief and hope in the effectiveness of medication, and 
simultaneously, a fear of medication dependence. However, they admitted that they used over the 
counter medicines for their pain. Participants’ reports indicated that they were acutely aware about 
the effects and side-effects of medication. Their beliefs about analgesics surfaced as well as their 
irregular pattern of taking analgesics. Only two participants revealed that they use traditional 
medicine as an adjunct with prescribed management. 
The injection helped for a while. He told me I should give the injection two months to work. But 
when I went back to him, I told him, Doctor, that injection is worthless. It did not help me. (P15, 
50y, shoulder pain) 
Then he gave me Tramadol. Yes it actually helps for the pain. It lets me sleep well, and it takes 
the pain away a little bit. But when you are busy, then you feel the pain is there again. (P17, 
67y, back and multiple joint pain) 
And many times they ask me how I use my pills. Then I say, not often, as you say, as needed. 
When I feel there is pain and it is not getting less. Then I will drink the pill, not that I really 
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want to. The only pills I take regularly are my hypertension and water pill. If I get home and it 
(medication) does not work, then I buy ... If I have pain then I buy something else). (P6, 66y, 
LBP, leg pain) 
There are days that you feel despair; you feel you can’t handle it any more. Then you turn to the 
medication. I don’t willingly take pills. It is just an aid. It helps for a short while and then it is 
past. And that is how it goes. But it is not easy. (P10, 69y, LBP, leg pain) 
(P6, 66y, LBP, leg pain) 
My husband brought me a book about herbal remedies for ailments. I believe in it. My mom also 
used it when I was a child and we never went to the doctor. We ate out of the fields. I go on with 
that and also the pain medication. (P6, 66y, LBP, leg pain) 
- Non-pharmacological options 
Findings indicated appreciation for therapeutic exercise as a valued intervention. Other 
interventions mentioned as having a positive effect included manual therapy, electrotherapy and 
heat application. Two participants mentioned breathing exercise and cognitive therapy as 
interventions received from the psychologist. Although participants valued the therapeutic 
rehabilitation interventions, they acknowledged that these interventions had a positive but 
temporary effect.  
The way I am feeling now, I am satisfied. The exercise we do here, our conversations, how we 
must sit, how we must do this and that, how we must do our housework, it helps a lot. For me, 
personally, it helps tremendously, because the pain I had, I would not wish it on anybody. (P1, 
47y, LBP, leg pain) 
But the lady taught me, I should draw my breath in, and I must keep it as long as possible, and 
then let it out slowly. It helps me a lot. I do a lot. It helped me a lot because she taught me 
something I can do when the pain is there. The physiotherapist taught me other things. I always 
went to her to be treated with the machine and be massaged. It helped a lot; and also the 
cycling. (P6, 66y, LBP, leg pain) 
I am very satisfied, they helped me a lot. My arm is not the way it was before. My arm can move 
since I started with physiotherapy. I can wash myself now. (P16, 49y, shoulder pain) 
If I can’t take it anymore, and I become despondent, I make an appointment with the 
physiotherapist. Then I go for two or three times, and then I feel better. But it comes back again. 
I think all her patients must go regularly, that is the unfortunate case. (P10, 69y, LBP, leg pain) 
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- Advice and group therapy 
Participants appreciated the advice and explanations they received from the practitioners, which 
was often delivered during group therapy and had the added benefit of socialisation and sharing of 
ideas. A small subset of participants reported that some HCPs provided explanations that 
counteracted empowering advice. This disempowering advice can be recognised in advice to be 
inactive and advice that creates fear/anxiety.  
It is good to exercise in the group, and also the questions. Sometimes I don’t even need to ask 
the question, and then somebody else asks it. Then I also get the answer! (P1, 47y, LBP, leg 
pain) 
She will explain to us a better way of dealing with this pain and teach us how to exercise in the 
morning, there is nothing better than to exercise. She told us what the cause of the chronic pain 
is, and everything that we need to know. (P3, 57y, multiple joint pain) 
Then he (the doctor) told me: You must do nothing. You must lie down more often. But I told my 
husband I can’t do nothing! (P6, 66y, LBP, leg pain) 
- Goals for therapy 
Participants generally were unsure about their goals for attending care, and these centred on the 
reduction of pain, prevention and cure. 
For pain relief. That is it. Pain relief. (P7, 58y, leg, multiple joint pain) 
I don’t know if it is going to help, but I attend, I take part in the physiotherapy, let me see what 
happens. My shoulder was not like this, it was never like this. (P15, 50y, shoulder) 
3.3.2.3 THEME 3: Healthcare system influences 
- Healthcare pathway 
Participants disclosed that they used a combination of private and public healthcare systems. Private 
health care was used for quick access to care, avoidance of the long waiting times, wanting a second 
opinion and employer assistance. The cost of health care played a role in their choice to consult. 
Participants reported two types of patient journeys. A rapid journey was evident when physical 
trauma was a precipitating factor. The delayed journey was characterised by fragmented care and a 
lack of appropriate referral, which led to frustration.  
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But when I am really ill, I go to the private doctor, because she is closer to me. (P17, 67y, back 
and multiple joint pain) 
I was still attending the clinic, but I just wanted a different opinion, maybe he can do better. Yes 
maybe there can be a difference when you can visit the private doctor. I found out that I was 
getting the same pills that I am getting at the public clinic. (P3, 57y, multiple joint pain) 
I went to three different doctors, and the one told me what this could be. But for three months I 
received Voltarens, injections, and by the fourth month I had enough. I told the sister, I can’t 
get injections and pills all the time and you don’t refer me. And I asked her; where I should go 
for this, because I also did not really know. (P1, 47y, LBP leg pain) 
- Healthcare system mechanics 
The strongest theme within the system factors was the threats to continuity of care, namely access 
to care, long waiting times and consistency of care. Having to wait outside the clinic in designated 
waiting areas were particularly bothersome to those participants affected by it. Most participants 
acknowledged that they did not understand how the system works and why processes were managed 
in a certain way. They requested more information regarding system mechanics.  
I gave in my card and waited. After two hours, I asked where my card is, and then for three 
hours, I then asked: What happened to my folder? That to me is unacceptable. (P7, 58y, leg, 
multiple joint pain) 
People are standing outside. They close the gate. It can be hot, it can be raining, but people are 
standing outside. We can’t go in. Even if you have an appointment. You have to stand there until 
whenever. One day, I just left, without getting any assistance. I don’t even want to go the clinic 
any more. (P9, 71y, foot, leg pain) 
If a person can get one doctor, and you can see the same doctor every time, then it would be 
better. Now you get the other doctor, and then that doctor does his own thing. (P18, 51y, LBP)  
They put the (appointment) times a bit too far apart. It has been two months now. Of course she 
is fully booked, and she also works alone. So okay, one should actually go more regularly (P8, 
68y, multiple joint pain) 
Yes sometime we spend a lot of time at the clinic just sitting here and sometime go back home 
with nothing and we didn’t do that before. I think it’s because of the lack of knowledge; they 
need to give us more information about how they operate. (P2, neck and upper quadrant pain) 
Stellenbosch University  https://scholar.sun.ac.za
 41 
- Satisfaction 
Despite the many barriers to pain care management that participants identified, most were satisfied 
with and grateful for the care they received at the community health centre. Non-satisfaction was 
linked to pain persisting despite healthcare management. 
I am very satisfied, I can’t lie. I also encourage the others. (P1, 47y, LBP leg pain) 
Everything to me is… the exercise, everything that I have experiences here at the hospital, the 
physiotherapists, it is all good treatment. I cannot complain. (P11, 53y, neck and shoulder 
pain) 
The pain is just not going away. If the pain was entirely gone, I would be satisfied, but the pain 
is still there. (P15, 50y shoulder pain) 
3.3.2.4 THEME 4: Social and environmental influences 
- Family influence 
The family, as the participants’ immediate circle of influence, played an important part in the 
participants’ pain experience. The family largely had a positive influence, but negative accounts 
(albeit limited) were mentioned. Some participants were concerned about the care of their family 
members; therefore, they often prioritised their family’s wellbeing above their own pain care.  
The children are also, just like me, they don’t know what to do. I go to doctors and 
physiotherapists; I go to the pharmacy, to get medication. And they also bring medication for 
me. (P9, 71y, foot, leg pain) 
My child is 18 years; I have to take care of him. I have a grandchild that I have to care for. I 
can’t disappoint them, and I am not old. (P15, 50y, shoulder) 
I must not think about the pain, but you are human and if I think about the pain, it becomes 
worse. Because I used to stress a lot about my daughter, who is divorced and living with me. 
Sometimes I ask her to do something and she refuses. Then I stress about it and then the pain 
becomes worse. (P13, 59y, multiple joint pain) 
- Financial circumstances 
Limited finances were identified as a barrier to seeking health care for pain; the inability to work 
and generate and income was reported to be a substantial stressor.  
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There was a doctor, my physician that I’m attending, but now I don’t have money.... because 
I’m thinking of going to the doctor, but I don’t have money. (P4, 42y, shoulder, back pain) 
Well, if I don’t work, then I don’t have an income. Then I begin to stress, because I have to pay 
the rent, I have to buy food. Then it starts, then I sit with the pain, and I feel the strain in my 
back, and the pain becomes worse and worse and worse. (P14, 43y, multiple joint pain) 
- Occupational factors 
Pain had an effect on work and vice versa. There was a subset of participants who continued 
working despite the pain, while another group chose to leave employment due to pain. Work 
conditions and especially responsibilities at work were cited as barriers to attending care. The 
occupational barriers included the employer’s or manager’s attitude, non-support from co-workers, 
and their work schedule (deadlines and targets).  
Sometimes I have no choice but to go (to work), even though my leg is paining. What will I eat? 
Because I don’t have the money, I must get some income. (P9, 71y, foot, leg pain) 
When I felt the pain I felt that I cannot take it anymore. So much that I did not even care that I 
am not working, I decided to just sit at home and do nothing. (P19, 70y, multiple joint and leg 
pain) 
I work on the machine. If I sit at the machine for more than an hour, then the pain tells me I 
have to move. They say it is because I am a machinist, and that it is a general problem with 
machinists. (P1, 47y, LBP, leg pain) 
I started with physiotherapy, but due to the nature of my job, I can’t come regularly. I can’t take 
off so much time from work. So if I can’t take it anymore and I gnash on my teeth, then I go for 
some more physiotherapy. (P11, 53y, neck and shoulder pain) 
- Distress 
Different causes of stress and anxiety were identified in the participants’ narratives, the most 
important cause being financial hardship. Other reasons for distress were identified personal loss, 
family circumstances, post-traumatic stress and the individual’s natural tendency to stress. 
No, I‘ve got this fear; I don’t know whether I am going to get another baby. I don’t know. (P4, 
42y, shoulder, back pain) 
And of course the stress. Stress also works on my pain, because I had the shock. Just a lot of 
stress and then my muscles go into spasm. (P11, 53y, neck and shoulder pain) 
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Remember, anxiety also affects this back. So I can’t compare my personal circumstances with 
any other person. It depends on the person. But I am a nervous person and if I drank an 
antidepressant, it is if I can relax a bit. And then it is also better. (P10, 69y, LBP, leg pain) 
3.4 SUMMARY OF FINDINGS 
The study discovered rich accounts of the participants’ experiences regarding their condition, and 
their interaction with the healthcare system. The sample was predominantly female, and 40 years 
and older, which was congruent with national and international studies on chronic pain (Upshur et 
al., 2010; Igombur et al., 2011; Matthias et al., 2012; Rauf et al., 2013; Igwesi-Chidobe et al., 
2016). Consistent with Igombur et al. (2011) and Rauf et al. (2013), the prevalent body area for 
chronic pain was LBP, followed by limb joint pain. However, in the current study, leg pain was 
very common (50%), while leg pain prevalence was very low (5%) in Igombur et al. (2011). 
The main findings of the study indicate that CMSP impacted the participants in multiple ways, 
which was also evident in the results of the NPRS, K10 and PDI. The findings about the 
multidimensional impact of pain are congruent with qualitative systematic reviews about the patient 
experiences of CMSP (Bunzli et al 2013; Snelgrove et al 2013; Toye et al 2013; MacNeela et al 
2015).  CMSP challenged participants’ ability to continue with meaningful life activities. Internal 
and external factors mediated the patients’ pain experience. Internal factors included the 
individual’s beliefs and coping mechanisms. The external factors included social and environmental 
influences and treatment received. Participants highlighted the emotional impact of pain, which 
included fear and worry about pain and the consequences of pain. However, few patients reported 
the use of cognitive strategies part of as self-management. The results indicated that patients’ 
beliefs about pain influenced their interaction with the condition and health care system; and their 
choices about pain and its management.  
Participating patients reported the dual use of the private and public healthcare sector, which 
complicated their healthcare pathway. This complexity was influenced by the participant’s own 
preferences (e.g. second opinion) and by system factors (e.g. waiting times, cost). Additionally, 
participant reports indicated delayed referral to rehabilitation practitioners. Practitioners identified 
as involved in the healthcare journey were predominantly medical doctors, nurses and 
physiotherapists. Reported interactions with occupational therapists, psychologists and other 
practitioners were limited.  
Most participants in this study had a biomedical (structural) understanding regarding their CMSP, 
which seemingly encouraged participants to continue searching for a diagnosis and cure. The 
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biomedical view was also evident in the participants’ hope to find a solution for their chronic pain 
via stronger medication. However, ambivalence about the use of analgesia was reported as hope of 
analgesia as a solution for pain, contrasted by irregular use of medication. Exercise and advice were 
identified as useful strategies for treatment and self-management. However, exercise and analgesics 
were used as needed; and were not reported to be part of a daily routine. Participants acknowledged 
that the treatment received had a positive, but temporary effect, which could indicate that 
participants have not accepted their CMSP as a chronic condition. The participants’ conversations 
revealed that they trusted practitioners to provide them with advice, guidance and opportunities for 
collaborative decision making.  
Four themes of contextual factors that influenced the CMSP experience and management emerged 
from the participants’ narratives, namely individual factors, treatment received, health care system 
factors, and social factors, environmental and occupational factors. The personal characteristic of 
resilience appeared to facilitate coping with pain. Patient knowledge and beliefs about treatment 
appeared to influence, in part, their adherence to prescribed treatment. Prolonged waiting times at 
the healthcare centre, a lack of continuity of care and regularity of care were system factors 
identified as impacting optimal care. Family played an important role in supporting the participants; 
however, some family situations were reported to cause distress. Additionally, limited finances, as a 
social factor, were nominated as significant stressor and were reported as a barrier to seeking and 
maintaining health care. Participants reported that tension exists between pain and work. A subset 
of participants chose to continue working despite pain, while others chose to terminate employment, 
regardless of the negative consequences of not being employed. Work conditions were discussed as 
either barriers to pain care or facilitators of pain care. 
Despite the participants open hearted discussion about the barriers to access and continuity of care 
in the PHC system, the majority concluded that they were satisfied and indeed grateful for the care 
they receive at the community health centres. 
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CHAPTER 4  
HEALTHCARE PRACTITIONERS’ PERSPECTIVES 
ABOUT THE PRIMARY HEALTHCARE OF CHRONIC 
MUSCULOSKELETAL PAIN  
4.1 RESEARCH QUESTION 
The research question for this part of the research project was formulated as follows: 
What are healthcare practitioners’ perspectives about the primary health care of patients with 
chronic musculoskeletal pain; in particular the pathway of care and the barriers and facilitators in 
implementing pain management in primary health care? 
4.1.1 Objectives 
 To provide a demographic profile of the participating practitioners, to aid understanding of their 
perspectives. 
 To discover practitioners’ experiences and perspectives about management of patients with 
CMSP, in particular: 
 To describe practitioner practice patterns for managing CMSP in primary care, including 
inter-/multi-disciplinary strategies, the referral system, and the care process, and 
 To determine the barriers and facilitators that practitioners experience for optimum 
primary health care of CMSP. 
4.2 METHODS 
4.2.1 Study design 
An exploratory, descriptive, qualitative study was conducted, using an interpretive research 
paradigm, and phenomenological approach to gain an in-depth understanding of practitioner 
experiences, perspectives and practices regarding the management of CMSP in PHC (Pope & Mays, 
2006).  
Stellenbosch University  https://scholar.sun.ac.za
 46 
4.2.2 Study setting 
The research was conducted at the community healthcare centres/clinics in the communities as 
described in Chapter 3 (section 3.2.2) and Appendix 5.  
4.2.3 Population and sample 
The population was comprised of all healthcare practitioners involved in the management of adults 
with CMSP at the clinics. The practitioners could be doctors, nurses, physiotherapists, occupational 
therapists, psychologists, social workers or community health workers. Purposive (strategic) 
sampling in the form of criterion sampling was used to ensure maximum exposure to key variables 
(Palys, 2008) and included: 
 geographical area of the clinic (rural, township and urban), 
 occupation (diversity of practitioners at each clinic), and 
 involvement in the care of patients with CMSP. 
The aim was to recruit 20-25 practitioners, which is similar to sample sizes in previous studies 
(Patel et al., 2008; Allegrettia et al., 2010; Kenny, 2004; Crowe et al., 2010; Matthias et al., 2010). 
This number was thought to be adequate to identify core elements of the phenomenon, and to 
provide adequate answers for the research question (Ritchie et al., 2003). The intention was to 
recruit more participants if data saturation were not achieved. 
4.2.4 Instrumentation  
Semi-structured individual interviews 
In-depth, semi-structured interviews were conducted, to accommodate clinician work schedules. 
Each interview lasted 30-60 minutes, using the principles as outlined in Chapter 3 (section 3.2.4). 
An interview schedule (Appendix 13) was developed, guided by the research objectives and based 
on available literature (Patel et al., 2008; Matthias et al., 2010; Kenny, 2004; Allegrettia et al., 
2010). The topics in the interview schedule were participants’ narratives about healthcare 
management of CMSP, their beliefs about; practice pattern for; and barriers and facilitators for 
optimal management of CMSP in primary care. The PI conducted all the interviews in Afrikaans or 
English, as she is proficient in both languages.  
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Questionnaires 
Each participant completed a short questionnaire after the interview (Appendix 14). The 
questionnaire consisted of three parts, namely socio-demographic information, use of CPGs, and 
CMSP conditions. 
Translation of the interview schedule and questionnaires 
The interview schedule and questionnaire were available in English and Afrikaans that was 
translated by the SU Language Centre, and verified by the PI.  
4.2.5 Procedures 
The health centre manager was requested to assist in the identification potential participants, namely 
those involved in the management of CMSP. The PI contacted the practitioners, provided them with 
detail about the study, and invited them to participate. Written informed consent was obtained prior 
to participation in the study (Appendix 15). The interviews were conducted at the practitioner’s 
office, to enable the natural setting of the therapeutic encounter.  
4.2.6 Data management  
Interviews were recorded on a digital voice recorder. The recordings were downloaded on the PI’s 
personal computer; unique serial numbers were allocated and were transcribed by a professional 
transcription company. The interviewer authenticated each transcription by verifying the recording 
with the transcription and correcting any discrepancies. Selected member checking was done to 
assist with data validation by e-mailing the transcription to the participant for feedback (three 
participants per site). Additionally, all participating practitioners at the participating health care 
centres were invited to attend a session where a summary of the data was presented.  Data were 
audited by member checking, external auditing by the supervisors and a research assistant; and were 
appraised by external audiences (conferences and peer group discussions). The data from the 
questionnaires was scored by the PI, captured on an Excel spread sheet for analysis and verified by 
a research assistant.  
4.2.7 The role of the researcher in the research process 
The role of the researcher in data generation and management has been discussed in Chapter 3 
(section 3.2.7). In this part of the study, the researcher being a physiotherapist might have 
influenced participant responses. The researcher built rapport and trust at the start of the interview, 
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emphasising the contribution of the participant and the envisaged outcome of the project being a 
CPG.  
4.2.8 Data analysis 
Inductive, thematic content analysis of the interview transcripts was undertaken, using the 
framework method and the same principles and quality criteria as explained in Chapter 3 (section 
3.2.8). Data analysis involved an iterative process of immersion in the data; familiarising self with 
the data; highlighting significant statement (quotes); creating a codebook; coding the data; 
developing clusters of meaning (categories); sorting categories based on their relations and 
linkages; and establishing themes (Gale et al., 2013; Pope et al., 2006; Richie et al., 2003). Data 
analysis took place in the language of the interview transcript (Afrikaans or English). The Afrikaans 
quotes were translated by the PI for this dissertation and to enable auditing by the research assistant 
and research supervisors. Appendices 16 and 17 provide the codebook for analysis and examples of 
translated quotes. 
The questionnaire data were recorded and analysed in a purpose-built data collection sheet in MS 
Excel and were conveyed as frequencies, proportions and percentages (Kirkwood & Sterne, 2003). 
4.2.9 Qualitative quality criteria 
The research adhered to the applicable quality criteria for qualitative research, highlighted by 
Frambach et al. (2013) as credibility, transferability, dependability and conformability (see section 
3.2.9). In addition to validation by member checking and external auditing, a concise report was 
sent to participating practitioners and centre managers towards the end of the project. 
4.3  RESULTS 
4.3.1 Quantitative results 
Twenty-one practitioners participated in the study. Twenty-three practitioners were invited and two 
declined.  A psychiatric nurse in the urban township setting declined, due her report of not 
managing any patients with CMSP.  A doctor in the urban township setting declined, due to her 
busy schedule. The questionnaire data are presented in Table 4.1 and the reported body sites of 
CMSP can be seen in Figure 4.1.  
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Table 4.1: Sociodemographic and practice information of participating practitioners 
Variable  Number 
(n=21) 
(%) Mean (SD) 
Geographical location 
Rural 
Urban  
Urban township 
 
9  
7 
5  
 
43 
33 
24 
 
Occupation 
Nurse 
Occupational therapist/technician 
Medical doctor 
Physiotherapist 
Clinic manager 
Family physician 
Psychologist 
Social worker 
 
5  
5 
4  
3  
1  
1  
1  
1  
 
24 
24 
19 
14 
5 
5 
5 
5  
 
Gender 
Female  
Male  
 
18 
3 
 
86 
14 
 
Language  
Afrikaans 
English 
isiXhosa 
 
13  
6  
2  
 
62 
28 
10 
 
Ethnicity 
White  
Coloured 
Black 
 
11 
8  
2 
 
52% 
38% 
10% 
 
Age (years)
a 
<20 
20 – 30 
31 – 40 
41 – 50 
51 – 60 
61 – 70 
71 >  
 
- 
6  
4  
6  
3  
1  
- 
 
- 
30 
20 
30 
15 
5 
- 
41 (12) 
Years practising occupation
a 
< 5 years 
5 – 10 years 
11 – 20 years 
>20 years 
 
6  
5  
4  
5  
 
30 
25 
20 
25 
14 (10) 
Years practising at clinic
a 
< 5 years 
5 – 10 years 
11 – 20 years 
>20 years 
 
9  
6  
5  
- 
 
45 
30 
25 
- 
8 (5) 
Estimated % of patients seen with chronic pain  
(per week)
a 
0 – 25% 
26 – 50% 
51 – 75% 
76 – 100% 
 
 
5  
5 
5 
4 
 50% (29%) 
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Variable  Number 
(n=21) 
(%) Mean (SD) 
Estimated % of patients seen with CMSP (per 
week)
a 
0 – 25% 
26 – 50% 
51 – 75% 
76 – 100% 
 
 
7 
4 
4 
5 
 35% (31%) 
 
Satisfaction with the provision of CMSP care 
Highly satisfied  
Satisfied  
Little satisfied  
Unsatisfied  
 
2 
9 
6 
1 
 
10 
47 
32 
5 
 
Use of CPGs 
Use CPGs in pain care 
Occasionally use CPGs in pain care 
Do not use CPGs in pain care 
 
11 
3 
5 
 
58 
16 
26 
 
a
One or two data points missing 
 
 
Figure 4.1: Estimated regions of pain treated by practitioner (per one month)  
 
4.3.2 Qualitative results 
The participants’ narratives largely corresponded to the contextual factors identified by patient 
participants in Chapter 3 and revealed eight major themes: 
0 1 2 3
Head
Neck
Thorax
Shoulder
Arm
Elbow
Wrist/Hand
Abdomen
Pelvis
Low Back Pain
Leg
Hip
Knee
Ankle
1 = Very often  
2=Sometimes  
3 =Hardly ever  
Body area 
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1. Conception of CMSP  
2. Interdisciplinary care: important but difficult to implement 
3. The patient healthcare pathway 
4. Team roles and management interventions  
5. The patients’ needs and roles in management 
6. Negotiation of healthcare system factors in pain management 
7. Social and environmental factors complicates pain management 
8. Use of evidence-based practice 
The themes and categories were analysed for potential barriers to and facilitators of management 
(see Table 4.2). Verbatim quotes are provided and referenced by indicating the participant number 
and occupation (e.g. P6, Psychologist).  
4.3.2.1 THEME 1: Conception of CMSP  
The majority of participants attributed CMSP pain in the population under study to occupational 
factors. Physical work involving repetitive movements, together with incorrect ergonomics, was 
thought to play a role in chronicity. Additionally, participants attributed chronic pain development 
to ‘wear and tear’ and osteoarthritis, which they thought developed as a consequence of ageing and 
previous injuries. Overweight, lifestyle components and psychosocial stress were identified as 
contributing factors to the development of chronicity. 
We get lots of chronic pain with arthritis. There are a lot of them here, from wear and tear and 
all the hard work on farms, where they pick up very heavy loads. (P1, clinical nurse) 
Motor vehicle accidents and accidents definitely play a role – you know if it is a fracture or any 
injury, it comes back to you later in life. You might not feel it now, but then when you get older, 
you develop arthritis after the injury. (P9, clinical nurse) 
It’s the type of labour and type of work people are doing, it’s most manual type of jobs that 
patients are doing which causes back pain, which causes overuse injuries. So it probably needs 
a specific programme or programmes need to target the factories and employers more that if 
people are more empowered to take care of themselves in the workplace. (P17, occupational 
therapist) 
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4.3.2.2 THEME 2: Interdisciplinary care is important but difficult to implement 
Participants emphasised the need for a holistic and interdisciplinary approach to care, which was 
thought to be underpinned by a thorough assessment of CMSP. This approach was, however, 
limited by time constraints and the sheer number of patients that needed care.  
I think we need a more holistic approach for chronic pain. We can do something for arthritis, 
the end-stage also. But we must have a diagnosis; we must know the reason for the pain to make 
the right diagnosis. We definitely need a multi-disciplinary team to manage pain, because there 
are different reasons for the pain. So I don’t think that enough time and attention is spent on it. 
(P3, doctor) 
- Organisational factors 
Differences were reported in the clinical practice patterns regarding referral, lines of 
communication and application of interdisciplinary care at the participating clinics. The facilitators 
in interdisciplinary care mentioned included the recognition of team roles, collaborative 
communication between members, commitment to interdisciplinary care and close proximity of 
team members. Several barriers were thought to impede on interdisciplinary management, e.g. the 
lack of awareness of interdisciplinary management, organisational culture, lack of collaborative 
communication, and non-efficient referral systems. Participants indicated that access to certain team 
members was hindered by the patient load and by some team members servicing several clinics, and 
thus travelling to different sites. 
The system is not perfect, but we try to be accommodating. The interdisciplinary approach 
makes a huge difference in our work. I can’t tell you enough. You need to make an appointment 
to see the physiotherapist, because she travels to other clinics. That is a very difficult concept. 
(P4, doctor) 
Yes, but that working together as a team with the pain patients with the chronic pain patients I 
would love to see the family physician, the physiotherapist, occupational therapist, nurses, 
pharmacists, part of a team working better together in various ways. I’m not quite sure how to 
structure it. We are not collaborating nicely and there is a lot of opportunity for that; it’s just 
the time constraints. (P17, occupational therapist) 
We have a physiotherapist and occupational therapist here. The problem is they are so fully 
booked, that a patient has to wait for some time, so the patient numbers are a challenge. (P16, 
doctor) 
Stellenbosch University  https://scholar.sun.ac.za
 53 
We work well together. I enjoy the collaboration. And the fact that we moved to this location 
now, makes it (collaboration) a lot easier. (P7, physiotherapist) 
- Referral  
Primary and tertiary (specialist) care referral was cited as occurring in clinics with well-functioning 
referral systems. First-line practitioners mainly referred patients with CMSP to physiotherapy. The 
reported referral to occupational therapy in pain management was limited while referral to the 
dietician centred on weight management to decrease joint load. Referral to the mental health 
practitioners such as psychologists, psychiatrists and mental health nurses was identified to be 
reserved for patients with clearly identifiable mental disorders. The stated barriers to 
interdisciplinary referral were abundant and included access to team members, feedback after 
referral, patient abilities and roles, transport, patient numbers, staff capacity, and the long waiting 
lists for tertiary care. 
We are very lucky to have physiotherapist and occupational therapist here and we do make use 
of them and I do send patients to see them. But you know it’s also difficult for patients who have 
got chronic pain and are not mobile to get here to come in so they don’t always keep their 
appointments. (P10, doctor)  
We have a physiotherapist and occupational therapist here. The problem is they are so fully 
booked that a patient has to wait for some time, so that is a barrier. (P16, doctor)  
We refer a lot to the social worker and psychologist. However, the services are not always 
available, because the psychologist only visits the clinic twice a month. We do not get feedback 
to hear, did anything happen. You refer and you hope for the best. (P2, clinical nurse) 
The referral to specialists is very difficult. The waiting period is very long. It can take five, six 
months before the patient can get an appointment. So it is very problematic. (P16, doctor) 
4.3.2.3 THEME 3: The healthcare pathway 
Participants discussed a delay in the care pathway for patients with CMSP. Some practitioners even 
attributed the transition from acute to chronic pain to delays in the pathway. A delayed pathway for 
a patient with CMSP may thus be an important barrier to optimum care and recovery. The reasons 
for the delays were identified to be multifactorial and included patient-originated delays, delayed 
interdisciplinary referral and system factors. System factors include the load leading to long waiting 
times to obtain an appointment for rehabilitative care.  
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I think there is a problem with referring people. The doctors and nurses maybe first to their 
interventions with medication and then only if that doesn’t work, they send them here. I think of 
the many people with overuse injuries, they often only come six months down the line and it’s 
become chronic already so one has to try and get the interventions or try and find ways to get 
the people to come sooner because some people then it’s kind of too late. (P17, occupational 
therapist)  
I really think patients need to get to us sooner. Because a patient will have pain for some period 
of time; a hand or an arm or a back; they present to XXX after three weeks of having pain, and 
say they have endured the back pain for three weeks. Once again, it is about education, so that 
the patient knows, if I have pain, I need to seek help. If it is painful for two or three days, come 
immediately and ask for help, because the sooner you stop it, the better. (P5, occupational 
therapist) 
4.3.2.4 THEME 4: Team roles and management interventions 
Clinical nurse practitioners were the first contact practitioners at the clinics. They assessed the 
patient, referred to other practitioners, referred for special investigations if indicated and could 
prescribe certain analgesia. The role of physiotherapy was communicated to be patient education 
and advice, exercise prescription, facilitation of self-management, and home adaptations. While 
practitioners reported that they seldom directly refer to occupational therapists for pain care, the 
occupational therapists were diversely involved in exercise prescription, relaxation, work 
assessment and the provision of coping skills as part of chronic pain management groups. Reports 
indicate that only one centre had access to a psychologist involved in pain care. In line with the 
practitioners involved in the CMSP care pathway, discussions elaborated on medication, exercise 
and education. 
- Medication 
Prescribing practitioners reported that they follow the stepped care approach for analgesic 
prescription, basing their decisions on the guidelines of the EML for PHC (National Department of 
Health, 2014). The main types of medication prescribed were Paracetamol, NSAIDs, Tramadol and 
in selected cases Amitriptyline (confirmed in Table 3.2). Prescribing participants described the 
barriers to CMSP care as the type of analgesics available in PHC, the inadequate maximum allowed 
amount of analgesics they could prescribe and patients’ patterns of analgesics use. The facilitators 
for providing pain care were labelled as the availability of the EML, the focus on re-assessment, and 
careful consideration of side-effects.  
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I think you need to do a step care pain approach and they definitely need more than ten Panado 
a month or ten Tramadol. The other medication that we can use is Amitriptyline for chronic 
pain and we can use anti-inflammatory. The chronic pain that I find the most difficult to deal 
with is chronic joint pain: lower back pain, joint pain and because the reason being we are only 
allowed to prescribe limited amounts so we have our hands tied behind our backs. (P10, doctor) 
The main barriers would be the type of medication we can prescribe and continuity of care and 
then also activities that the patients have to do. (P15, doctor)  
You should always ask: How are you using the medication? They don’t use it as prescribed, for 
many reasons. (P3, doctor) 
- Exercise 
Participants were positive towards the benefits of exercise for muscle strengthening, enhancing 
mobility and function, prevention of re-occurrence, counteracting inactivity, counteracting 
depression and enabling the patients to continue with their occupation. The most common mode of 
exercise prescription for CMSP was group therapy. Participants emphasised that the patient 
compliance and adherence was important in the success of exercise programmes. 
So support and physical exercise keeps the patient going. I think that is the most important 
thing. And the biggest mistake they make is by not being active. Because depression is next on 
the list. Then it is very difficult to get back from there. (P16, doctor) 
We also refer to the Physio. So that patients can get exercise for their pain and help them to 
become more mobile and get pain control. (P9, clinical nurse) 
It’s because they can take it (exercise) home. They can do it on their own. For people who are 
compliant, it’s better for them, because they can do it at home, they cannot always come to the 
clinic. (P11, occupational therapist) 
- Education 
The conversations with participants revealed that they placed a high therapeutic value on patient 
education. Rehabilitation practitioners used education as an integrated thread and core part of their 
practice. The content of education included teaching exercises, ergonomics, reassurance and 
explanation of the cause of pain. Education about analgesics was rarely described; the potential lack 
of this type of education may be a barrier to pain care. Language differences and time constraints 
were identified as the main barriers affecting educational interventions. Participants preferred visual 
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and verbal modes of education above written education to facilitate patient understanding. The 
importance of appropriate language and type of information was emphasised. 
I think that the patients have a low educational level, especially in rural areas. They appreciate 
it when you take time to explain something to them. Especially about their illnesses, or this is 
how the pill works. Nobody else, I guarantee you, have explained to them how it works. (P4, 
doctor) 
The psychologist and I, we went together and explained to patients the complete anatomy and 
physiology about pain. We did that and it worked very well, the people reacted very well to it. 
They came regularly and with that to the exercise group. Afterwards, the patients did not attend 
the clinic again, not at all. They did not return for the usual treatment. (P7, physiotherapist) 
So it’s very difficult and all of this taken into consideration the language barrier. So now you 
have to explain to them how pain works. (P12, physiotherapist) 
Patients need to be educated as to what the problem is, what causes it, what aggravates it, what 
they can do to make it better and so on and often we don’t have enough time to explain those 
types of things to patients. (P15, doctor) 
- Group therapy 
Group therapy was identified as the prominent strategy used for the delivery of rehabilitation of 
patients with CMSP and was presented in all three participating centres by physiotherapists and 
occupational therapists, and in one centre input from the psychologist was reported. Groups ran for 
three weeks in one centre and six weeks in the others. Participants reported high expectations for 
group therapy, regardless of whether they were involved in the group therapy or not. The aims of 
group therapy were reported to be provision of support, education, and empowerment for self-
management. The participants had many positive recollections about the outcomes of group therapy 
sessions.  
We have support groups for different types of joint pains. We have an arthritis group, which is 
six weeks in duration. We teach them about joint management, pain management, relaxation, 
exercise and assistive devices. We work together with the occupational therapist. (P19, 
physiotherapist) 
I think what the therapists do, the support groups, where they actually talk with the patients; it 
is very underestimated by a lot of people. I think it makes a huge difference; those support 
groups where they counsel the patient and explain how pain works. We referred a lot of patients 
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there, and we did not put those patients on medication. Some we could put on minimum 
medication and we could control their pain. (P4, doctor)  
4.3.2.5 THEME 5: The patients’ needs and roles in management 
- Patients’ need for psychological support 
The need for psychological support for patients with CMSP was strongly emphasised by 
participants. Participants reported that they deal with patients’ emotional needs by listening to the 
patient and acknowledging patient’s suffering. The majority of participants did not mention using 
coping skills for psychological and social concerns as part of therapeutic interventions. Significant 
barriers to the provision of psychological support were highlighted as limited access to 
psychologists and other mental health practitioners in PHC; mental health services were prioritised 
to those with diagnosed psychological conditions; the complex interaction of social circumstances 
influencing treatment options and priorities; furthermore, it was reported that patients do not often 
realise or accept the impact of psychosocial distress on their pain symptoms.  
Sometimes even before I start treating them, before I do any physical treatment on them, just 
allowing them to talk, allowing them just, you know, just open up a little bit, and while they are 
talking, then they will tell me: I am starting to feel better now, and I can see the faces … Some 
will even say, you know what, my pain is gone. I don’t even feel my pain anymore. (P19, 
physiotherapist)  
No, we only have an intern psychologist that comes once a week for three hours so it is very 
difficult; she is seeing those that are at the top of the list. (P14, clinical nurse) 
It is a blind spot for patients. Very few of them will say that if I am stressed, my headache starts, 
especially if the social issues are not sorted out. The totality of patients that we see, it is a way 
of communication. To me, pain started to look like a language, the patient can put it (suffering) 
in words, and it is an easier way to explain something. (P6, psychologist) 
Many times, I found that patients with those psychological aspects that are negatively 
influencing them, I battle with that. I get very little results with them. It is very difficult. (P7, 
physiotherapist) 
- Self-management 
Most participants emphasised self-management as essential in the management of CMSP, in 
resource-constrained environments. Patients’ acceptance of the pain condition, as well as their 
adherence to and compliance with self-management was described as playing a central role in the 
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attainment of self-management. The development of skills towards self-management appeared to be 
allocated to rehabilitation therapists. 
I think understanding is a big part of it – if the patient understands they get much better 
acceptance for something that can’t really be cured. You have to live with it and you need to 
accept it. I think it is here where the value of the multi-disciplinary team plays a role. There are 
a lot of patients that buy into that. They are not pain free, but they can manage their pain and 
they can get some of their functionality and life back. I think it is difficult, and it depends a lot 
on the patient, their disposition and how they understand it. (P3, doctor) 
It’s because they can take it (exercise) home. They can do it on their own. For people who are 
compliant, it’s better for them, because they can do it at home, they cannot always come to the 
clinic every time they are sick. (P11, occupational therapist) 
Self-management, I teach my patients, you need to take responsibility; you need to look after 
your joints and change your lifestyle. It is tough, because our patients are so used to: the doctor 
will sort me out, the nurse will sort me out, and the physiotherapist will sort me out. (P19, 
physiotherapist) 
- Adherence 
Several individual factors were reported to influence pain management, which included patients’ 
expectations and beliefs, patients’ willingness to take ownership and to adhere to treatment, and the 
need for behaviour change. Participants reported that they activate this ownership by explaining the 
condition to the patient and building a relationship with the patient. Several participants commented 
on the need for behaviour change amongst patients, and acknowledged that behaviour change can 
be difficult. 
For a person really who wants to get better, they do get better. If patients are not compliant, 
then it doesn’t work. (P11, occupational therapist) 
You need to have a good therapeutic relationship with your patient. You can’t just ask about 
their pain. You need to enquire about whom they are, you must get to know them, because then 
they will trust you so much more and they trust your treatment so much more. (P5, occupational 
therapist) 
It is easier to drink the medication than to do exercise to prevent and help with the pain. Their 
mind-set is more directed to medication, than on anything else. That is why we refer them to 
physiotherapy, because when they get into that exercise programme, we see them less and their 
complaints are also less. (P2, clinical nurse) 
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4.3.2.6 THEME 6: Negotiation of healthcare system factors in pain care 
Participants identified interconnected system barriers to care of CMSP, which includes that patients 
have to wait long periods of time for consultation, time constraints during the consultation, 
continuity of care, and limited access to care due to staff shortages.  
- Waiting times 
Long waiting times were seen to affect the provision of care as well as patients’ follow-up and 
adherence to care. Practitioners described incidents where patients opted to default care due to long 
waiting times. The long waiting times with accompanying non-attendance were described as a 
causative factor in the pathway to the development of chronicity. The implementation of the lean 
system and triage was hoped to bring an improvement in waiting times at clinics.  
I think the patients also become despondent, because they have to wait so long. They might 
decide that they can live with the pain, and a few months later when the pain is worse, and it 
changed into chronic pain. (P16, doctor) 
There are a lot of patients at the clinics. To provide quality care, it is a good thing to give the chronic 
pain appointments, some clinics have lean systems. I think those patients have a better chance of being 
seen by the doctor because they are not all there at the same time. There is no chaos, and there is 
more time, it is more organised, there is time for you to talk to the doctor. (P4, doctor) 
It is very difficult, as you can see there are about a hundred people waiting here to be seen. We 
are under pressure to finish, because we know more will come. These are not all the people; 
there are more patients in the other waiting areas. (P16, doctor) 
- Consulting time 
Participants verbalised the overwhelming feeling of time constraints, not having enough time to 
spend on holistic assessment, or for listening to and educating the patient. This constrained time 
was reported to be caused primarily by the number of patients that has to be cared for in one day, 
and was reported to impede the management options they could offer. 
I suppose you would have to do motivational interviewing but you know the thing is there is no 
– there is limited time. (P10, doctor)  
Well, time is obviously a factor here in seeing patients. Patients need to be educated as to what 
the problem is, what causes it, what aggravates it, what they can do to make it better and so on 
and often we don’t have enough time to explain those types of things to patients. (P15, doctor) 
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- Continuity and access to care 
Continuity of care was considered to be hindered by staff shortages, high staff turnover and system 
overload. Participants discussed the barriers to follow-up and continuity of care by not being 
followed up by the same practitioner. 
But there are only so many doctors and only so many nurses for thousands of people. So you 
and I can do nothing about that. We try our best with it. But it would have been better; it would 
have helped if we could spend more time per patient. (P3, doctor)  
I think continuity of care – patients don’t come back and see the same doctor so often when they 
come back it’s the same story explained again. (P15, doctor) 
The physiotherapist is fully booked three months in advance. If somebody with low back pain is 
referred, she can only help them in three months’ time. (P5, occupational therapist)  
4.3.2.7 THEME 7: Social, environmental and family factors complicate pain care provision  
Participants highlighted some social realities that have an impact on families and communities, for 
example drug abuse, domestic violence and gangsterism. These factors were thought to be a major 
cause of stress for individuals that are affected by them and increased the burden on patients.  
- Hardship 
Economic hardship was a reality and resulted in competing interests, leading patients to pursue 
disability insurance for their CMSP.  
A lot of our patients, there is a whole lot of social influence, there is a lot of parents that deals 
with children with drug problems and financial problems and stuff, and you can see those 
people they, you know … it influences their life, it influences their pain. Stress influences their 
pain a lot. (P19, physiotherapist) 
You can see it on their body language and everything about them, so I think yes, they might end 
up with body aches, but it might be because they’re so tensed up of having to struggle to make a 
living. And I would refer those patients to the social worker for poverty or some sort of a social 
assistance, but I don’t know how possible that is from the social worker. (P12, occupational 
therapist) 
I think a huge proportion of our population in this area is unemployed, and there is no money 
for pain medication or anything else. They would rather buy food than pain medication. (P2, 
clinical nurse)  
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- Occupation 
Occupation factors and hardship were reported as having an impact on patients’ healthcare-seeking 
behaviour and compliance with treatment. Specific factors that played a role were the type of work 
patients do (labour) as well as employer expectations. Participants noted that occupational factors 
can lead to psychological stress and become a barrier to pain care if patients need to continue their 
normal work activities despite pain.  
Yes, definitely, the stress comes from the fact that most of the times, when the pain is severe; the 
patient can’t go to work. If the patient can’t work, then there is no money and no food in the 
house. That leads to a lot of stress. (P9, clinical nurse) 
They wanted to come, but they couldn’t come because they had to go to work because who is 
going to give them that work’s pay? Even though you tell them you going to get a medical 
certificate, some of the people are on contract and that contract means no work no pay. (P13, 
clinical nurse) 
- Disability insurance 
With regard to disability insurance, participants identified two subsets of patients, namely (1) those 
who sought pain care to enable them to return to their activities and work, and (2) patients who 
sought care for pain, whilst also seeking disability insurance. The search for social-economic relief 
through the healthcare system was described as influencing patient compliance to treatment 
prescription, to disempower and demotivate patients, and to sustain the pain.  
And the one group of patients that tell you as they walk in, that they are struggling to get 
disability insurance, which the doctor does not want to approve, and they need a report. And 
that is why they came for physiotherapy. And in time, as they get better, they realise that they 
don’t have to get disability insurance. But if they have already decided in their heads that they 
are not going to work, they already resigned at work, I am only here for the report, and then 
you struggle. You struggle to get past that barrier. (P7, physiotherapist) 
4.3.2.8 THEME 8: The use of evidence-based practice  
- Clinical practice guidelines 
The participants appeared to have a wide-ranging understanding of what comprises a CPG. Their 
understanding of CPGs included the standard treatment guidelines and EML (2014), care pathways 
(for example the PACK/PULSA Plus), health policies and acts, textbook information, and the 
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principles of care as learnt in the under- and postgraduate training. A need for a chronic pain 
guideline was indicated. 
We use the PULSA PLUS as a guideline, and then we use our EML as standard guidelines for 
chronic care, then also most probably what you have learned in the basic training as your own 
guidelines. We haven’t got specific guidelines saying let’s put this type of pain with that type of 
– you use your clinical text book as your guidelines as well. (P13, clinical nurse) 
We basically use the mental healthcare act and then all the policies and procedures pertaining 
to that. (P14, clinical nurse) 
I realised that they have a need to get up-to-date information about what type of medication can 
be used for chronic pain; because it is a problem for everybody, for example, what medication 
for neuropathic pain? (P7, physiotherapist) 
- Evidence-based practice 
Participants reported to keep up to date with new information and evidence-based practice using 
web based searches, continuing professional education courses and reading articles and textbooks. 
The lack of resources, internet access and time was discussed as barriers to the use of evidence-
based practice. 
Over the past couple of years, I have assembled up a few websites that I trust and can obtain 
information from. That is my guidelines that I use. But if you want information that is based on 
evidence, which is based on experience and understanding, and that, is based on what works, 
that information is not so accessible. (P16, doctor) 
I read a lot since I am still young in the profession. I go back to my books if I really don’t know. 
And I ask my colleagues. (P5, occupational therapist) 
Everything that we know we can use, is not always available here. Our resources are not the 
same as in private practice. (P3, doctor) 
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Table 4.2: Summary of barriers to and facilitators of pain management discussed by 
practitioners 
THEME Category  Barrier Facilitator  
Practitioner beliefs Origin  Biomedical model Biopsychosocial model 
Clinical practice 
patterns 
Assessment Time constraints  
Number of patients seeking care 
Holistic approach 
Belief in thorough assessment 
Interdisciplin
ary 
management 
Lack of awareness of value 
Organisational culture limiting 
teamwork 
Non-efficient referral system 
Availability/access to team  
Distance to team 
Commitment to interdisciplinary 
management 
Awareness of team roles 
Collaborative communication 
Close proximity of team members 
Referral Non-efficient referral systems 
Lack of access to team members 
Waiting lists 
Limited feedback after referral 
Patient role 
Staff capacity (system load) 
Reliance on analgesics 
Efficient referral system 
Close proximity of team members 
Pathway of 
care 
Patient delay in seeking care 
Delayed referral 
System overload 
Early referral 
Interventions for 
pain 
Medication Type of analgesics available 
Amounts allowed to prescribe 
Patient analgesic use 
Essential medicines list 
Re-assessment practice 
Consideration of side-effects 
Exercise Patient non-
adherence/compliance 
 
Benefits of exercise 
Patient adherence/compliance 
Education Lack of education on analgesics  
Language differences 
Time constraints 
Facilitates understanding 
Contribution to self -management 
Psychological 
support 
Limited access to mental health 
practitioners 
Complex interaction of social 
factors 
Patient influence (acceptance) 
Realisation of need 
Group 
therapy 
No involvement of medical 
officer or nursing staff 
 
Interdisciplinary involvement 
High expectations 
Observed positive outcomes 
Self-
management 
Patient adherence and compliance Patient adherence and compliance  
System factors Access to 
care 
Non-availability of practitioners  
Limited consultation times 
Staff shortages, staff turnover 
Availability of practitioners 
Waiting 
times  
System load 
Numbers of patients seeking care 
Lean system 
Triage 
Explanation to patients 
Social and 
environmental 
factors 
Family  Major stressors (e.g. drug abuse, 
domestic violence, gangsterism) 
Support 
Social 
realities 
Economic hardship 
Disability grants 
Occupational influence 
Positive occupational context 
Patient individual 
factors 
- Patient not taking ownership  
Difficulty changing behaviour  
Patient taking ownership  
Behaviour change 
Evidence based 
practice 
Use Time 
Resources 
Internet access 
Availability of guidelines 
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4.4 SUMMARY OF FINDINGS  
This chapter explored practitioners’ beliefs, perspectives and practice patterns for the management 
of CMSP in three public sector community health centres/clinics in the Western Cape of SA. The 
sample included a diverse group of healthcare professionals, who were mostly females and 
Afrikaans-speaking. Participating practitioners conveyed a partly developed biopsychosocial 
construction of CMSP; which was dominated by a structural model, with acknowledgement of the 
influence of psychological, social and environmental factors in the pain experience.  
Participating practitioners identified a variety of factors that influenced pain care as barriers to, or 
facilitators for optimal CMSP management. These barriers and facilitators were largely congruent 
with the contextual factors that influenced pain management as identified by patients in Chapter 3, 
and were: individual characteristics of patients and clinicians, intervention (treatment) factors, 
healthcare system factors and social, environmental and occupational factors (summarised in Table 
4.2). Patients’ adherence to prescribed treatment and taking ownership for self-management were 
regarded as important aspects of pain management. Additionally, practitioners communicated their 
need for education and access to information to optimize evidence-based practice. The system 
factors that practitioners identified to that play a role in the provision of pain care is in accordance 
of those identified by participating patients (Chapter 3), namely long waiting times for consultation, 
limited time during consultation, lack of continuity of care and access to health professionals. There 
were indications that patients’ healthcare pathways are influenced by delayed health care seeking, 
delayed referral to rehabilitation and reliance on analgesics. 
A variety of strategies were reportedly used for pain management, which consists mainly of 
analgesics, advice, education and exercise. Participants acknowledged the importance of holistic 
and interdisciplinary care for CMSP, but admitted that several factors limited optimal 
interdisciplinary care. The EML (National Department of Health, 2014) and PACK Adult 
(Knowledge translation unit, 2016) (see section 2.3.4) were reported to play a central role to guide 
the practice pattern of nurses and doctors in this context. However, participants had a wide-ranging 
use and understanding of the concept of CPG’s (theme 4.3.2.8). The management of CMSP was 
reported to be complex due to the many societal, psychological and system factors that influenced 
pain care. Practitioners recognized the patients’ need for psychological support to cope with the 
challenges experienced as part of CMSP. However, there was a low reported use of cognitive 
therapies and psychologically based therapies; that could indicate a low use of psychosocial 
management options. Practitioner participants confirmed the tension that exists between working 
despite pain and unemployment that patient participants acknowledged in section 3.4.2.4.  
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PART 1: UNDERSTANDING THE CONTEXT 
SUMMARY  
The focus of Part 1 of the dissertation was on exploring and reporting on the authentic context 
within which CMSP is managed in PHC in selected resource-constrained community health care 
centres/clinics in the Western Cape of SA. The key informants were patients with CMSP and 
practitioners involved in the healthcare management of patients with CMSP.  
The findings indicate that CMSP is relatively common complaint in PHC practice (Table 4.1). 
CMSP was reported to be experienced as a multidimensional phenomenon, which influenced the 
patients who participated in this study in multiple ways. Participants largely agreed on the type of 
contextual factors that influence pain management. These contextual factors nominated by 
participants in Chapters 3 and 4 are summarised in Figure Part1b and include personal 
characteristics of the patient, the social and environmental circumstances within which the patient 
lives, the healthcare interventions received, and healthcare system factors. These constructs are 
congruent with the conceptual framework of the ICF (WHO, 2013), in which activity limitations are 
viewed as the interaction between the individual, the health condition, and a range of environmental 
circumstances. Patients’ social, environmental and family circumstances and the realities of their 
financial and social needs were reported to complicate the treatment of pain by influencing the 
management priorities. Allegrettia et al. (2010), in a United Kingdom (UK)-based study, found 
similar complexities for pain management. Surprisingly, and in contrast to the literature about 
patient-centredness (Mead & Bower, 2000; Kidd et al., 2011), the personal characteristics of the 
practitioner were not reported to be a key determinant in the provision of care for CMSP. 
The exploration and understanding of the context and the perspectives of stakeholders were needed 
to inform the development of a CPG for CMSP in this context. The findings indicated that patient 
participants’ beliefs influenced their interaction with the healthcare system (e.g. health-seeking 
behaviours) and their interaction with the condition (e.g. coping skills). Contextually relevant 
education could play a vital role in quality care of patients with CMSP, to affect patients’ belief 
systems about CMSP and its management. Similarly, there are indications that the perspectives of 
practitioners influenced their management choices, for example how they explained pain to patients. 
Practitioner participants elaborated on several context-specific barriers to the care of CMSP and the 
relevant facilitators, which can be utilised for the contextualisation and implementation of the CPG. 
Practitioners identified interdisciplinary care, empowerment for self-management, and occupational 
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enablement as important issues to be addressed in CMSP management. A similarity identified 
between participating patients and practitioners was the need for psychological support for patients 
with CMSP. The findings highlight the strengths and limitations in the primary healthcare provision 
for CMSP and attention to these factors may influence practice patterns, healthcare systems, 
education and CPG development and implementation.  
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Figure Part 1b: Framework  of contextual factors 
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PART 2: EVIDENCE SOURCING AND SYNTHESIS 
INTRODUCTION 
Part 1 provided a portrayal of the context in which the CPG for CMSP was envisaged to be 
implemented. The next step in the process was to source and summarise evidence-based strategies 
for the management of CMSP through a systematic review and synthesis (Figure Part2a).  
The development and implementation of CPGs is an emerging concept in the healthcare sector in 
SA (section 2.3.4). When considering the development of a CPG for the management of CMSP in 
the SA context, it was important to consider whether such a guideline already exists, whether 
existing guidelines are of high quality and whether such guidelines represents the holistic and 
multimodal management for CMSP. Knowledge about the existence and quality of a CPG for 
CMSP in primary care would inform the choice between adoption, adaptation, contextualisation or 
de novo development of a CPG(s) (see section 2.3.3). A systematic review of existing CPGs was 
therefore conducted to address this knowledge gap (reported on in Chapter 5). 
In Chapter 6, which is essentially an extension of Chapter 5, the process of extracting, evaluating 
and synthesising evidence-based recommendations from existing high-quality CPGs as identified in 
Chapter 5, was described. The crafting of recommendations by grouping, analysing and merging 
similar recommendations is described. Additionally, the criteria used to methodically analyse and 
merge the recommendations while retaining their underpinning evidence base are demonstrated. 
This adoption and transformation of the recommendations is a core process in CPG 
contextualisation. As part of contextualisation, particular attention is paid to phrasing synthesised 
recommendations. Gagliardi, Brouwers, Palda, Lemieux-Charles and Grimshaw (2009) and Woolf 
et al. (2012) argue that the content, format and wording of guideline recommendations can have an 
impact the use and uptake of a CPG in clinical practice. If a recommendation is worded 
appropriately, the end-users of the recommendation should be able to understand the foundational 
message, as well as the strength of the body of evidence underpinning the recommendation.  
The end-product of the Part 2 of this dissertation was a core set of carefully worded evidence-based 
recommendations for the multimodal management of CMSP in PHC settings. 
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CHAPTER 5  
A SYSTEMATIC REVIEW OF CLINICAL PRACTICE 
GUIDELINES FOR THE PRIMARY HEALTH CARE OF 
CHRONIC MUSCULOSKELETAL PAIN  
5.1 AIM  
The aim of this systematic review was to methodically identify and appraise the available evidence-
based clinical practice guidelines for the management of adults with chronic musculoskeletal pain 
in primary health care settings.  
5.1.1 Objectives 
The objectives were the following: 
 Identify profession-specific or inter-/multi-disciplinary CPGs on the management of CMSP in 
PHC settings. 
 Critically appraise the quality of the included CPGs using the AGREE II tool. 
 Determine the currency of the CPGs. 
 Determine the grading systems used to define the level/quality of evidence and the strength of 
the recommendation in the CPGs. 
 Summarise the content of the high-quality CPGs. 
5.2 METHODS 
5.2.1 Study design 
A systematic review for clinical practice guidelines regarding the primary care of CMSP was 
conducted, to systematically identify and appraise current, existing CPGs on the topic (Green 2005). 
The review protocol was registered on PROSPERO (registration number CRD42015022098). 
5.2.2 Study criteria  
The study criteria were formulated using the PIPOH format (Population, Intervention, Professions, 
Health Outcomes and Health setting) for guideline reviews (ADAPTE II Collaboration, 2009). The 
types of studies eligible were CPGs available in full text and published from January 2000 to May 
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2015. The cut-off date was set to ensure up-to-date CPGs. The target population and disease 
characteristic for the review included adults with CMSP. It was anticipated that recommendations 
for CMSP would be included in CPGs for chronic non-malignant pain. CPGs that focused 
exclusively on chronic pain from non-musculoskeletal origin such as sickle cell disease, 
neuropathic pain and malignancy were excluded due to the differences in pathology, pain 
mechanisms and possible management strategies.  
The types of interventions could include evaluation, diagnosis and management of CMSP. 
Examples of such interventions are pharmacological and non-pharmacological management, 
rehabilitative options and self-management. CPGs targeting any healthcare professionals involved 
in the management of CMSP were eligible for inclusion. The expected outcomes of CPGs could 
include patient outcomes, system outcomes or public health outcomes. For the purpose of this 
review, only CPGs focused on PHC settings were included. CPGs that focused solely on secondary, 
tertiary or specialist healthcare settings were excluded due to different management options offered.  
5.2.3 Search strategy  
The PI searched the electronic databases of the following guideline clearinghouses: the US National 
Guideline Clearinghouse (US NGC); the Agency for Healthcare Research and Quality (AHRQ); the 
Guidelines International Network (G-I-N); the Scottish Intercollegiate Guidelines (SIGN); the 
United Kingdom’s National Institute for Health and Clinical Excellence (NICE); the New Zealand 
Guidelines Group (NZGG); the WHO guidelines; the TRIP database; the National Institutes of 
Health (NIH); the Monash University Centre for Clinical Effectiveness; Australia’s National Health 
and Medical Research Council (NHMRC); the Canadian Medical Association Clinical Practice 
Guidelines Infobase, and the Institute for Clinical Systems Improvement (ICSI). In addition, the 
following online databases were searched to include those guidelines that were peer reviewed and 
published in journals: CINAHL, PEDro; PubMed, EBSCO host and Medline. The broad search 
terms included: clinical practice guidelines; OR clinical guidelines; OR care pathway; OR clinical 
pathway; OR care protocol; AND chronic pain; OR chronic musculoskeletal pain; OR chronic non-
malignant pain; OR chronic non-cancer pain; AND adults; AND primary care; OR primary health 
care.  
The initial search was conducted from July 2014 to October 2014, and the search was updated 
during May 2015. The inclusion and exclusion criteria were applied by screening the identified 
CPG titles and objectives to select the eligible CPGs. The data were extracted in the PIPOH format 
to enable this analysis. The process was verified by the co-authors on a random audit basis. A 
record of search yields and decision-making was kept.  
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5.2.4 Data extraction  
The PI extracted the following data into custom-built Excel data extraction sheets: 
 The clinical question formulation using the PIPOH format  
 Guideline currency: The publication date of the CPG and periods covered by the literature 
search in the guideline and date of revision 
 General information: The developing organisation/authors; country of publication and language 
of publication 
 Guideline content: The PI extracted all recommendations contained within the high-quality 
CPGs into an Excel spreadsheet to develop a comprehensive recommendation matrix (ADAPTE 
II Collaboration, 2009).  
5.2.5 Critical appraisal 
The methodological quality of eligible CPGs was independently assessed by three reviewers using 
the AGREE II instrument. The AGREE II is an internationally developed, widely accepted, valid, 
reliable, easy to use and transparent instrument to assess the reported methodological rigour of the 
CPG (Vlayen et al., 2005; AGREE Enterprise, 2010; Brouwers, Kho, Browman, Burgers, Cluzeau, 
Feder, Fervers, Graham, Grimshaw, Hanna, Littlejohns, Makarski & Zitzelsberger, 2010). It 
contains 23 key quality items categorised in six domains, scored on a 7-point Likert scale. The 
AGREE II evaluates the process of CPG development and the quality of reporting. However, it does 
not evaluate the content of the CPG, nor the quality of evidence supporting the recommendations. 
Each AGREE II domain focuses on a separate aspect of guideline quality, namely scope and 
purpose, stakeholder involvement, rigour of development, clarity of presentation, applicability, and 
editorial independence.  
The reviewers’ AGREE II scores were entered into Excel by the PI. Any difference in score higher 
than two points was discussed amongst the project team to reach consensus. A quality score was 
calculated for each of the six AGREE II domains using the guiding principles and formula provided 
in the user manual. All item scores in a domain were summed and the total was standardised as a 
percentage of the maximum possible score for that domain. The data was nonparametric and 
therefore the median domain score and range for each domain was calculated (Kredo et al. 2012). 
The manual warns against aggregating all domain scores into one single quality score. The 
following formula was used: 
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Domain score =  
Obtained score – Minimum possible score 
____________________________________________     x 100 
Maximum possible score – Minimum possible score 
=  % 
5.3 RESULTS 
5.3.1 Search results 
The results of the systematic search are summarised in Figure 5.1. The search yielded two 
categories of CPGs, namely comprehensive CPGs and CPGs that were published in journal article 
format. Where indicated, contact was made with the authors to obtain full-text CPGs. Thirty-four 
eligible CPGs were considered for inclusion. After applying the inclusion/exclusion criteria, 12 
CPGs were included. The main reasons for exclusions are summarised in Figure 5.1. 
5.3.2 Included clinical practice guidelines 
Table 5.1 summarises information about the included CPGs and their currency. Six out of the 12 
included CPGs focused exclusively on the prescription of opioids (CPGs 1, 3, 6, 7, 8 & 10), and 
two focused specifically on the management of musculoskeletal pain (CPG 9 & 12). One CPG 
originated from SA (CPG 10). 
5.3.3 Methodological quality  
The AGREE II domain scores (median and range) are provided in Table 5.2. The domains with the 
lowest median score were domain 2 (stakeholder involvement), domain 3 (rigour of development) 
and domain 5 (applicability). Further analysis of each question within a domain is represented in 
Table 5.3.  
CPGs consistently did not adhere to topic 5 in domain 2 (views and preferences of target 
population). Only 3 of the 12 included CPGs reported that they sought patient perspectives as part 
the CPG development. The methods used in these CPGs were focus groups with patients (CPGs 3 
and 2), patients as part of the guideline development group (CPG 5), a literature search of patients’ 
preferences (CPG 5), and an environmental scan through surveys, key informant interviews and 
focus groups (CPG 2). Some CPGs also did not identify the strengths and limitations of evidence 
(topic 9). Within domain 3, topic 14 had the lowest scores, indicating that few CPGs included a 
procedure for updating the CPG. All four topics in domain 5 (applicability) were challenging for the 
CPG developers, as indicated by the low scores. 
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Figure 5.1: Diagram of search results (PRISMA format) 
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Table 5.1: Included clinical practice guidelines (n = 12) 
CPG 
number 
Title of guideline Organisation/Authors 
Country of 
origin 
Guideline currency 
Date for 
revision 
Publication 
date 
Search dates 
covered 
CPG 1 
 
Guidelines for responsible opioid 
prescribing in chronic non-cancer pain:  
Part 1 – Evidence; Part 2 – Guidance 
American Society of 
Interventional Pain Physicians 
(ASIPP) (Manchikanti et al., 
2012) 
USA June 2015 2012 
(update on 2008 
version) 
Not stated 
CPG 2 Assessment and management of chronic 
pain 
Institute for Clinical Systems 
Improvement (ICSI) (Hooten et 
al., 2013) 
USA Every 24 
months, i.e. 
December 2015 
2013 
(update on 2011 
version) 
August 2011-
August 2013 
CPG 3 Canadian guideline for safe and effective 
use of opioids for chronic non-cancer 
pain 
National Opioid Use Guideline 
Group (NOUGG) (2010) 
Canada Not stated 2010 2005-July 2009 
CPG 4 Assessment and management of pain Registered Nurses’ Association 
of Ontario (RNAO) (2013) 
 
Canada Every 5 years, 
i.e. 2018 
2013 
(update on 
2002, 2007 
versions) 
2007-2012 
CPG 5 Management of chronic pain: A national 
clinical guideline  
 
Scottish Intercollegiate 
Guidelines Network (SIGN) 
(2013) 
UK In 3 years, i.e. 
2016 
2013 
 
2007-2012 
CPG 6 Managing chronic non-terminal pain in 
adults, including prescribing controlled 
substances 
University of Michigan Health 
System (UMHS) (2011) 
USA Not stated 
(Previous was 
2009, 2011) 
2011 1995-2010; 
(search dates 
1998-2002) 
CPG 7 Interagency guideline on opioid dosing 
for chronic non-cancer pain: an 
educational aid to improve care and 
safety with opioid treatment 
Washington State Agency 
Medical Directors Group 
(WSAMDG) (2010) 
USA Not stated 
 
2010 
(update on 2007 
version) 
Not stated 
CPG 8 Clinical guidelines for the use of chronic 
opioid therapy in chronic non-cancer 
pain 
American Pain Society (APS) – 
American Academy of Pain 
Medicine (AAP), (Chou, 
Franciullo, Fine & Adler, 2009) 
USA 2012 2009 Through to July 
2008 (not stated 
from when) 
CPG 9 Managing musculoskeletal complaints 
with rehabilitation therapy: Summary of 
the Philadelphia Panel evidence-based 
The Philadelphia Panel Members 
and Ottawa Methods Group, 
2001 (Harris & Susman, 2002) 
Canada and 
USA 
Not stated 2002 Through to July 
2000 
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CPG 
number 
Title of guideline Organisation/Authors 
Country of 
origin 
Guideline currency 
Date for 
revision 
Publication 
date 
Search dates 
covered 
clinical practice guidelines on 
musculoskeletal rehabilitation 
interventions 
CPG 10 South African guideline for the use of 
chronic opioid therapy for chronic non-
cancer pain 
Raff et al. (2014) SA Not stated 2014 Not stated 
Four existing 
CPGs published 
between 2009 
and 2012 were 
chosen (CPG 1, 
2, 8 in this 
table) 
CPG 11 Evidence-based clinical practice 
guidelines for interdisciplinary 
rehabilitation of chronic non-malignant 
pain syndrome patients  
Sanders, Harden and Vicente 
(2005) 
USA Every 4 years 2005 
(update on 
1995, 1999 
versions) 
September 1999 
(end-date not 
stated) 
CPG 12 Update on guidelines for treatment of 
chronic musculoskeletal pain 
Schnitzer (2006) USA Not stated 2006 Not stated 
(CPG = Clinical Practice Guideline; USA = United States of America; UK = United Kingdom; SA = South Africa) 
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Table 5.2: Combined AGREE II scores in % 
 CPG 
1 
CPG 
2 
CPG 
3 
CPG 
4 
CPG 
5 
CPG 
6 
CPG 
7 
CPG 
8 
CPG 
9 
CPG 
10 
CPG 
11 
CPG 
12 
Median IQR 
Domain 1:  
Scope and purpose 
89 96 98 80 93 48 89 76 67 78 63 48 79 24 
Domain 2:  
Stakeholder involvement 
65 85 91 70 100 52 63 80 57 35 22 15 64 34 
Domain 3:  
Rigour of development 
72 85 94 88 94 47 40 84 60 30 51 30 66 41 
Domain 4:  
Clarity of presentation 
91 89 87 96 98 87 69 90 83 69 57 72 87 19 
Domain 5:  
Applicability 
60 79 75 92 79 53 32 43 21 14 15 7 48 57 
Domain 6:  
Editorial independence 
97 100 100 67 67 97 44 100 25 100 0 86 91.5 39 
TOTAL 474 534 545 493 531 384 337 473 313 326 208 258   
Overall score out of 7 5 5.6 6 5.3 6.5 4 3.6 5 3.6 3 3 3   
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Table 5.3: All AGREE II domain scores 
 
CPG 
1 
CPG 
2 
CPG 
3 
CPG 
4 
CPG 
5 
CPG 
6 
CPG 
7 
CPG 
8 
CPG 
9 
CPG 
10 
CPG 
11 
CPG 
12 
Total % 
DOMAIN 1: SCOPE AND PURPOSE 
1. Overall objectives specific 21 20 21 17 18 18 19 17 15 16 13 14 209 83% 
2. Health questions specific 18 20 21 19 21 9 18 16 14 15 13 9 193 77% 
3. Population specific 18 21 20 16 20 8 20 17 16 20 17 12 205 81% 
DOMAIN 2: STAKEHOLDER INVOLVEMENT 
4. Guideline development group 19 18 20 15 21 15 18 19 20 7 6 10 188 75% 
5. Views and preferences of target 
population 5 21 18 11 21 6 7 14 2 4 3 3 115 46% 
6. Target users clearly defined 20 16 20 21 21 16 18 19 18 17 12 4 202 80% 
DOMAIN 3: RIGOUR OF DEVELOPMENT 
7. Systematic methods 15 17 21 21 21 19 10 13 12 6 16 4 175 69% 
8. Criteria for evidence selection 14 19 21 21 21 17 5 15 19 7 16 4 179 71% 
9. Strengths and limitations of evidence 13 19 20 18 18 6 5 20 19 10 9 4 161 64% 
10. Methods for formulating 
recommendations 19 17 21 18 19 8 10 21 17 5 8 11 174 69% 
11. Health benefits, side-effects, risks 
were considered in formulating 
recommendations 20 19 19 17 19 19 21 21 9 18 12 20 
 
214 85% 
12. Explicit link between 
recommendations and evidence 19 17 21 20 21 12 10 19 17 11 12 12 
 
191 76% 
13. Externally reviewed prior to 
publication 15 18 21 16 21 6 16 18 15 7 10 9 172 68% 
14. A procedure for updating guideline 13 20 15 20 19 5 4 18 3 3 14 3 137 54% 
DOMAIN 4: CLARITY OF PRESENTATION 
15. Recommendations specific; 
unambiguous 20 19 21 20 20 18 17 20 17 15 13 18 218 87% 
16. Different options for management 18 19 14 21 21 20 13 18 18 15 15 16 208 83% 
17. Key recommendations easily 
identifiable 20 19 21 20 21 18 16 20 19 14 12 14 214 85% 
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CPG 
1 
CPG 
2 
CPG 
3 
CPG 
4 
CPG 
5 
CPG 
6 
CPG 
7 
CPG 
8 
CPG 
9 
CPG 
10 
CPG 
11 
CPG 
12 
Total % 
DOMAIN 5: APPLICABILITY 
18. Barriers to and facilitators of 
application 15 16 19 20 17 11 6 8 11 4 4 5 136 54% 
19. Advice/tools to put recommendations 
to practice 14 20 21 20 18 8 13 10 9 7 8 6 
 
154 61% 
20. Potential resource limitations have 
been considered 9 13 12 18 15 11 7 12 4 3 3 3 
 
110 44% 
21. Monitoring and audit criteria 15 20 14 20 19 20 9 13 3 8 8 3 152 60% 
DOMAIN 6: EDITORIAL INDEPENDENCE 
22. Views of funding body vs guideline 
content 20 21 21 15 10 20 14 21 12 21 3 17 195 77% 
23. Competing interests of guideline 
development group members have been 
recorded and addressed 21 21 21 15 20 21 8 21 3 21 3 20 195 77% 
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5.3.4 Evidence-grading systems used in clinical practice guidelines 
The CPGs used a variety of grading systems to categorise the levels/quality of evidence and the 
strength of the recommendation. These grading systems are summarised in Table 5.4. Three CPGs 
did not grade the level of evidence or the strength of the recommendation. Four CPGs graded the 
level/quality of evidence, but not the strength of the recommendation. 
5.3.5 Guideline content analysis 
The recommendations contained in the good quality CPGs were extracted for further use to ensure 
soundness of recommendations. The AGREE Enterprise (Brouwers et al., 2010) does not provide 
cut-off scores to differentiate between high-quality and poor-quality guidelines. They advise that 
the decision of poor- and high-quality guidelines should be made by the user and taking the context 
into account. A range of criteria were therefore used to identify the CPGs that did not qualify for 
further content analysis for the purpose of the project (see below). CPGs 6, 7, 9, 10, 11 and 12 were 
excluded from further analysis based on a combination of the following criteria: 
 No clear recommendation statements were identifiable (CPG 9, 10, 11 & 12). The writing style 
of these CPGs focused on a discussion of relevant information, and was less focused on making 
clear recommendations.  
 The CPG median score for methodological quality was below 50% (CPG 6, 7, 10 &12). This 
was a more conservative exclusion than Brosseau, Rahman, Toupin-April, Poitras, King, De 
Angelis, Loew, Casimiro, Paterson and McEwan (2014), who used a quality cut-off score of 
mean 60%.  
 The CPG did not link their recommendations to the evidence base or references (CPG 6, 7, 9, 
10, 11 & 12) 
 Recommendations were condition specific or did not differentiate between acute and chronic 
pain (CPG 9 &12). 
A total of 156 recommendations were extracted from CPGs 1, 2, 3, 4, 5 and 8. The 
recommendations were grouped into similar health questions/topics which consisted of general 
assessment, approach to care, non-pharmacological management and pharmacological management. 
Table 5.5 provides an overview of the number of recommendations that were made per health topic 
and indicates from which CPG the recommendation originated.  
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Table 5.4: Grading systems used to determine the level/quality of evidence and the 
strength of the recommendation 
Guideline 
Name of grading 
system 
Level/quality of 
evidence grading 
Strength of 
recommendation 
CPG 1 ASIPP 
2012 
United States 
Preventive Services 
Task Force 
(USPSTF) criteria 
Good 
Fair 
Poor 
None 
CPG 2 ICSI 2013 In transition from 
ISCI system to 
GRADE Thus using a 
hybrid system 
High-quality 
evidence 
Low-quality evidence 
None 
CPG 3 NOUGG 
2010 
- I  
II-1 
II-2 
II-3 
OR III 
A  
B  
C 
CPG 4 RNAO 
2013 
Adapted SIGN Ia  
Ib  
IIa  
IIb  
III  
IV  
None 
CPG 5 SIGN 
2013 
SIGN 1++; 1+ 
2++; 2+; 2- 
3 
4 
A  
B 
C  
D 
Good practice point 
CPG 6 UMHS 
2011 
- A 
B 
C 
D 
I 
II 
III 
CPG 7 WSAMD
G 2010 
Rating scheme (not 
provided) 
Not provided None 
CPG 8 APS AAP 
2009 
Adapted GRADE 
methodology. 
High-quality  
Medium quality  
Low-quality  
Strong  
Weak  
CPG 9 Harris & 
Susman 
2002 
Modified Canadian 
Task Force Grading 
System 
I, 
II-1 
II-2 
II-3  
 III 
A,  
B,  
C 
CPG 10 Raff et al. 
2014 
- None None 
CPG 11 Sanders 
et al. 2005 
- None None 
CPG 12 Schnitzer 
2006 
- None None 
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Table 5.5: Summary table of number of recommendations extracted from high-quality 
CPGs 
5.4 SUMMARY OF FINDINGS 
This systematic review focused on identifying and appraising profession-specific or inter-/multi-
disciplinary CPGs for the management of CMSP in the PHC context. Twelve up-to-date CPGs were 
included in the review; of which half contained multi-disciplinary recommendations. The 
publication dates of the CPGs ranged from 2002 – 2014. Eleven of the 12 guidelines originated 
from developed countries and one originated from SA.  
The included CPGs varied in their scope, coverage, format and quality. One guideline focussed 
specifically on CMSP. Recommendations for the management of CMSP were mostly imbedded in 
the CPGs for the management of chronic non-malignant pain. Six out of the 12 CPGs were rated as 
high-quality using the AGREE II (2013) criteria. The lowest scores were obtained for the AGREE 
II domains of rigour of development, stakeholder involvement and applicability. The highest 
AGREE II scores were obtained for the domains of scope, focus and clarity of presentation. An 
important finding was the inconsistent use of frameworks to aggregate the level of evidence, quality 
of the body of evidence and the strength of the recommendation in the CPGs. The preliminary 
content analysis of the high-quality CPGs indicated that the recommendations for CMSP in primary 
care focussed on opioid prescription; there is little focus on non-pharmacological management 
options. In Chapter 6, the content analysis of the recommendations was further explored. 
  
RECOMMENDATION 
TOPIC 
TOTA
L 
Total 
% 
CPG 
1 
CPG 
2 
CPG 
3 
CPG 
4 
 CPG 
5 
CPG 
8 
General assessment 11 7%  5  4 2  
Approach 6 4%  1  4 1  
Non-pharmacological 
options 
27 17%       
Physical therapy    7   5  
Psychology    2  1 3  
Education     1 1 1  
Multi-disciplinary       1  
Complementary therapies    1   1  
Self-management    1   2  
Pharmacological options 112 72%       
Pharmacology (non-opioids) 26 17%  10  1 15  
Pharmacology (opioids) 86 55% 22 4 25 1 9 25 
Total 156 100 22 31 16 12 40 25 
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CHAPTER 6  
WORD-SMITHING:  
CONTEXTUALISING RECOMMENDATIONS 
6.1 AIM 
The aim of this chapter is to describe the process of synthesising the recommendations extracted 
from the high-quality CPGs identified in Chapter 5. 
6.1.1 Objectives 
The objectives of this chapter were the following:  
 Merge compound (multiple but similar) recommendations extracted from the different CPGs 
into one recommendation/phrase. 
 Write the recommendations in such a way that they reflect the combined level/quality of 
evidence and strength of the recommendation as extracted from the source CPGs. 
 Develop a core list of evidence-based recommendations that incorporates multimodal strategies 
for inter-/multi-disciplinary care. 
6.2 METHODS 
6.2.1 Methodology  
The methodology of this chapter is an in-depth content analysis of recommendations that were 
extracted as part of the systematic review (Chapter 5). Additionally, this chapter describes the 
principles and procedures of merging CPG recommendations as a step in the CPG contextualisation 
process.  
6.2.2 Data extraction and analysis 
The data consisted of the 156 recommendations that were extracted as part of the systematic review 
presented in Chapter 5. The PI extracted the following information in an Excel spreadsheet: The 
health question (topic), the exact wording of each recommendation, the level/quality of evidence 
assigned, the strength of the recommendation, and the references accompanying each 
recommendation. Similar recommendations were grouped in preparation for further 
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contextualisation. Each recommendation was evaluated according to the criteria developed for 
contextualising CPGs by the Philippine Academy of Rehabilitation Medicine (PARM) group 
(Gonzalez-Suarez et al., 2012; PARM, 2012) as outlined in Table 6.1. Due to the different 
frameworks used to evaluate the level of evidence (Table 5.4); a conversion table for the level of 
evidence between studies was developed to enable consistency (Table 6.1(b) and Appendix 18).  
6.2.3 Merging of recommendations 
The wording and evidence level of each compound recommendation was merged using the adapted 
PARM writing guide (Table 6.2 and Appendix 19), to form a merged recommendation statement. 
The guide was adapted to include more evidence criteria and to provide either a strong or a weak 
recommendation. The approach of providing either a strong or weak recommendation provides 
greater clarity and is congruent with the approach of GRADE (Grading of Recommendations, 
Assessment, Development and Evaluation) (Woolf et al., 2012), NHMRC (Australian National 
Health and Medical Research Council) (Hillier, Grimmer-Somers, Merlin, Middleton, Salisbury, 
Tooher &Weston, 2011) and the United Kingdom’s National Institute for Health and Clinical 
Excellence (NICE, 2016). The writing guide was used to categorise the level of evidence using 
specific criteria, in order to guide the phrasing of the recommendations. The faces in the writing 
guide were adopted from the PARM group and were thought to be an easy way to recognize the 
level of evidence underpinning a recommendation (Table 6.2 and Appendix 29). Final 
recommendations statements were created by applying these principles consistently to the 
recommendations. Due to the total number of recommendations that had to be merged, only 
examples are illustrated in Table 6.3 (and Appendix 20). The examples illustrate how similar 
recommendations were analysed and merged using the writing guide. If there was only one 
recommendation about a health topic, that recommendation was adopted and re-phrased using the 
writing guide. Once the full CPG document is produced, all original recommendation statement will 
appear verbatim as stated in the original CPG, and will be appropriately referenced.  
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Table 6.1: Criteria for evaluating recommendation statements (PARM, 2012a; Gonzalez-
Suarez, 2012) 
Criteria Explanation of criteria 
a) Consistency of 
recommendations 
content 
Consistency of the recommendations relating to a health/clinical 
question within the different CPGs was compared for their level of 
similarity/comparability. This construct was labelled ‘uniformity of 
thought’.  
b) Consistency within 
the levels of 
evidence 
The consistency of the levels of evidence underpinning each 
recommendation was compared. The level of evidence was rated as 
consistent or inconsistent based on the homogeneity of the levels of 
evidence that CPG developers assigned to that recommendation.  
The quality level of evidence was graded high, moderate, or low.  
• High-quality evidence could be variously described as levels I or II; 
A or B in the guidelines.  
• If the evidence was graded as either level II or III/B or C, it was 
classified as moderate-quality evidence.  
• Low-quality evidence was described as level III or IV/C or D. 
• Recommendations based on expert opinion or the consensus of the 
guideline development group was identified as Good Practice 
Points (GPPs), and a level of evidence was not assigned. 
c) Volume of 
literature 
The volume of literature was assessed and graded according to the 
following principles: 
• low volume (3 references or less) 
• moderate volume (4-7 references)  
• high volume (8+ references) 
d) Currency of 
literature 
To determine the currency of literature for each recommendation, the 
age of the references was assessed. A six-year cut-off was used to 
determine currency, to allow for the lag in production to publication of 
CPGs: 
• Current: If 50% of the papers cited were published later than 2009  
• Non-current: If 50% of the papers cited were published prior to 
2009  
e) Strength of 
recommendation 
The strength of the recommendation is influenced by contextual 
factors. For this part of the process, only the strength of the evidence 
and the balance between desirable and undesirable effects was 
considered. The strength of the recommendation was thus not used 
during the merging, due to the limited reporting of the strength of the 
recommendations in CPGs. 
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Table 6.2 Writing guide for merging the level of evidence  
Phrase for strength of evidence 
Words for writing the 
endorsements 
Symbol 
There is strong evidence. We strongly recommend. 
 
There is evidence. We recommend. 
 
There is limited/conflicting 
evidence. 
OR  
There is expert consensus that 
it is good practice. 
*We suggest that clinicians 
consider.  
There is no evidence. 
We do not recommend. 
 
(Adapted from Gonzalez-Suarez et al., 2012) 
*In the absence of a strong evidence base, but where plausible hypotheses exist for a particular 
recommendation (such as theoretical explanations, physiological rationale, expert consensus or other forms 
of such data), the clinician should use his or her own discretion by applying clinical reasoning to make a 
decision.  
 
 
 
 
6.2.4 Quality assurance and data verification 
The PI extracted the recommendations from the relevant CPGs. The analysis and merging of 
wording and evidence levels of recommendations was led by the PI, and it was verified by a 
member of the PARM contextualization innovation, a research assistant and the two supervisors. 
The tables of recommendations (as illustrated in Table 6.3 and Appendix 20), together with the 
analysis and merged statement was presented to the PARM member and the research assistant and 
discussed until consensus was reached. The two supervisors verified the accuracy of the statements. 
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Table 6.3: Example of recommendation on approach: shared decision-making and goal-
setting 
Recommendation  
Source 
guideline 
Quality level of 
evidence 
Strength of 
recommendation 
References 
(15) 
Shared decision-making for 
treatment of chronic pain 
needs an understanding of the 
patient's ethnic and cultural 
background, age, gender and 
spirituality in order to work 
with the patient's chronic pain 
symptomatology. 
ICSI, p23 High quality  
Moderate 
quality  
Low quality  
- 4 
 
Collaborate with the person to 
identify their goals for pain 
management and suitable 
strategies to ensure a 
comprehensive approach to 
the plan of care. 
RNAO, p8 High quality  
Moderate 
quality  
Low quality 
- 10 
Clinicians should define the 
goals of therapy before 
prescribing medications, and 
tailor medications to meet the 
individual goals of each 
patient. 
ICSI, p35 Low quality - 1 
Criteria for evaluation: there is uniformity of thought; with inconsistent levels of evidence and 
a high volume of non-current references. 
Merged level of evidence: There is evidence. 
Merged endorsement statement: We recommend collaborative decision-making which includes 
identifying patient goals; developing a comprehensive and patient-specific pain management 
strategy that considers the age, gender, ethnic and cultural background; and spirituality of the 
patient. 
 
 
6.3 RESULTS 
The original 156 individual recommendation statements were reduced to 43 individual statements, 
by merging statements and eliminating statements concerning opioids that were not relevant to the 
SA PHC policies (see section 2.3.4). Examples of merging recommendations are shown in Table 
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6.3 and Appendix 20. These examples illustrate the varying use of the strength of recommendation; 
the use of appropriate and non-appropriate phrasing to communicate the strength of the evidence.  
A summary of the merged recommendations and their level of evidence are provided in Table 6.4. 
One statement had a strong recommendation, based on a strong body of evidence; and one 
statement could not be endorsed base on insufficient evidence for efficacy. Several other 
interventions were discussed in CPGs, for which no recommendations were made, perhaps due to 
insufficient evidence for or against their use (Woolf et al., 2012). The interventions for which no 
recommendations were the following: acceptance and commitment therapy; aromatherapy; dietary 
therapies; herbal medicine; homeopathy; hypnotherapy; Reiki; healing touch/therapeutic touch; 
mindfulness meditation; diaphragmatic breathing; imagery; autogenic training; progressive muscle 
relaxation training; music therapy; pain neurophysiology education; reflexology and traction.
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Table 6.4: Summary of merged recommendations and their level of evidence  
Topic 
 
Sub-topic 
Recommendations 
merged into 1 
Merged level of evidence Endorsement 
Approach  Patient-centredness 3 There is evidence We recommend 
Shared decision-making and goal-setting 3 There is evidence We recommend 
Interprofessional collaboration 3 There is evidence We recommend 
Assessment Holistic assessment  5 There is evidence We recommend 
Assessment tools/instruments 2 There is evidence We recommend 
Reassessment 2 There is some evidence We recommend 
Classification of pain Classification of pain 2 There is some evidence We recommend 
Special investigations Special investigations 2 There is evidence We recommend 
Advise and educate Address concerns 1 There is evidence We recommend 
Advice to stay active 1 There is some evidence We recommend 
Brief education 1 There is evidence We recommend 
Pharmacological 
management 
Education about analgesia  2 There is some evidence We recommend 
Analgesic review 1 There is limited evidence/ 
There is expert consensus 
We suggest that the 
clinician considers 
Paracetamol 3 There is some evidence We recommend 
Oral NSAIDs 3 There is evidence We recommend 
Topical NSAIDs 2 There is evidence We recommend 
NSAIDs risks 3 There is evidence We recommend 
Muscle relaxants 1 There is insufficient 
evidence 
We do not endorse 
Topical rubefacients 1 There is some evidence We recommend 
Antidepressant therapy  2 There is some evidence We recommend 
Antidepressant therapy review 1 There is limited evidence/ 
There is expert consensus 
We suggest that the 
clinician considers 
No Tricyclic antidepressants for CLBP 1 There is evidence We recommend 
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Topic 
 
Sub-topic 
Recommendations 
merged into 1 
Merged level of evidence Endorsement 
Tricyclic antidepressants for 
Fibromyalgia 
1 There is some evidence We recommend 
Anti-epilepsy/Anti-convulsants 2 There is some evidence We recommend 
Selective serotonin re-uptake inhibitors 1 There is some evidence We recommend 
Serotonin norepinephrine re-uptake 
inhibitors 
1 There is strong evidence We strongly recommend 
Informed consent for opioids 3 There is evidence We recommend 
Opioid therapy 3 There is evidence We recommend 
Physical therapy Manual therapy 3 There is evidence We recommend 
Manual therapy and exercise 1 There is some evidence We recommend 
Exercise 2 There is evidence We recommend 
Delivery of exercise 2 There is evidence We recommend 
Electrotherapy  TENS 2 There is some evidence We recommend 
Low-level laser therapy 1 There is some evidence We recommend 
Psychological 
therapies 
Identification of comorbid psychological 
disorders 
2 There is some evidence We recommend 
Refer to psychologist 1 There is limited evidence/ 
There is expert consensus 
We suggest that the 
clinician considers 
Operant behavioural therapies 1 There is some evidence We recommend 
Cognitive behavioural therapies 3 There is evidence We recommend 
Respondent behavioural therapies 1 There is evidence We recommend 
Complementary 
medicine  
Acupuncture 2 There is evidence We recommend 
Referral  Pain management specialist 2 There is some evidence We recommend 
Multi-disciplinary programmes 1 There is evidence We recommend 
Self-management Self-management 3 There is evidence We recommend 
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6.4 SUMMARY OF FINDINGS 
Chapter 6 provided a description of the in-depth content analysis of the recommendations extracted 
from high quality CPGs identified through a systematic review (Chapter 5). One of the main 
findings was that there was congruence (consistency) in the guideline recommendations about 
similar health topics. However, although the recommendations content were congruent, the quality 
level of evidence underpinning each recommendation varied considerably. Only three of the six 
CPGs that underwent content analysis provided a rating for the strength of the recommendation. 
Furthermore, in certain instances, guideline developers chose not to make specific 
recommendations about the health topic investigated.  
In this chapter the process of synthesising recommendations from different CPGs, through a 
stepwise process of merging the wording and level/quality of the underpinning evidence is 
described. The process of synthesizing led to the assembly of a core set of 43 clinical 
recommendations (see Appendix 29), which formed the basis of a multimodal approach for the 
contextualized CPG. The content of the core set included recommendations about the approach to 
care, assessment, advice and education, referral, pharmacological management, physical therapy, 
electrotherapy, psychological therapy, complimentary therapy and self-management.  
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PART 2: EVIDENCE SOURCING AND SYNTHESIS 
SUMMARY 
Part 2 of the dissertation focused on sourcing evidence-based practice recommendations for the 
management of chronic musculoskeletal pain in public health care, by systematically reviewing 
current existing clinical practice guidelines on the topic. Specific elements for improvement in the 
development and reporting of future CPGs for CMSP are highlighted in Chapter 5. These elements 
may play a role in the uptake of CPGs into practice and were the enhanced reporting of 
methodological aspects, the inclusion of patient preferences and values and the consideration of 
contextual factors. To date, CPGs for CMSP have focused on opioid prescription with a paucity of 
recommendations on non-pharmacological management. Given the limited number of CPGs with 
an inter-/multi-disciplinary approach and the lack of focus on multimodal recommendations, there 
is a need for more holistic CPGs about the management of CMSP. The latter is important as CPGs 
direct clinical decision-making about care, and may influence healthcare policy about CMSP. The 
inclusion of non-pharmacological strategies in CPGs may facilitate inter-/multi-disciplinary 
management to address the multiple dimensions of CMSP and optimise care for CMSP (WHO, 
2007; Scascighini et al., 2008; Stein et al., 2010).  
The findings of this review indicate that, due to the existence of high-quality CPGs on the topic of 
CMSP in PHC, existing CPGs can be adapted, adopted and contextualised to local contexts, instead 
of the de novo development of CPGs, particularly in resource-constrained environments. In this 
way, resources may be used to further the uptake of CPG recommendations with a rigorous 
implementation plan and sustainability strategy, instead of resources being spent on de novo CPG 
development (Gonzalez-Suarez et al., 2012). Furthermore, the majority of the included CPGs 
originated from Western countries with well-developed healthcare systems (Table 5.1). As 
illustrated in Chapter 3 (section 3.2.2), the intended setting for the CPG is a resource-constrained 
environment. CPGs developed for well-resourced healthcare settings needs to be contextualised for 
use in resource-constrained settings with different societal, political, environmental and economic 
contexts (Gonzalez-Suarez et al., 2012; Schünemann et al., 2006). Therefore, the process of CPG 
contextualisation was chosen and commenced.  
In Chapter 6 a step-by-step formula for synthesising practice recommendations to their new form as 
part of the contextualisation process, was provided. Several aspects of guideline recommendation 
writing were highlighted in Chapter 6, for example, the importance of phrasing recommendations to 
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communicate a strong or weak recommendation. Wording of the recommendations was deemed 
important as it influences behaviour change (Michie & Johnston, 2004). Additionally, the 
importance of using a writing guide to ensure consistency in writing recommendations was 
underscored. The use of strength of the recommendation in future CPG was advocated. The study 
identified several interventions for which no recommendations were made, indicating a need for 
future primary and secondary research to address these topics in the management of CMSP.  
The next step in the guideline contextualisation process was to authenticate the core set of 
multimodal recommendations derived from the synthesising process for the intended setting of 
community health centres in a SA context. 
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PART 3: ULTIMATE CONTEXTUALISATION 
INTRODUCTION 
In Part 3, of the research project, a multi-disciplinary group of healthcare professionals evaluated 
the merged evidence-based recommendations for their applicability in the SA context. The 
recommendations proposed for inclusion in the contextualised CPG were twice tested for validity in 
the intended setting, firstly by a group of experts using a consensus study (Chapter 7); and 
secondly, via a survey completed by external reviewers (Chapter 8) (see Figure Part3a).  
During the final process of contextualisation, the information gained in Parts 1 and 2 of the 
dissertation were united to customise the CPG for the intended context. A modified Delphi 
approach was used to establish consensus about the inclusion of proposed recommendations. The 
consensus view of an expert panel was deemed important in enhancing decision-making, 
developing review criteria and synthesising professional norms (Campbell & Cantrill, 2001). It is 
postulated that the views of a group have greater validity and reliability than the judgement of an 
individual (Raine, Sanderson & Black, 2005). Additionally, the multi-disciplinary panel 
participated in a consensus meeting and generated key context and practice points for the 
implementation of the recommendations. Context points were defined as contextual (personal and 
environmental) factors that may have an impact on implementation, and practice points were 
defined as general practical matters for implementation of the recommendation. Context points 
form a core part of the contextualisation process.  
The validated CPG recommendations with their context points were organised in a realistic patient-
care pathway by the PI, using the information obtained in Part 1 of the dissertation. A short form of 
the guideline was compiled containing the background, process information, pathway and 
recommendations. This draft version was approved by the panel and reviewed by an external panel 
of reviewers (Chapter 8). The aim of the external review was to evaluate the applicability and 
feasibility of the proposed CPG.  
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Figure Part3a: Outline of the final contextualisation process 
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clinical practice 
guideline 
PART C 
Contextualisation 
 
Chapter 7: 
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CHAPTER 7  
VALIDATION AND CONTEXTUALISATION OF 
EVIDENCE-BASED RECOMMENDATIONS:  
A CONSENSUS STUDY 
7.1 AIM 
The aim of this study was for a multi-disciplinary group of experts to evaluate, endorse and 
contextualise the clinical guideline recommendations that were developed for the local context. 
7.1.1 Objectives 
The objectives of this study were the following: 
 Evaluate and validate the evidence-based recommendations that were generated, for their 
applicability to the local context. 
 Identify context and practice points that represent standards for the implementation of the 
evidence-based recommendations. 
7.2 METHODS 
7.2.1 Study design 
There is an increasing trend to use formal consensus methods in CPG development (Halcomb, 
Davidson & Hardaker, 2008). In this study consensus methodology was used to enable a multi-
disciplinary group of experts to make decisions about the evidence-based recommendations that 
were generated from the systematic review. The Delphi technique was used and combined with a 
consensus meeting. Von der Gracht (2012) and Hsu and Sandford (2007) describe the primary aim 
of the Delphi technique as the efficient structuring of a group communication process, to achieve 
convergence of opinion on a specific, real-life situation. The consensus meeting added benefit as it 
allowed discussion of best available information and concerns, as well as for consensus and 
validation between key stakeholders (Halcomb et al., 2008).  
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7.2.2 Participants 
Participants comprised of experts (panel members), who were defined as individuals who had 
practical experience and interest in CMSP. A diverse group of participants was invited to ensure a 
wide range of opinions and limit bias, as advocated by Hutchings and Raine (2006). In particular, 
potential end-users were invited to foster engagement and facilitate ownership of the CPG 
(Halcomb et al., 2008). Purposive sampling was used to define the consensus panel using the 
following key criteria:  
 Different healthcare settings/sectors: a focus on PHC practitioners, but including government 
health subdivisions, academic institutions and private practitioners; 
 A multi-disciplinary group of clinicians, namely medical doctors, clinical nurse practitioners; 
physiotherapists, occupational therapists, psychologists, managers and researchers; 
 Skills, interest and experience in CMSP; 
 Skills and experience in CPG development. 
Panel members were identified through their contributions at the pain and public health 
conferences, and/or their involvement in the public healthcare sector in the Western Cape. Patients 
were not included in this part of the process as patients’ views were incorporated during Part 1 of 
this study. Appendix 21 lists the professionals who participated in the consensus study. 
7.2.3 Instrumentation and procedure 
The PI invited panel members via e-mail, explaining the purpose of the study, the process followed 
to construct recommendation statements, the process of consensus development, informed consent 
and conflict of interest (Appendices 22 and 23). The process involved three occasions of 
participation over three months. Firstly, the panel members were required to complete an online 
questionnaire as round 1 of the Delphi process (SUNsurvey, Checkbox, version 6). In the survey, 
the panel were presented with the 43 recommendation statements, accompanied by the evidence 
base for each recommendation. They were required to rate their agreement with each 
recommendation on a Likert scale for the applicability of the recommendation for the SA context. 
The scale had five points, with ﬁxed statements that were represented by different ratings: strongly 
agree (1), partly agree (2), undecided (3), partly disagree (4) and strongly disagree (5). The 
participants could use the non-applicable (N/A) button if a statement was beyond their area of 
experience or expertise. The use of N/A was counted as a missing data point. The survey also 
enabled the participants to write comments, if desired.  
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One month after the survey opened and two weeks after it closed, a consensus meeting was held, 
where the results of the first round was presented and discussed, focusing on problematic 
statements. During the second session of the consensus meeting, the panel members worked in 
focused groups to generate and document context and practice points for each recommendation, 
using the format for contextualisation framed by Gonzalez-Suarez et al. (2012) (Appendix 24). The 
four focus groups were for general approach and assessment; pharmacological management, 
psychological management and physical therapy and other management. The PI chaired the 
consensus meeting, assisted by a research assistant. The meeting was audiotaped and the PI took 
notes during the discussion to create an audit trail. The panel were also provided with the 
framework of contextual factors that patients and practitioners reported in Part 1 of the dissertation 
(Appendix 25; Figure Part1b).  
The meeting was followed up by a second-round electronic questionnaire one week after the panel 
meeting, where participants could rate their agreement with the reformulated statements that were 
discussed during the first session of the consensus meeting. Additionally, all pharmacological 
management recommendations were reviewed by a clinical pharmacologist. The PI organized the 
recommendations (Appendix 29) and drafted a report and a patient pathway which formed the short 
form of the CPG. The document was circulated to the panel to enable member checking and 
validation. 
7.2.4 Data management and analysis 
The PI extracted the data from the Delphi survey into an Excel spreadsheet. The method of 
aggregation for the two Delphi rounds was explicit (Halcombe et al., 2008). The median was used 
as a measure of central tendency to facilitate the presentation of collective judgements of 
respondents (Hsu & Sandford, 2007). The level of dispersion for the median was indicated by the 
IQR which consists of the middle 50% of the observations (Von der Gracht, 2012). Consensus 
could indicate the level of agreement or disagreement with a statement. An IQR of 1 or less was 
taken as consensus as this was found to be a suitable consensus indicator for 4- or 5-unit scales 
(Von der Gracht, 2012). All comments from the survey remained linked to its recommendation and 
the comments were analysed narratively (Appendix 26).  
The context and practice points that were generated and documented by the consensus meeting 
participants were summarised and categorised by the PI. Context or practice points that had direct 
influence on the implementation of a single recommendation were added to the recommendation 
statement as specific context points. The full list of context points will be included as tables in the 
final CPG document (see Appendix 27 & 28 for examples).  
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7.3 RESULTS 
Twenty-six professionals were invited to participate. Seventeen practitioners participated in round 1 
of the online survey, and 14 in round 2. Thirteen participated in the consensus meeting. Table 7.1 
provides an overview of the participants for each stage of the process. Table 7.2 presents the 
statements with consensus, and Table 7.3 indicates all statements with no consensus or undecided 
ratings. In the consensus meeting, participants nominated pain neuroscience education to be 
included in the CPG. Table 7.4 contains a summary of all context points as standards of care for 
implementation. Examples of the context points per health question are provided in Appendices 27 
and 28. 
Table 7.1: Characteristics of the panel 
(
a
Social anthropologist) (
b
Medical Scientific Liaison: Pain) 
  
 Delphi  
Round 1 
Consensus 
meeting 
Delphi  
Round 2  
Total participants 17 % 13 % 14 % 
Gender 
Female 
Male 
 
13 
4 
 
76 
24 
 
12 
1 
 
92 
8 
 
12 
2 
 
86 
14 
Occupation 
Clinical nurse practitioner 
Medical doctor 
Occupational therapist 
Physiotherapist 
Psychologist 
Other 
 
2 
4 
2 
5 
3 
1
b 
 
12 
24 
12 
29 
18 
6 
 
1 
1 
1 
9 
0 
1
a 
 
7 
7 
7 
47 
0 
7 
 
2 
2 
2 
5 
2 
1
b 
 
14 
14 
14 
36 
14 
7 
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Table 7.2: Validated recommendation statements and their ratings received  
ROUND 1 Panel 
meeting  
ROUND 2 
Statement Median IQR  Median IQR 
1. Patient centredness  1 0  - - 
2. Shared decision-making 1 0  - - 
3. Inter-professional collaboration 1 0  - - 
4. Holistic assessment 1 0  - - 
5. Assessment tools 1 0  - - 
6. Classification of pain 2 1  - - 
7. Special investigations 1 1  - - 
8. Addressing concerns 1 1  - - 
9. Brief education 1 1  - - 
10. Advice to stay active 1 0  - - 
11. Education about analgesia 1 1  - - 
12. Analgesic review 1 1  - - 
13. Paracetamol 1.5 1  - - 
14. NSAIDs 2 1  - - 
15. NSAIDs risks 1 0  - - 
16. Muscle relaxants 1 1  - - 
17. Anti-convulsants 1.5 1  - - 
18. Opioid (Tramadol) consent 1 1  - - 
19. Opioid (Tramadol) therapy 2 1  - - 
20. Manual therapy 1 0  - - 
21. Manual therapy (neck) 1 0  - - 
22. Exercise 1 0  - - 
23. Delivery of exercise  1 0  - - 
24. TENS (Trans-electrical nerve stimulation) 2 0.5  - - 
25. Acupuncture 2 0.25  - - 
26. Psychological comorbidities 1 0  - - 
27. Referral to psychologist 1 1  - - 
28. Operant behavioral therapy 1 1  - - 
29. Cognitive behavioral therapy 1 1  - - 
30. Respondent behavioral therapy  2 1  - - 
31. Antidepressant therapy 1 1  - - 
32. Antidepressant therapy review 1 0  - - 
33. Re-assessment 1 1  - - 
34. Referral to multi-disciplinary pain management 
programme 
1 1  - - 
35. Referral to pain management specialist 1 1  - - 
36. Self-management 1 0  - - 
37. Pain neuroscience education - -  1 0 
Key to rating: strongly agree (1), partly agree (2), undecided (3), partly disagree (4), strongly disagree (5) 
IQR ≤ 1 = consensus 
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Table 7.3: Recommendation statements with no consensus or undecided ratings after Delphi round 1; and results of round 2  
ROUND 1 
Panel 
meeting 
ROUND 2 
Statement Median IQR Modified statement and context points Median IQR 
We recommend topical NSAIDs in the 
treatment of patients with chronic pain from 
musculoskeletal conditions. 
3 1  We recommend topical NSAIDs for the treatment of 
inflammatory pain in patients with chronic 
musculoskeletal pain.  
* Avoid the simultaneous use of oral and topical 
NSAIDs due to cumulative effects. Consider side-
effects (skin irritation). 
2 1.25 
We recommend topical rubefacients for the 
treatment of pain in patients with 
musculoskeletal conditions if other 
pharmacological therapies have been 
ineffective. 
3 1  We recommend topical rubefacients for the 
treatment of pain in patients with musculoskeletal 
conditions.  
* The research base focused on Capsaicin. These 
expensive creams are not available in SA.  
2 2 
We recommend that tricyclic antidepressants 
are not beneficial for the management of 
chronic low back pain. 
4 1.5  We suggest that the clinician considers tricyclic 
antidepressants for the management of chronic low 
back pain with concomitant depression.  
* A thorough evaluation of health status is 
warranted. The dosage is dependent on numerous 
factors. Refer to the EML (2014). 
2 0.25 
We recommend Amitriptyline for the 
treatment of patients with fibromyalgia. 
2 1.25  * Amitriptyline is recommended as an adjuvant for 
the management of chronic non-cancer pain in the 
EML (2014).  
2 1 
We recommend Fluoxetine for the treatment 
of pain and depression in patients with 
fibromyalgia. 
(SSRI = Selective serotonin re-uptake 
inhibitor) 
2 1.5  *Fluoxetine is included in the EML (2014) for the 
treatment of major depression. 
2 0.5 
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ROUND 1 
Panel 
meeting 
ROUND 2 
Statement Median IQR Modified statement and context points Median IQR 
 
We strongly recommend Duloxetine for the 
treatment of patients with fibromyalgia or 
osteoarthritis. 
(SNRI = Serotonin norepinephrine re-uptake 
inhibitors) 
 
2.5 1  We strongly recommend Duloxetine (where 
available) for the treatment of patients with 
fibromyalgia or osteoarthritis.  
* Research studies on SNRIs for pain focused on 
Duloxetine. Cost and availability in SA limit its use. 
Duloxetine/Cymbalta is not included in the EML 
(2014). Cost and availability in SA limit its use.  
2 0.75 
We recommend low level laser therapy as a 
treatment option for patients with chronic 
low back pain. 
3 1  * Consider the cost of apparatus, safety with 
application and training required; laser is not 
readily available in PHC.  
3 0.25 
Key to rating: strongly agree (1), partly agree (2), undecided (3), partly disagree (4) and strongly disagree (5) 
IQR ≤ 1 = consensus 
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Table 7.4: Key practice and context points for standards for implementation of 
recommendations in primary health care in a South African setting  
Organisational  
 
 An interdisciplinary team, which includes access to rehabilitation and 
mental health practitioners 
 A functioning referral system  
 An electronic communication system is essential for referral and feedback  
 Adequate consultation time per patient 
 Access to analgesia 
 A risk management system in place for adverse effects  
 Measures for continuity of care 
Practice 
method  
 The initial session is most important and requires good communication 
skills, patient-centredness, cultural sensitivity, and motivational 
interviewing 
 Thorough assessment to identify comorbidities, risks, precautions for 
interventions 
 Use short, validated screening tools and outcome measures  
 Classify pain (nociceptive, neuropathic, central sensitisation) 
 A combination of pharmacological and non-pharmacological management  
 Patient education and empowerment 
 The use of educational material such as leaflets, pamphlets, posters, 
multimedia  
 The delivery of chronic pain management groups in PHC settings to 
facilitate efficient interdisciplinary management 
 Work-based interventions 
 Supported self-management as a core part of management 
 Community-based support programme  
 An outcome-based approach 
Staff (who)  Prescribing clinicians (medical doctor or clinical nurse practitioner) 
 Chronic care nurse 
 Dispensing clinicians (pharmacist) 
 Therapy clinicians (physiotherapists, occupational therapist) 
 Mental health practitioners (psychologist, psychiatric nurse, psychiatrist) 
 Social worker 
 Support staff and community workers/volunteers may play an important 
role in adherence to prescribed treatment 
Resources  Availability of medicines as on EML 
 Rehabilitation services 
 Access to equipment (where indicated) 
 Room space to conduct group and individual sessions 
 Patient educational material (information leaflet, important for high risk 
medicines)  
 Screening tools available in different languages; and culturally relevant 
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Training  Diverse, and may include: 
o Communication skills; motivational interviewing 
o Chronic pain management programme 
o Health promotion  
o Occupational health 
o Pain neuroscience education  
o Cognitive behavioural therapy  
o Risk screening  
o Use of CPG 
Re-assessment  Before and after specific interventions (outcome-based approach); 3/12 
and later 6/12 earlier as required 
 Side-effects 
 Adherence to prescribed medication and treatment 
 Use of home remedies/over the counter medicines 
 Changes in social environment/physical symptoms 
Referral   Pharmacological and non-pharma management are needed 
 If required/indicated 
o Refer early for rehabilitation therapy 
o Refer to Department of Social Services if social determinants 
affect health 
o Refer for workplace-based interventions 
o Refer to a community support structure  
o Provide regular feedback to colleagues 
o Refer to pain specialist  
o Refer for special investigations  
Patient/family  Patient should be empowered to take part in decision-making  
 Education/explanation needs to be delivered using appropriate language 
and providing appropriate information to aid understanding and improve 
adherence 
 Educate patient on the role of therapy; expected effects; adverse effects  
 Patient preference may play a role 
 Family education and workplace education to enhance support 
 Refer to or provide trustworthy information sources 
 Education for self-management  
Policy 
 
 An integrated approach as part of PACK Adult  
 Western Cape on Wellness (WoW) project  
 Healthcare 2030, integrated care 
 Standard treatment guidelines and EML 
 Linkages with Social Services 
 Mental health policy 
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7.4 SUMMARY OF FINDINGS 
Chapter 7 describes how a modified Delphi approach was used as part of the contextualisation 
process, to establish consensus about the applicability of the merged evidence-based 
recommendation statements for the SA PHC context. The electronic Delphi questionnaire allowed 
the participants to provide their opinion about the applicability of the proposed evidence-based 
recommendations for the SA context privately. The agreement of the experts was interpreted as 
validation for the applicability of a recommendation in the SA context and motivation for its 
inclusion in the CPG.  
The multi-professional panel of experts, although from diverse backgrounds, professions and work 
sector, reached consensus on 41 statements after two Delphi rounds interspaced by a consensus 
meeting. At the end of round one of the Delphi, there were seven problematical recommendations, 
of which six was about pharmacological management and one about electrotherapy. After 
discussion at the panel meeting, modification of the statements and electronic re-voting, the panel 
still reached no consensus for topical NSAIDs and topical rubefacients; and the panel was 
undecided about the applicability of Laser therapy. The panel members offered context factors as 
reasons and were concerned about the safety, efficacy, cost and availability of these interventions in 
the SA context. Pragmatic factors were one of the main reasons why the panel were tentative about 
pharmacological management recommendations, such as Duloxetine and Fluoxetine. Duloxetine, 
for example, is not listed in the EML (National Department of Health 2014), and is not available for 
prescription in the public sector. The panel nominated an additional recommendation for inclusion, 
namely the use of pain neuroscience education. The end-result was thus a set of 42 
recommendations to be included in the CPG.  
During the consensus meeting, the panel discussed and agreed upon on context and practice points 
that would enable the implementation of the CPG recommendations in the intended context. The 
panel members generated a range of context points, using their own experience and contextual 
information generated in Part 1 of the research project. Important context and practice points were 
linked to the applicable recommendation as indicated in Appendix 29. Context points are 
summarized in Table 7.4 and were: the effective organization of care to enable integrative care and 
appropriate referral; the need for an electronic communication system to enhance communication 
between team members; focus on an outcome based approach; patient and family education; 
practitioners training; group therapy; resources; community integration and policy to practice 
integration. Panel members made their choices against the background of their scientific 
knowledge, their values and beliefs, their clinical expertise, their experience with patients and their 
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contextual knowledge. There are indications the quality of care for CMSP is not only dependent on 
the implementation of evidence-based interventions, but is also influenced by practice patterns, and 
healthcare system organization and governance. The findings indicate that the expert panel weighed 
up the available evidence against pragmatic considerations which included e.g. economic 
conditions; benefits vs harm ratio and staff training; policy and patient preference.  
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CHAPTER 8 
ASSESSMENT OF THE APPLICABILITY AND 
ACCEPTABILITY OF THE CONTEXTUALISED 
CLINICAL GUIDELINE  
8.1 AIM 
The aim of the study was to evaluate whether the contextualised clinical practice guideline for 
primary health care of adults with chronic musculoskeletal pain is applicable and acceptable to the 
intended setting. 
8.1.1 Objectives 
The objectives of the study were the following: 
 Assess whether the recommendations within the contextualised CPG are applicable to Western 
Cape public PHC sector. 
 Assess whether the recommendations within the contextualised CPG are acceptable to the 
Western Cape public PHC sector.  
8.2 METHOD 
8.2.1 Research design 
A descriptive study, using a small-scale survey, was conducted to obtain the views of different 
stakeholders about the CPG and its recommendations (Fink, 2003; ADAPTE II Collaboration, 
2009; Gonzalez-Suarez et al., 2012). The feedback from the stakeholders was used to refine the 
CPG where indicated. 
8.2.2 Population and sample  
In this external review, policy makers, decision makers, organisations and clinicians were targeted 
to appraise a short form of the CPG. This population was chosen as they would potentially have to 
endorse the CPG for further use in PHC, or would be end-users of the CPG during clinical practice 
(ADAPTE II Collaboration, 2009; Gonzalez-Suarez et al., 2012). Patients were not included in the 
external review, to limit creating expectations that cannot be met. Consultations with patients will 
Stellenbosch University  https://scholar.sun.ac.za
 108 
take place to inform the implementation plan and development of end-user documents when 
appropriate. 
The sample strategy was multi-pronged to obtain diverse feedback. The first group of reviewers 
invited to participate consisted of: 
 SA public health care sector divisions (Department of Health), whose involvement include 
governance of primary health care: 
o National Department of Health, SA (Directorate: Disease, Disability and Geriatrics) 
o Western Cape Department of Health (Sub Directorate: Chronic Disease, Geriatrics, 
Rehabilitation and Prevention of Blindness). 
 An organisation involved in producing clinical guidance for public sector primary health care: 
o   The Knowledge Translation Unit of the University of Cape Town 
 The Chronic Pain Management Clinic at Groote Schuur Hospital (University of Cape Town), 
which is a multidisciplinary public sector pain clinic in the Western Cape. 
 The Society of Pain in SA (PainSA), a SA professional body, whose mission is to improve pain 
management in all aspects in SA (PainSA, 2016). 
The second group of reviewers was practitioners (doctors, nurses, physiotherapists, occupational 
therapists, psychologists) at a resource constrained semi-urban community health centre that did not 
participate in the study described in Chapter 4. 
8.2.3 Instrumentation and procedures 
The summary of clinical recommendations and context/practice points (Addendum 29), together 
with the proposed patient pathway, formed the basis on which participants evaluated the CPG. The 
short version of the CPG was used to provide a concise version, and not to overburden the 
evaluators. A short questionnaire was developed to accompany the short form CPG (Appendix 31). 
The questionnaire focused on aspects of applicability and acceptability of the CPG for the intended 
setting, and was developed based on information from ADAPTE II Collaboration (2009) and 
Gonzalez-Suarez et al. (2012) 
 The assessment of applicability covered cultural and organisational context, availability of 
health services and expertise, population characteristics, beliefs and value judgements.  
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 The assessment of acceptability covered strengths and weaknesses, suggestions for 
modification, impact on current routines, training required, barriers and facilitators, resource 
implication and practicality.  
Participants were required to rate their agreement with each statement on a Likert scale The scale 
had five points, with ﬁxed statements that were represented by different ratings: strongly agree (1), 
partly agree (2), undecided (3), partly disagree (4) and strongly disagree (5). The content validity of 
the questionnaires was evaluated by the supervisors, a member of the consensus group (Chapter 7) 
and a clinician.  
The PI contacted the government departments, units and professional bodies and invited them to 
participate. The CPG and informed consent letter (Appendix 30) was e-mailed to the institutional 
representatives, and they could provide anonymous feedback using an electronic survey 
(SUNsurvey, via checkbox, version 6), or complete the MS Word version of the questionnaire. 
Additionally, the PI attended the weekly clinical meeting at the selected healthcare centre. The PI 
explained the process and purpose of the study and the CPG was presented to the attendees. Each 
practitioner received a copy of the short form CPG and proposed pathway. Written informed 
consent was gained and the practitioners completed the questionnaire.  
8.2.4 Data management and analysis 
The data were recorded in a purpose-built data collection sheet in MS Excel. Ordinal data were 
summarised using the median and IQR, while interval data were summarised using the mean and 
SD (Kirkwood & Sterne, 2003). The open-ended questions were summarised narratively.  
8.3 RESULTS 
Eighteen responses were received from the reviewers (six from the organisations and twelve from 
the community health centre). All representatives from group one accepted the invitation to 
participate, except the Society of Pain representative, who did not respond to the invitation, despite 
two follow up invitations. All clinicians who attended the clinical meeting (reviewer group two), 
participated in the survey. The response rate was therefore 95%. The completion of the survey was 
anonymous and therefore responses could not be linked to specific organisations. Tables 8.1 and 8.2 
outline the feedback from the group. 
 
Stellenbosch University  https://scholar.sun.ac.za
 110 
Table 8.1: Profile of external review participants 
Variable Number 
(n=18) 
% Mean 
(SD) 
Profession 
Anaesthesiologist / Pain management 
Clinical nurse practitioner 
Family physician 
Physiotherapist 
Medical doctor and guideline developer 
Medical doctor 
 
1 
4 
2 
2 
1 
8 
 
6 
22 
11 
11 
6 
44 
 
Average years of practising profession -  8 (6) 
Work setting
a 
Community clinic  
Community health centre   
Central/tertiary hospital  
District hospital 
Private practice   
Regional hospital  
University 
Organisation/professional body 
Other  
 
3 
12 
6 
2 
- 
- 
3 
- 
1 
 
17 
67 
33 
11 
- 
- 
17 
- 
6 
 
Description of main professional roles
a 
Continuing professional education  
Evaluation/assessment 
Diagnosis 
Follow up  
Mental health  
Patient education  
Pharmacological management 
Physical therapy  
Referral 
Rehabilitation   
Student education  
Other:  
 Research 
 Health policy 
 Consultant 
 
2 
14 
12 
9 
5 
11 
14 
1 
8 
1 
2 
 
1 
1 
4 
 
11 
78 
67 
50 
28 
61 
78 
6 
44 
6 
11 
 
6 
6 
22 
 
a
More than one option possible 
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1
1
 
Table 8.2: External review results 
Statement Median  (IQR) Verbatim comments 
1. The recommendations in the guideline will address the needs and 
expectations of most patients in the primary health care setting. 
2 1  
2. The patients will benefit from the recommendations in the guideline. 2 1 I am surprised by the implied low level of evidence for 
the role of education in improving chronic pain. My 
impression is that the evidence warrants a stronger 
recommendation. 
3. The recommendations in this guideline allows for clinical decision-
making for individualised management. 
2 1  
4. The guideline recommendations will be culturally/socially acceptable 
to patients. 
2 0  
5. There is a need for a guideline on chronic musculoskeletal pain. 1 0  
6. The recommendations in this guideline are suitable for the primary 
health care context.  
2 1 Access to medications may be a limitation 
7. It will be easy to apply the recommendations. 2 1 Access to medications may be a limitation. Many 
recommendations (especially pharmacological 
options) are unavailable. 
8. Little re-organisation of services/systems will be required to 
implement this guideline.  
2 1 Need an evaluation of existing referral pathways and 
resourcing 
9. The recommendations will improve the use of resources.  2 0  
10. Primary care practitioners are adequately skilled to implement this 
guideline. 
3 2 Many primary care practitioners are naive to the 
proper management of chronic pain and may require 
additional training in addition to simply issuing of the 
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1
1
2
 
Statement Median  (IQR) Verbatim comments 
guideline. 
11. The patient journey (pathway of care) is relevant to primary health 
care. 
1 1  
12. I agree with most of the recommendations in the guideline. 1 1  
13. I already implement some of these recommendations. 2 1  
14. I think that the recommendations will improve patient outcomes.  2 1  
15. The recommendations in this guideline are specific and unambiguous.  1.5 1  
16. The recommendations in this guideline are easy to understand.  2 1  
17. The patient pathway is a useful visual tool. 2 1 Purpose and user of pathway is unclear. 
Scale: 1 = strongly agree 2 = agree 3 = undecided    4 = disagree 5 = strongly disagree 
IQR = interquartile range 
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Box 8.1: Summarised narrative feedback from participants 
 Missing information 
Scope of practice implications and limitations (who does what) 
The role of the physiotherapist in counselling 
More guidance needed on undetected psychological distress and depression 
Elaborate on psychological treatment and support 
More information on pharmacological prescription needed (efficacy and drug interactions) 
The role and management of co-morbidities 
The level of evidence for patient education should be higher 
A more comprehensive classification system for pain is required  
 Anticipated skills training required  
Counselling skills 
Screening for psychologic distress 
Classification of pain 
Accurate detection of pain conditions  
Expand training for the multidisciplinary team at primary health care 
 Unclear  
The symbols for the levels of evidence 
The “do not offer” box in the pathway 
The applicability of acupuncture in this context 
 Suggestions 
The words “regular” and “short term” are not specific enough 
Correction of formatting and language used 
We need a specific quick easy way to manage the patient 
 Resources 
The amount of patients far exceeds the amount of resources (e.g. psychologists, physiotherapists) 
 Other feedback 
Great work 
Long overdue 
Excellent guideline 
Much needed in primary healthcare 
Thank you for doing it 
8.4 SUMMARY OF FINDINGS 
The results from the small scale external review by potential end-users and stakeholders indicate 
that the CPG can be applicable to and acceptable in the intended context.  However, several key 
topics, as indicated below, need be further developed to enhance the successful uptake of the 
proposed CPG. Training of primary care practitioners to use the CPG and to implement its 
recommendations is a key prerequisite for ensuring successful implementation and achieving 
important outcomes. Training in classification of pain, psycho-social evaluation and management 
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and information about pharmacological prescriptions was mentioned. Additionally, the use of the 
patient pathway needs to be clarified during training. The implementation of the CPG will require 
re-organisation of services; which includes role clarification of the professions involved. The 
inclusion of recommendations regarding acupuncture and certain medications should be re-
evaluated due to their unavailability in PHC.  
While the authentication of the CPG recommendations is a starting point; and the context factors 
highlight uniquely SA circumstances, the external review underscored the need to develop and test 
a thorough and multilevel implementation plan to ensure the successful uptake of the CPG for 
CMSP. 
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PART 3: ULTIMATE CONTEXTUALISATION 
SUMMARY 
A multidisciplinary group of experts validated a list of 43 evidence-based recommendations for the 
management of CMSP in the SA context. Two recommendations were not validated due to limited 
evidence for efficacy; unclear benefit vs harm relationship and context factors such as cost and 
availability of resources. The panel identified several context factors that positioned the 
recommendations within the context of application for SA PHC. Practical applications as minimum 
standards for implementing the CPG were provided. An important practice point is that the outcome 
of healthcare for a patient with confirmed CMSP should be an empowered patient, who is equipped 
with the skills for supported self-management. To accomplish this outcome, inter-/multi-
disciplinary care with multimodal and patient-centered management is a requirement. The 
management options contained in the CPG may not be acceptable to all patients. Collaborative 
decision making with the patient is thus imperative; and tools to assist patients in making decisions 
about their care are needed. Cross cultural adaptions of internationally developed outcome measures 
and interventions are needed to be applicable to the diverse SA population (Table 7.4). The panel 
emphasized the importance of community involvement in the discharge plan to ensure adherence 
and continuity of care through a supported self-management program. These suggestions are 
supported by policy (Western Cape Government: Health, 2014), indicating the urgency of moving 
beyond policy to dissemination in practice. 
The findings of the external review in chapter 8 confirm the findings of chapter 7, indicating that 
the recommendations in the CPG can be applicable to and acceptable in the intended context, but 
that a thorough implementation plan is required. Additionally, external reviewers highlighted the 
importance of training of practitioners to enable successful uptake of the CPG. The findings from 
the part 3 of the study indicate that changes in practice patterns, healthcare system organisation and 
governance will need to be considered for the successful implementation of the evidence-based 
CPG.  
The end-product of part 3 was an evidence-based CPG, containing 44 recommendations, with 
context and practice points and a patient pathway for the management of CMSP in community 
health centres in the Western Cape of SA (Appendix 29 and Figure P3b).  
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Figure Part3b: Proposed patient pathway 
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CHAPTER 9 
DISCUSSION 
9.1 INTRODUCTION TO THE CHAPTER 
The overall aim of the study was to develop a contextualised, evidence-based, multimodal clinical 
practice guideline for the primary health care of adults with chronic musculoskeletal pain in the 
Western Cape province of South Africa. To achieve the overall aim of the study, five interlinked 
studies were performed which are presented in three parts in the dissertation:  
 Part 1: Two qualitative studies were conducted to discover patient and practitioner perspectives 
about CMSP and its management in selected public sector community health centres in the 
Western Cape province of SA. The findings aided understanding of the authentic context within 
which CMSP is managed in this setting. 
 Part 2: A systematic review was undertaken to source and synthesise evidence-based 
recommendations from high-quality CPGs for the PHC of CMSP. Evidence-based clinical 
recommendations were extracted from the different high-quality CPGs and these were 
synthesised to form a core set of multimodal recommendations to be included in the 
contextualisation process. 
 Part 3: A consensus study and external review were conducted to validate the synthesised 
evidence-based recommendations for the SA PHC context. A multi-professional panel of 
experts validated the recommendations via consensus methodology, and developed context and 
practice points relevant to the framework of contextual factors that were identified in Part 1. 
The validated evidence-based recommendations were organised and aligned within a realistic 
patient journey, and was externally reviewed for its applicability and acceptability to the local 
context using a survey. 
The purpose of this chapter is to provide an integrated discussion highlighting the most important 
findings and contributions of the research project. This chapter was therefore structured in three 
units, namely optimising CMSP care through a clinical guideline, contextual challenges and 
opportunities, and strengthening of healthcare systems for optimal CMSP care. 
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9.2 A CLINICAL PRACTICE GUIDELINE TO OPTIMISE CHRONIC 
MUSCULOSKELETAL PAIN CARE  
The outcomes of this project showed that there is great potential to optimise and improve the 
management of CMSP at primary care level in the Western Cape province of SA. While the current 
care of CMSP is not ideal, both practitioners and patients reported on the use or at least the 
awareness of evidence-based strategies for the management of CMSP as reported in Part 1 of this 
dissertation. Due to numerous contextual factors, evidence-based strategies as recommended in 
high-quality CPGs are not efficiently applied in the SA context to optimise patient outcomes in the 
way that it should. The main contextual factors found to be hindering evidence-based care in PHC 
include a combination of features, namely individual beliefs, social factors, delivery mode of 
interventions, fragmented care delivery and health systems issues such as overload and a lack of 
continuity of care (Figure Part1b; Table 4.2). The fragmented and delayed patient care pathways 
reported in Chapters 3 and 4 (sections 3.4.2, 3; 4.3.2.2 & 4.3.2.3); reflect some of the contextual 
complexities. The existence of the many contextual complexities indicates the need for a 
multipronged and multisystem approach to optimise outcomes for patients with CMSP 
(Commission on Social Determinants of Health, 2008; IASP, 2009a; Hoy et al., 2014). Although 
system factors may be difficult to change, there is a tangible opportunity to improve the care of 
people with CMSP by addressing the mode and type of healthcare delivery in this context.  
One strategy to improve the mode of care of CMSP at PHC level in SA is the development of a 
CPG which is context-specific. As part of the research project, the framework of an evidence-based 
CPG, which takes into consideration local, social, healthcare organisational and system factors, was 
developed. Lau et al. (2016) contend that context-specific interventions will maximise the uptake of 
CPGs in primary care and will facilitate the implementation and outcome of interventions. In this 
project, a novel approach to develop such a contextually relevant CPG was followed. The approach 
was adapted from the contextualisation approach developed by Gonzalez-Suarez et al. (2012) in the 
Philippines. The de novo development of CPSs is often not feasible and possible in a low- or 
middle-income setting; hence the need for alternative methodologies such as the contextualisation 
of existing CPGs.  
While there have been prolific efforts to advance the methodological rigour of de novo CPG 
development in high-income regions, there have been minimal efforts to advance understanding and 
methods to further the contextualisation and implementation of evidence in lower income regions 
(Schünemann, Brożek, Guyatt & Oxman, 2013; Dizon et al., 2016). The approach followed in this 
projects, builds on the current body of knowledge about contextualisation by refining and 
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enhancing the features of the contextualisation process. The exploratory approach in this research 
has enhanced the field of CPG contextualisation by proposing a feasible way to integrate multi-
stakeholder qualitative evidence. The qualitative evidence was used to frame the clinical 
recommendations to be sensitive to the local context (Appendix 29) and to incorporate the 
recommendations in a locally applicable clinical pathway (Figure Part3b). The findings indicated 
that the recommendations within the CPG addresses to a large extent, the needs of patients as who 
participated in this study (Chapter 3).  The project also highlighted a need in the current care 
provision, namely the need for integrated psychosocial interventions. Additionally, the approach 
highlighted potential lacks in the CPG, which should be further addressed, for example, the need for 
a vocational interventions identified in this study. In the study, the process of merging 
recommendations was refined and a stepwise method was provided (Chapter 6). This merging 
process is fundamental in the contextualising process.  The inclusion of formal consensus 
methodology to endorse the clinical recommendations further enhanced the authenticity of the 
contextual integration process (Halcomb et al., 2008). This approach to incorporate contextual 
evidence is expected to facilitate the implementation and uptake of the CPG recommendations into 
practice.   
The contextualised approach followed in my project provided a unique blend of evidence-based 
practice and patient-centredness within the context of SA. The blended approach is in harmony with 
the Healthcare 2030 Strategic Framework of the Department of Health (Western Cape Government: 
Health, 2014), which emphasises integrative care, patient-centredness, an outcomes-based approach 
and efficiency of care through the C
2
AIR
2
 (Care, Competence, Accountability, Integrity, 
Responsiveness, Respect) approach. Integrated management for CMSP is strongly emphasised in 
the clinical recommendations and the pathway of care, to address the burden of the condition and to 
contribute to quality care for CMSP in the local SA context.  
9.3 CONTEXTUAL CHALLENGES AND OPPORTUNITIES 
An intricate mesh of complex factors was found to influence the local context in which CMSP is 
managed; and has acted as barriers to and facilitators of optimum CMSP care (Figure Part1b; Table 
4.2). The identified contextual factors cannot be viewed in isolation as they represent the interaction 
between the individual, features of the health condition and the overall context in which the person 
lives (IASP, 2009a; WHO, 2013). Contextual factors within historically disadvantaged communities 
in the SA context often stem from broad societal issues such as economic and social factors, 
injustices of the past, levels of education, health literacy and multi-culturalism (Kagee, 2004; 
Kagee, Le Roux & Dick, 2007). The complex factors are multi-sectoral; and may indicate that an 
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inter-sectoral approach beyond the health system and including political support is needed for 
successful implementation of the guideline. The SA Strategic plan for the prevention and control of 
non-communicable diseases motivates that a politically enabling environment is important for inter-
sectoral collaboration; and advocates that different departments need to work together to achieve 
the positive outcomes for non-communicable diseases, such as musculoskeletal conditions 
(National Department of Health, 2013:35). Collaboration with other sectors will need to be sought 
to address contextual influences.  Considering the framework of contextual factors presented in 
Figure Part1b, an evidence-based, contextually sensitive CPG for CMSP pain management is likely 
to meaningfully influence individual factors, organisational factors and, in part, healthcare systems. 
An important contextual factor that spans across individual and organisational contexts relates to 
education. In Chapter 3 and 4, the education provided to empower patients emerged as an important 
factor, influencing individual patient beliefs, coping skills and adherence to prescribed 
management, such as taking medication and regular physical activity. Educational interventions, 
which include providing information and advice, and training for self-care, can lead to behaviour 
change and enhanced healthcare literacy (Engers, Jellema, Wensing, Van der Windt, Grol & Van 
Tulder, 2008; Hayes & Hodson, 2011). However, practitioners participating in this research said 
they do not have sufficient time or educational tools to provide adequate education which could 
lead to improved outcomes (section 4.3.2.6). This lack of time for consultation is in agreement with 
published literature in a similar context where patients reported inadequate consultation time for 
LBP (Mayor-Helsloot et al., 2014). Therefore, feasible strategies for education are needed to 
optimise outcomes for the management of CMSP. The prescription of analgesics is one example of 
the need for feasible educational strategies to enhance beliefs and adherence to care. While the 
prescription of analgesics per se was well aligned with policy and evidence-based strategies, 
practitioners mentioned that there was limited time to educate and advise patients about the 
appropriate use of analgesics (section 4.3.2.4). Consequently, practitioners and patients reported 
poor adherence to analgesics as patients feared the potential side-effects of medication (sections 
3.3.2.2 & 4.3.2.4). Several other studies found that patients with CMSP were reluctant to take 
analgesics (Woolf et al., 2004; Crowe et al., 2010; Cowan et al., 2003); which lead to the under-use 
of analgesics as a major barrier to adequate pain management.  These negative consequences could 
perhaps have been minimised with appropriate education and advice about analgesics. In the 
example provided, patient knowledge about analgesia influenced their beliefs and adherence to 
evidence-based treatments.  
In the presence of a high system burden and limited consultation times, there is an impetus to 
develop educational material that is culturally sensitive and at a suitable level of language to ensure 
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that the patients understands the message. Additionally, Kagee (2004) advises that health literacy in 
SA is not only about patients understanding the biomedical conceptions of disease and illness, but 
also the influence of personal and cultural beliefs. The aspect of suitable educational material to 
improve health literacy is indicated, as more than half of the patients in in this research completed 
only primary school (Table 3.1), and population studies show that less than 40% of the population 
in the communities studied completed high school (Appendix 5; City Statistics and Population 
Census, 2013).   
A locally relevant educational toolkit for patients can enhance patients’ understanding of CMSP and 
address the current barrier of limited time for education, as the educational content can be delivered 
in ways which would complement individual education. Such an educational toolkit would need to 
contain a diverse approach to include patient and family education, for example written, visual, 
social media, multi-media education and group information sessions (Table 7.4). A combination of 
individual and group education and additional resources may play an important role in empowering 
patients for self-management (Du, Changrong, Xiao, Chu, Qiu & Qian, 2011; Davies, Quintner & 
Parsons, 2011). However, the importance of individual education should not be neglected; it was 
clear in this research that participants trusted practitioners to provide them with advice, guidance 
and opportunities for collaborative decision-making. This trust relationship may indicate a power 
imbalance, also influenced by contextual factors, such as healthcare literacy. Kagee (2004) explains 
that in the SA context, practitioners are often seen as persons in authority, with specific expertise, 
which may explain the trust patients place in practitioners. Practitioners in this context can use their 
authority to develop a therapeutic alliance with the patient, for empowerment towards self-
management (Skuladottir & Halldorsdottir, 2008). The practitioner remains an important part of the 
educational toolkit for patients to assist them in understanding and coping with persistent pain. 
In Chapter 3, the majority of participating patients had a biomedical understanding of pain and most 
practitioners communicated a partly developed biopsychosocial understanding in Chapter 4. 
Although the patients and practitioners were not matched pairs, the reasons for the mismatch 
between their understandings may indicate that practitioners did not transfer their understanding to 
the patients. One explanation may be that practitioners did not explain persistent pain to patients 
due to time limits or inadequate training (Meyer et al., 2007; Hoy et al., 2014; section 4.3.2.8; table 
8.2). Practitioners may furthermore have omitted the psychosocial explanation to patients, as they 
believed that patients may not accept this explanation (section 4.3.2.5).  Parsons et al., (2007) in a 
UK based review, similarly found that practitioners limited their explanation to the patient when 
they thought it would affect outcomes negatively. However, the multi-disciplinary panel (Chapter 
7) underscored the importance of explaining persistent pain to patients, and in addition to the four 
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educational recommendations in the contextualised CPG, they nominated pain neuroscience 
education (Moseley & Butler, 2015) as an option (see Tables 7.2 & 7.4). Given the diversity of 
patients and variety of cultures in SA, the panel accordingly framed a context point that pain 
neuroscience education needs to be cross-culturally validated and available in different languages to 
form a culturally appropriate framework to educate patients about CMSP (Table 7.4). None of the 
participants in Chapter 4 disclosed the use of pain neuroscience education, and the minority 
indicated that they used a biopsychosocial approach to explain CMSP, indicating that the 
implementation of the CPG may require training in models to explain CMSP to patients. The 
importance of cultural sensitivity of explanatory frameworks to address patients’ understanding of 
CMSP is emphasised (Kagee, 2004; Nijs & Meeus, 2015). Such explanatory models may be useful 
to assist patients with coping and leading a meaningful life, despite CMSP (Allegrettia et al., 2010). 
The patients participating in this study had trouble coping with CMSP, despite having received 
treatment for it. Coping mechanisms were complicated by their hope of finding a cure for pain, 
which was rooted in their biomedical understanding of CMSP (section 3.4.2.1). Additionally, 
patients were not active self-managers of CMSP. Chapter 3 (section 3.4.2.2) presents evidence that 
the patients’ toolkit for self-management was limited, and that they used self-management when in 
pain and not as part of a daily routine. The IASP (2015) states that CMSP cannot be cured, but 
indeed optimally managed, therefore, the outcome of a CMSP management programme should be 
an empowered patient, equipped with skills for supported self-management, as indicated by the 
clinical pathway of the contextualised CPG (Figure Part1b). The management strategies employed 
by practitioners who participated show the components of what could be a self-management 
programme, but lacked the outcome-directedness for supported self-management. The self-
management programme for patients in this context can be enhanced by including the judicious use 
of analgesics, cognitive strategies, relaxation, stress management, self-tailoring and a flare-up plan 
(Du et al., 2011). Du et al. (2010) advocates that a holistic self-management program for CMSP 
should include the core skills of  problem solving, decision making, resource utilization, a patient–
provider partnership, action planning and self-tailoring.  The findings indicate a new focus for the 
management of CMSP in this context, namely equipping patients as active self-managers, with 
knowledge on when to seek help for their condition. Such an approach is congruent with the 
proposed new definition of health as “the ability to adapt and self-manage in the face of social, 
physical and emotional challenges” (Huber, Knottnerus, Gree, Van der Horst, Jadad, Kromhout, 
Leonard, Lorig, Loureiro, Van der Meer, Schnabel, Smith, Van Weel & Smid, 2011:1). An 
empowered patient may have enhanced resilience to adapt to and cope with CMSP (Ramirez-
Maestre, Esteve & López (2012).  
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The outcome of an empowered patient can be achieved if practitioners work as a coordinated team. 
The needs of patients (section 3.3.2.3) and the practice patterns of practitioners (sections 4.3.2.2 & 
4.3.2.3) indicated the need for coordinated care and particularly early and appropriate referral for 
rehabilitation. Strategies to foster inter-disciplinary referral in this context should be implemented 
to address the multiple dimensions of CMSP to affect short- and long-term outcomes (Stein et al., 
2010; Scascighini et al., 2008; Major-Helsloot et al., 2014). A lack of collaboration may leave 
therapeutic interventions for CMSP underutilised or unutilised (Hayes & Hodson, 2011). Inter-
professional collaboration is a recommendation in the contextualised CPG and the realistic patient 
pathway that was developed as part of this research project may guide early referral and facilitate 
collaboration between different healthcare practitioners (Figure Part3b). Additionally, the multi-
disciplinary panel nominated Data Harmonising in PHC as a context strategy to enhance inter-
professional collaboration (Table 7.4). Data Harmonising involves the transparent sharing of 
information and avoidance of duplication (WHO, 2016). The process of implementing an 
information and communication technology system to document patient information is one of the 
strategic objectives for Healthcare 2030 (Western Cape Government: Health, 2014:xxi).  The goal 
of Data Harmonising is to provide integrated information about patients’ health care journey in the 
public health care sector, to improve continuity of care. A coordinated care approach to CMSP in 
this context, whether multi-disciplinary or interdisciplinary, and using electronic communication 
systems, may assist in addressing the system burden by minimising the duplication of assessment, 
administration and care interventions (Wagner, Bennet, Austin, Greene, Schaefer & Vonkorf, 2005; 
Balasubramanian & Spurgeon, 2012; Scascighini et al., 2008). Such an approach would contribute 
to time, cost and quality efficiency. However, the manner in which care is organised (multi- or 
interdisciplinary) will depend on the resources available at the health centre. Not all community 
healthcare centres have access to rehabilitation practitioners; therefore alternative care models, such 
as trained assistants, will have to be sought in those circumstances. Based on the information 
presented in Chapters 3 and 4, a coordinated system of care is urgently needed to prevent a 
disconnected, delayed patient care pathway, to facilitate efficient practice methods and 
interdisciplinary collaboration towards strengthening the healthcare system. 
9.4 STRENGTHENING THE HEALTHCARE SYSTEM FOR CHRONIC 
MUSCULOSKELETAL PAIN CARE 
The successful implementation of a holistic, multimodal CPG for CMSP is dependent on the 
availability of and access to a multi-professional team. An important human resource aspect that 
needs to be addressed in the SA PHC context is the shortage of therapists (physiotherapists, 
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occupational therapists, psychologists) (sections 3.3.2.3 & 4.3.2.6; Scheffler, Visagie & Schneider, 
2015). The limited access to rehabilitation professionals was identified as a barrier to early referral 
in this research and that of Scheffler et al., 2015. Indeed, the findings from this research indicate the 
intense awareness of the service load on rehabilitation practitioners in an overloaded system 
(section 4.3.2.6). Schefller et al., (2015), reports that one PHC center/clinic may service up to 1500 
per day, demonstrating the sheer volume of patients needing care. Upshur et al., 2006 and Matthias 
et al., 2010 were similar to those identified in this study. Sufficient staff may have an impact on the 
service delivery challenges identified in this study, namely the lack of continuity and regularity of 
care, and lengthy waiting times for consultation. Policy and organisational change to employ more 
rehabilitation staff is therefore warranted (Scheffler et al., 2015). Hoy et al. (2014) argue that the 
burden of musculoskeletal conditions can only be addressed with support and investment from 
health policy to provide adequate human resources and training of personnel. The Western Cape 
Government: Health (2014:48) acknowledges that rehabilitation services have been historically 
under-developed in PHC, with resulting limited access to rehabilitation in the PHC sector. The 
Healthcare 2030 framework and the Framework and Strategy for Disability and Rehabilitation 
Service in SA (Western Cape Government: Health, 2014; National Department of Health, 2015) 
consequently intend to increase the number of therapists for the provision of rehabilitation services 
at all levels of care to improve access to rehabilitation services, integrated care and quality of care. 
The access to and provision of psychological rehabilitation was a particular concern raised by 
patients and practitioners in this research project (Chapters 3, 4, 7 & 8). The need for psychological 
interventions in this small sample of patients potentially reflects the contextual topic of the burden 
of mental health in SA. Mental health conditions in SA are prevalent and are one of the top 
conditions for YLDs in sub-Saharan Africa (Demyttenaere et al., 2007; Global Burden of Disease 
2015 Disease and Injury Incidence and Prevalence Collaborators, 2016). The high prevalence of 
mental conditions and the reported lack of mental health management is a global issue; also in SA 
(Sorsdahl, Stein & Lund, 2012). In Part 1 of this inquiry, the patients’ needs for psychological 
support seemed to have exceeded the practitioners’ offering. Accordingly, psychological support 
and management are noted as evidence-based recommendations in the contextualised CPG, to 
address to needs of patients with CMSP in the intended context. The implementation of a validated 
screening tool for psychological distress is included as a recommendation and could facilitate early, 
appropriate referral and management of psychological distress (Hill, Whitehurst, Lewis, Bryan, 
Dunn, Foster, Konstantinou, Main, Mason, Somerville, Snowden, Vohora & Hay, 2011). However, 
it is uncertain which practitioner would take ownership for this missing component in the current 
care offering for patients with CMSP. Mash et al. (2012) highlight the need for training on 
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psychological and social aspects for practitioners in SA PHC. Likewise, a UK-based systematic 
review by Parsons et al. (2007) indicates that practitioners often had little time and little training to 
assess and manage both the physical, and the psychological aspects of pain. Current practitioners 
involved in CMSP care already face several constraints to provide care (Table 4.2). While the 
training of doctors, nurses and other rehabilitation practitioners in PHC is an option to address the 
psychological support needs of patients, this may not be the solution in an already constrained 
system of care provision. The most significant barriers to the provision of psychological support in 
this study appear to be the limited involvement and access to psychologists and other mental health 
practitioners (section 4.3.2.4 & 4.3.2.5). In the SA context, with limited availability of trained 
personnel, task shifting has been proposed to address the burden of metal health conditions. Task 
shifting involves community-based workers who are trained to deliver contextually relevant mental 
health services under supervision of mental health practitioners (Sorsdahl et al., 2012). However, 
the efficacy of such an innovation needs to be confirmed. Innovative ways to include mental health 
practitioners in the pain care team and to provide access to mental health services in the SA PHC is 
needed and needs to be further explored.  
In countries with well-developed health care systems, with adequate resources and workforce, 
physiotherapists are at the forefront of musculoskeletal health, which includes the integration of 
psychosocial interventions in physical therapy practice. Such a management approach can enhance 
patient outcomes as well as health system outcomes (Foster & Delitto, 2011).  Indeed, there is 
evidence that psychologically informed practice delivered by physiotherapists led to positive patient 
and healthcare system outcomes in Ireland and the UK (O'Keeffe, Purtill, Kennedy, O'Sullivan, 
Dankaerts, Tighe, Allworthy, Dolan, Bargary & O'Sullivan, 2016); Hill et al., (2011).  Additionally, 
physiotherapist as primary contact practitioners was shown to reduce waiting times and treatment 
duration in an Australian study (Bird, Thompson & Williams, 2016).  If physiotherapists are to 
assume these roles in future SA health care, training in such therapies and availability of the 
workforce would be prerequisites.  Physiotherapists has the potential to play an important role 
addressing integrated management for CMSP in future SA health care systems, by an approach that 
integrates contextual information into therapy.   
The contextual information on how psychological, social, environmental and occupational variables 
influence the patient and the management of CMSP (Figure Part1b) indicates the need for a stronger 
link between the PHC system, social services and the occupational sector. Patients may thus need 
the involvement of a social worker or counsellor as part of holistic pain care. Additionally, there is a 
strong need for workplace interventions in this context. The inability to work and generate an 
income was seen to be a substantial stressor for patients in this study (section 3.3.2.4). Practitioners 
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and patients agreed that a tension exists between CMSP and work, where some patients continued 
working despite the pain, and others left employment due to pain, regardless of the negative 
consequences of unemployment. Patients’ beliefs about work influenced their willingness to return 
to work and productive activity (sections 3.3.2.1 & 3.3.2.4). Workplace interventions pain may be 
an important strategy to address patients’ beliefs about work and CMSP pain, to prevent 
musculoskeletal pain, and to counteract the dilemma of pain and work (Fisher, Emerson, Firpo, 
Ptak, Wonn & Bartolacci, 2007; De Vries, Brouwer, Groothoff, Geertzen & Reneman, 2011). 
However, workplace interventions are currently not included as a component of CPGs for CMSP, 
and were not a feature of practitioners’ practice patterns (Chapter 4). Patients benefit from 
occupational activities when they find meaning in their work (De Vries et al., 2011); therefore there 
is a strong impetus to integrate work-based interventions with healthcare management and in a CPG 
for CMSP. It is important to consider that several factors play a role in the individual’s ability to 
continue work despite CMSP, which includes individual characteristics, work environment, the 
social grant system, the healthcare system as well as social circumstances (De Vries et al., 2011). 
Such an integrated systems approach requires advocacy in relevant policies.  
There are indications in this research that healthcare policies need to recognise CMSP as a chronic 
condition and include it in the policies for non-communicable conditions, together with other 
chronic diseases such as hypertension and diabetes. While the Strategic Plan for the Prevention and 
Control of Non-Communicable Diseases (National Department of Health, 2013), recognize 
musculoskeletal conditions as a chronic non-communicable condition, this recognition are not yet 
integrated in policies, health systems and practice patterns. CMSP, although chronic, is currently 
not conceptualised as a chronic condition by patients (sections 3.4.2.1 & 3.4.2.2); this may limit 
patients’ motivation to self-manage. The proposition of CMSP as a chronic non-communicable 
condition is supported by Lalkhen and Mash (2015), who classified osteoarthritis as a non-
communicable condition, and found it to be the third most common non-communicable condition 
after hypertension and diabetes in SA primary care. The Global Burden of Disease study 2013 
Collaborators (2015) and Hoy et al. (2014) also support a more comprehensive inclusion of non-
communicable conditions for burden of disease studies. Hoy et al. (2014) contend that a better 
integration of musculoskeletal conditions in healthcare systems and policies will lead to a more 
streamlined, cost-effective approach. If CMSP is conceptualised as a chronic condition, and 
consequently managed within the chronic care model, the focus of PHC management would be 
shifted towards an informed and actively involved patient who takes responsibility for supported 
self-management. Additionally, the healthcare team would need to be prepared and proactive, 
working in an integrated team to collaborate with the patient towards a specific goal (Wagner et al., 
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2005). The implementation of the contextualised CPG may provide a sound foundation to prepare 
the healthcare team with evidence-based and outcome-focused management options for CMSP as a 
chronic non-communicable condition. 
The management of chronic non-communicable condition requires multipronged, integrative 
systems approach (Mayosi et al., 2009).  The findings of this research indicate that an 
implementation of the CPG for CMSP will require a multipronged approach to address the 
contextual factors that influence pain management. The SA Strategy for the Prevention and Control 
of non-communicable diseases advocates for the management of chronic conditions through the 
Integrated Chronic Disease Model (National Department of Health, 2013). The core components of 
the model are the patient and family, the health care team, community partners, that is supported by 
optimal health care organisation and a positive policy environment.  The findings of this research 
support the notion of an Integrated Chronic Disease Model for the management of CMSP. The 
inclusion of CMSP as a non-communicable condition may enable more prioritised care for CMSP 
and facilitate access to chronic care practice methods and community resources. Community-based 
care and support groups are justified means to enable chronic care provision (Wagner et al., 2005), 
having advantages of peer support and community integration (Du et al., 2011). The aspect of 
linkages with the community is one of the key development domains targeted by the National Core 
Standards for Health Establishments in SA (National Department of Health, 2011). PHC in SA is 
currently in a transition from a curative approach to a prevention and wellness paradigm to provide 
chronic care for the rising burden of non-communicable diseases (Western Cape Government: 
Health, 2014:xiv). Congruently, one of the action plans of the Healthcare 2030 framework is to 
implement community wellness centres to target the collective modifiable risk factors for non-
communicable conditions.  The focus will be on increasing physical activity, promoting healthy 
eating and reducing smoking, including the recently launched WoW (Western Cape on Wellness!) 
community programme (Western Cape Government: Health, 2014:22; Western Cape Government: 
Health, 2016). Community care was found to be effective for chronic pain management in women 
with HIV/AIDs in a community-based programme led by peer leaders in a SA PHC setting similar 
to Part 1 of this research (Parker, Jelsma & Stein, 2016). Peers, near-peers and community care 
workers can play an important role in the provision of community-based CMSP programmes.  
Iwelunmor, Blackstone, Veira, Nwaozuru, Airhihenbuwa, Munodawafa, Kalipeni, Jutal, Shelley & 
Ogedegebe (2016) found that community involvement plays an important role toward sustainability 
of health interventions in sub-Saharan Africa.  Community support may be part of the development 
of an innovative SA PHC system that is advocated by Kautzky and Tollman (2008) and the Global 
Burden of Disease study 2013 Collaborators (2015) (section 2.4.2). 
Stellenbosch University  https://scholar.sun.ac.za
  128 
In summary: the findings of this research project indicate that the challenge of providing quality 
care to patients with CMSP can be addressed through an evidence-based approach using a 
contextualised CPG, a multimodal and inter-sectoral approach, and the way the healthcare system is 
organised and governed. Implementation of the CPG will require foundation work, to align it with 
organisational structures and to equip the workforce. The CPG forms a sound foundation to provide 
information about evidence-based pharmacological and non-pharmacological management 
strategies for CMSP.  The importance of early appropriate referral and inter-/multi-disciplinary 
care, the need for more comprehensive educational interventions, work-based interventions, the 
inclusion of psychological interventions, empowerment towards structured self-management and 
prevention of the condition is emphasised. A broad public health approach is indicated, with a need 
for policy support. Policy aspects to enhance the provision of quality care using a CPG for CMSP 
identified in my study include human resource provision, policies on non-communicable conditions 
and community initiatives. The CPG with its evidence-based recommendations is in alignment with 
key policies in the Western Cape as SA policies. The impetus for the SA PHC sector is to move 
beyond policy frameworks, towards realisation in practice. 
9.5 LIMITATIONS 
The studies conducted as part of this research project has limitations, which should be taken into 
account when interpreting the findings. The limitations are discussed below. 
The findings of the qualitative studies can only be generalized to similar contexts. Additionally, the 
sample of patients is not representative of all patients in the SA context. The consideration of 
patient values and beliefs in the CPG development process should not replace collaborative 
decision-making with the individual patient. The findings provide indications of where patient 
preference and choice may might play a role. The propositions made regarding patients’ views and 
preferences will need to be tested in different contexts, such as the deep rural areas of SA. The 
study relied on the participants’ reports of practice patterns. The findings about practice patterns 
and referral should be verified by prospective observation and mixed-method studies to limit the 
use of recall of information. 
The patient sample consisted of mostly females and people older than 40 years, which is congruent 
with previous studies on chronic pain. The inability to sample for more male participants, and 
younger participants, despite efforts made, might indicate that men and young adults with CMSP 
are not presenting to PHC clinics for management. For future studies, an alternative sampling 
strategy, such as quota sampling, a community or occupational sample, may be considered.  
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The practitioner sample included various members of the multidisciplinary team, with good 
representation of those practitioners who patients identified in their patient journey. Although two 
practitioners (one doctor and one nurse) declined to participate, the final sample was typical of the 
practitioners employed at community health care centres in SA. 
The role of the interviewer in qualitative research is acknowledged. The interviewer is a 
physiotherapist and participants’ knowledge about the occupation of the interviewer could have 
influenced their responses. The participants’ honest discussions about positives and negatives of 
treatment, and the agreement with international literature indicate that the interviewer as 
physiotherapist had little effect on this aspect. The second interviewer, who conducted interviews in 
isiXhosa, enabled participants to speak comfortably in their first language, which was envisaged to 
enhance communication. However, the research assistant was a male and this aspect could have 
hindered disclosure by female participants, due to cultural aspects. 
It is acknowledged that the meaning of sentences may alter during translations of transcripts; 
therefore, the analysis was conducted in the language of the transcription. Quotes were translated 
for validation and for the purpose of this documented version (the dissertation). The isiXhosa 
interview had to be translated into English to enable analysis by the PI. 
In the systematic review, the focus of the search strategy was specific to PHC settings and this may 
have excluded some guidelines that are applicable in this setting, but not stated overtly to be so. 
Additionally, CPGs in other resource constrained environments may have been excluded if they 
were not available in English; and were not published.  Recommendations were extracted only from 
high-quality CPGs; however, the AGREE II evaluates the reported rigour of development and this 
is affected by the quality of reporting. Permission was requested from CPG developers to use CPGs 
as part of the contextualisation process. However, few responded. Due to the relative novelty of 
CPG contextualisation, there might be a need to communicate with recognised CPG development 
bodies (e.g. NICE, SIGN) about the process and purpose of contextualisation.  
The Delphi study focused on consensus and did not include an analysis of the level of stability over 
Delphi rounds (Von der Gracht et al., 2012). Only two Delphi rounds were done due to the intensity 
of the three consensus activities. Additional Delphi rounds could have provided indications about 
stability of the scoring for each recommendation.  Additionally, not all panel members could 
participate in the consensus meeting due to travel distance and work responsibilities.  The choice of 
panel members may play a role in the consensus generation (Hutchings & Raine, 2006) and may 
lead to bias. The consensus participants were dominantly rehabilitation practitioners. However, the 
findings of the external review, where the sample consisted of mostly doctors and nurses, concurred 
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with the findings of the consensus process, indicating that bias may not have played a significant 
role. 
9.6 RECOMMENDATIONS 
It is recommended that a multi-level implementation plan be developed and tested/piloted to ensure 
the successful uptake of the contextualised CPG for CMSP. This multilevel implementation plan 
should address the contextual factors influencing pain management identified in this study as 
patient factors, practitioner factors, the social and environmental circumstances within which the 
patient lives, the healthcare interventions received, and healthcare system factors. The 
implementation of the contextualized CPG for CMSP would necessitate training of the key 
stakeholders to support and facilitate a change in practice patterns. Additionally, a range of end-user 
support documents is envisaged to facilitate the implementation of the CPG for quality chronic pain 
care. Examples of these end-user documents are: evidence summaries; guidance for inter-/multi-
disciplinary referral; a classification system of CMSP with matched treatment approaches and 
patient information/decision material. The implementation plan for the contextualized CPG would 
need a staff development plan.  Furthermore, there is a need for more information on the inclusion 
of work based interventions as part of the care plan for CMSP.  The tension between work and pain 
identified in this study and in particular the facilitators of, and barriers to staying at work despite 
CMSP in this context warrants further investigation, to develop appropriate work-based 
interventions. Additionally, the delivery and feasibility of coordinated integrated pain care 
management programmes, which combines a biopsychosocial approach in this context, should be 
investigated.   Clinic/centre-based and community-based CMSP intervention programmes, needs to 
be developed and their feasibility investigated.   
Novel ways to address system challenges such as prolonged waiting times, continuity and regularity 
of care should be developed and investigated, for example the lean system, development of 
authentic care pathways, clear lines for referral and community support groups.  Additionally 
innovative ways on how to integrate management of CMSP within policies and initiatives for non-
communicable diseases needs to be advocated, developed and evaluated. CMSP needs to be 
included in the priority non-communicable diseases to address its considerable burden on the 
healthcare system and on the patient.  
The theories proposed by this research, for example that patient perspectives and beliefs influence 
their healthcare utilisation, and that practitioner perspectives and beliefs influence their practice 
choices and patterns, should be further tested in different contexts. Further studies can elaborate on 
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the content and adequacy of education and training about chronic pain care in undergraduate 
healthcare curriculums. 
The findings of the Part 2 of this research signpost several indicators for guideline development. 
For example, the scarcity of CPG recommendations on aspects of non-pharmacological options for 
CMSP indicates that guidelines developers could extend the scope and coverage of the CPG, 
possibly by inclusion of the diverse professions in the guideline development team to ensure 
multimodal and holistic CPGs on CMSP management. Additionally, there is a need to include 
contextual factors during guideline development, to develop and document strategies to facilitate 
the successful uptake and implementation of CPGs into the intended setting. Guideline developers 
are encouraged to use well developed frameworks, such as GRADE and FORM, to communicate 
the level of evidence and strength of the recommendation. The list of topics for which no 
recommendations were made provides clear direction for suggested future primary and secondary 
research.    
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CHAPTER 10 
CONCLUSION 
The study achieved its overall aim by developing a contextually relevant, evidence-based, 
multimodal CPG for the PHC of CMSP in public sector community healthcare centres/clinics in the 
Western Cape of SA. The aims were achieved in a stepwise process by determining contextual 
factors that influence CMSP management and integrating them with a core set of evidence-based 
clinical recommendations. This study is important as it contributes to the knowledge base about 
how to address the burden of musculoskeletal conditions within the current constraints of a 
transforming healthcare system. The findings of the study indicate that the delivery of optimum 
health care for CMSP by implementing of the CPG will require patient empowerment, changes in 
practice patterns, changes in the content of current healthcare offerings and changes in healthcare 
organisation and policy. 
Optimal management of CMSP requires an understanding of the multiple contextual and non-
contextual factors that influence the occurrence and persistence of pain. The findings confirm 
CMSP as a multidimensional phenomenon which necessitates that management include 
pharmacological and non-pharmacological strategies. The current practice patterns of practitioners 
were partially aligned with evidence-based management options, indicating that the implementation 
of the CPG will contribute to optimising practices to be more comprehensive and efficient. There 
are indications that managing CMSP as a chronic non-communicable condition may enable a focus 
on empowering the patient for supported self-management and may provide access to various 
support systems in SA.   
The project findings confirmed that CPG contextualisation as opposed to the adoption, adaption or 
de novo development of CPGs is a feasible process in resource constrained environments. As part 
of the contextualising process, a framework of contextual factors that was developed should be 
tested in different PHC contexts. The contextual framework has contributed to the body of 
knowledge on potential facilitators of, and barriers to applying evidence-based practice in resource-
constrained settings. This information on the context and barriers and facilitators can be used to 
develop an implementation plan, which should be piloted in different contexts to determine the 
acceptability and feasibility of the CPG. 
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APPENDIX 2: PROVINCIAL GOVERNMENT OF THE WESTERN 
CAPE (DEPARTMENT OF HEALTH) PERMISSION 
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APPENDIX 3:  
SUMMARY OF ETHICS PRINCIPLES APPLIED IN THE 
PROJECT  
Autonomy: Written informed consent was obtained from all participants. The informed consent 
forms were available in Afrikaans, English and isiXhosa, and each participant received a copy. 
Participation was voluntary and the participant could withdraw from the study at any point. The 
PI/assistant explained the research aims and procedures to the participants. Separate consent (within 
the consent form) was requested for audio-taping the interview. The participants had the right to 
request that the audio-recorder be switched off during the interview, if they felt the need to do so.  
Confidentiality: The participants’ personal information remained confidential and measures were 
taken to assure confidentiality. All questionnaires used were coded and the content did not ask for 
identifying particulars from the participants. During the Delphi part of the consensus study, voting 
was anonymous. During the survey, feedback was provided anonymously. The voice recordings 
were assigned unique serial numbers, which were also allocated to the corresponding transcript. No 
personal particulars were used in the serial number. The audio files were stored on the PI’s personal 
computer which is password-protected. Personal, identifiable information about the participants will 
not be divulged when documenting findings or publishing the research. The participating healthcare 
centres are not named in this report and were deleted from transcripts. No individualistic feedback 
will be provided about the participating healthcare centres, to protect the participants and each 
participating healthcare centre.  
Non-maleficence: All questionnaires and forms were made available to the patient participants in 
English, Afrikaans and isiXhosa. It was anticipated that due to the nature of the topic, sensitive 
information might be shared during interviews, which may lead to emotional responses and inner 
conflict, especially by participating patients. The participants were warned about this aspect 
beforehand. The researcher had a list of mental health practitioners to which the patient could be 
referred to if needed. Three patients had significant psychosocial distress and had received 
counselling for it. The power relationship between the interviewee and interviewer was respected at 
all times by focusing on the perspectives of the interviewee and by establishing trust prior to the 
interview and communication of a willingness to learn from the participant. The impact of the study 
on service delivery and on work burden was minimal, as clinicians participated in single interviews 
which were not foreseen to last more than one hour. Only one consensus meeting was conducted, 
supported by the Delphi procedure, to limit impact on service delivery of clinicians. Participating 
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clinicians and professional body representatives could complete the Delphi survey as well as the 
external review in their own time (at a time convenient to them). 
Beneficence: No advice was provided during or after the patient interviews, as this may have 
compromised the research relationship and turned it into a counselling/therapy relationship (Pope & 
Mays, 2006). In cases where a participant requested more information on therapeutic aspects, the 
researcher provided basic information after the interview and motivated the participant to discuss 
these issues with their healthcare practitioner. Patient participants were reimbursed for their time 
and/or travel expenses (R120). Each practitioner who participated in the interviews received a small 
SU corporate gift. Panel members who participated in the consensus meeting received lunch and a 
monetary gift for travel expenses or points for continuing professional education). Written and 
verbal feedback on the study was provided to participating clinicians involved in the process, as 
part of the final phase of this study. Written feedback to centre management will be provided when 
appropriate. 
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APPENDIX 4: TABLE COMPARING ADAPT, CONTEXTUALISE 1 AND CONTEXTUALISE 2 
Process ADAPT CONTEXTUALISE 1 CONTEXTUALISE 2 
Reference ADAPTE (2009) Gonzalez-Suarez et al. (2012) My study 
Getting started  Establish development committee. 
 Select a topic. 
 Establish if adaptation is feasible. 
 Identify skills and resources 
needed. 
 Complete tasks for set-up. 
 Write adaptation plan. 
 Determine the health questions. 
 Form development group. 
 Decide scope and purpose. 
 Group constructs patient journey. 
 Identify working groups. 
 PI selected topic. 
 Determine the health questions. 
 Write contextualisation plan 
(protocol). 
 Identify skills and resources 
needed. 
 
Contextual analysis - -  Sample patients’ perspectives and 
preferences. 
 Sample practitioners’ perspectives 
and preferences. 
 Develop contextual framework. 
Systematic search, 
appraisal and 
synthesis of 
evidence 
 Search for CPGs and other relevant 
documents. 
 Screen retrieves CPGs. 
 Reduce number of retrieved CPGs. 
 Assess CPG quality, content, 
currency, consistency. 
 Assess applicability and 
acceptability of recommendations. 
 Search for CPG. 
 Screen for relevance to scope and 
patient journey. 
 Appraise CPGs  
 Retain high-quality CPG. 
 Request permission to use CPG. 
 Extract and analyse 
recommendations for wording, 
underpinning evidence and strength 
of the evidence. 
 Search for CPG. 
 Assess CPG quality and currency. 
 Retain high-quality CPG. 
 Extract and analyse 
recommendations for wording, 
underpinning evidence and strength 
of the evidence. 
 Request permission to use CPG. 
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Process ADAPT CONTEXTUALISE 1 CONTEXTUALISE 2 
Reference ADAPTE (2009) Gonzalez-Suarez et al. (2012) My study 
Decision and 
selection 
 Review assessments made. 
 Select between CGPs and 
recommendations to create and 
adapt CPG. 
 Identify recommendations relevant to 
specific steps in patient journey. 
 Decide to adopt, adapt or 
contextualise. 
 Identify recommendations relevant to 
policies in the setting. 
 
Contextualise   Collate a table of recommendations. 
 Develop the writing guide. 
 Write endorsements for each 
recommendation in the steps of the 
patient journey. 
 Assess the generalisability and 
acceptability of the recommendations 
using the NHMRC FORM and context 
points. 
 Map endorsements and context points 
into patient journey. 
 Collate a table of recommendations. 
 Adapt the writing guide. 
 Merge similar recommendations to 
form endorsements. 
 Multi-professional panel assesses the 
generalisability and acceptability of the 
recommendations for the intended 
setting, using consensus. 
 Multi-professional panel generates 
context and practice points using 
contextual framework. 
 Develop an ideal patient care 
pathway. 
 Map endorsements and context 
points into patient journey. 
Finalisation  Prepare a draft adapted CPG. 
 External review–target audience of 
the CPG. 
 Consult with endorsement bodies. 
 Consult with source CPG 
developers. 
 Acknowledge source documents. 
 Collate chapters for draft guideline 
and edit for consistency. 
 Develop implementation plan. 
 Present guideline to the association 
at national meeting. 
 Send completed guidelines for 
comment to included CPG 
 Prepare a short-form draft 
contextualised CPG. 
 Acknowledge source documents. 
 External review–target audience 
and professional organisations. 
 Adjust draft CPG. 
 To be done: prepare full guideline 
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Process ADAPT CONTEXTUALISE 1 CONTEXTUALISE 2 
Reference ADAPTE (2009) Gonzalez-Suarez et al. (2012) My study 
 Plan for aftercare of the adapted 
CPG. 
 Produce final guidance document. 
developers. 
 Undertake focused public 
consultations, including seeking 
additional context points. 
document and end-user material. 
Dissemination and 
implementation 
  Plan and evaluate CPG 
dissemination. 
 Plan with key health organisations 
and policy makers. 
 To be developed 
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APPENDIX 5: CONTEXT OF THE SELECTED COMMUNITY HEALTHCARE CENTRES/CLINICS 
The three healthcare centres included had several similarities and differences in their environmental context. The information on the communities that 
are served by the healthcare centres is summarised in the table below (City Statistics and population Census, 2013). 
 CENTRE 1 CENTRE 2 CENTRE 3 
Geographical area Semi-urban (township) Semi-urban (Cape Flats) Rural 
District  Khayelitsha Tygerberg Cape Winelands 
Population size 391 749 people 90 574 people 97 724 people 
Population 
characteristics 
 The population is predominantly 
Black African (99%).  
 36% of those aged 20 years and 
older have completed Grade 12 or 
higher  
 The predominant language is 
isiXhosa. 
 The population is predominantly 
Coloured (89%), Black African 
(7%) and Asian (3%). 
 28% of those aged 20 years and 
older have completed Grade 12 or 
higher.  
 The predominant language is 
Afrikaans. 
 The population is predominantly 
Coloured (89%), Black African 
(16%) and White (12%). 
 81% of inhabitants speak Afrikaans, 
10% speak isiXhosa and 3% speak 
English. 
 26% of those aged 20 years and 
older have completed Grade 12 or 
higher.  
Employment  62% of the labour force (aged 15 to 
64 years) is employed.  
 76% of the labour force (aged 15 to 
64) is employed.  
 66% of the labour force (aged 15 to 
64) is employed.  
Income   74% of households have a monthly 
income of R3 200 or less.  
 50% of households have a monthly 
income of R3 200 or less.  
 40% of households have a monthly 
income of R3 200 or less.  
Housing  45% of households live in formal 
dwellings. 
 62% of households have access to 
piped water in their dwelling or 
inside their yard.  
 72% of households have access to a 
flush toilet connected to the public 
sewerage system.  
 81% of households have their 
refuse removed at least once a 
 84% of households live in formal 
dwellings.  
 95% of households have access to 
piped water in their dwelling or 
inside their yard.  
 89% of households have access to a 
flush toilet connected to the public 
sewerage system.  
 95% of households have their 
refuse removed at least once a 
 91% of households live in formal 
dwellings.  
 95% of households have access to 
piped water in their dwelling or 
inside their yard.  
 83% of households have access to a 
flush toilet connected to the public 
sewerage system.  
 72% of households have their 
refuse removed at least once a 
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week.  
 81% of households use electricity 
for lighting in their dwelling.  
week.  
 95% of households use electricity 
for lighting in their dwelling.  
week.  
 94% of households use electricity 
for lighting in their dwelling. 
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APPENDIX 6:  
INTERVIEW SCHEDULE FOR PARTICIPATING PATIENTS 
Introduction: Aim, informed consent, the participant’s rights 
Thank you for your willingness to participate in the interview. 
1. Please tell me the story of how your pain started. 
Source of injury/pain 
2. In your opinion, what are the reasons why the pain did not go away? 
What do you think is the source of pain now – where is the pain coming from?  
3. Please describe to me how the pain influences your life.  
Does is have an impact on your work? 
How does it influence you to do things for yourself, your everyday function?  
Does it have an impact on your family? 
Does it have an impact on your social life? 
Does it have an impact on your feelings? 
4. Could you tell me about the treatment that you have received for the pain?  
Pathway of care: 
 When did you first seek help for the pain?  
 Where?  
 All the medical and non-medical personnel involved?  
 Patient journey (what happened first and what happened next)? 
Efficacy/usefulness: 
 Which treatment helped you the most? In what way did it help? 
 Did the treatment bring any change/relief – possible reasons?  
 Which treatments did not work for you (unsuccessful) – possible reasons? 
 What do you do to cope with the pain? 
Satisfaction with treatment 
 With which aspects of treatment are you satisfied: reasons?  
 With which aspects of treatment are you not satisfied: reasons? 
5. What do you hope to gain from the treatment at the clinic – what is your goals for 
treatment?  
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6. What are your main expectations about how you would want to be treated at the 
clinic/hospital?   
In your opinion, what can be done at the clinic to optimise/improve the treatment of pain?  
 Individual characteristics – what role do the people that work there play? How would you 
describe a good doctor/nurse/physio? 
 Treatment characteristics – which treatments would you prefer?  
 Healthcare system issues – are there issues at the clinic or hospital that could change?  
7. Community issues – which factors in the community influence your pain? 
o Aspects of family 
o Aspects of work 
o Aspects of finances 
o Aspects of culture  
o Aspects of religion 
8. Could you share with me your opinion (concerns/plans) for your pain at this stage?  
 
Thank you for your contribution! 
Explain what will happen next. 
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APPENDIX 7:  
PATIENT GENERAL INFORMATION QUESTIONNAIRE 
 
Please respond to each question by ticking the appropriate box with an X or ,  
OR by supplying the missing information. 
 
 The aim of the questions in this section is to obtain general information about you.  
The information will be kept confidential. 
1. Age: ___ years 
2. Gender:   
Male  Female  
3. Home language:  
Afrikaans English isiXhosa Other (please specify): 
 
4. Ethnic group:  
Asian Black African Coloured White Other (please specify): 
5. Marital status:  
Married In a relationship Single Divorced or 
separated 
Widowed 
6. Number of children: ____ 
7. Highest level of schooling:  
Primary school Secondary (high) 
school 
University, college or 
technikon 
Other (please 
specify): 
8. Employment:  
Full-time work  Part-time work  Housewife  
Retired/pensioner   Student  On sick leave  
Unemployed   Disability grant  Other (please specify):  
9. If you do have work, what is your occupation (job description)?  
  __________________________________________________________________________  
10. If you are a student, what are you currently studying? 
  __________________________________________________________________________  
11. If you receive a disability grant, what is the reason for that? 
  __________________________________________________________________________  
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The purpose of the next section is to obtain information about your health. 
The information will be kept confidential. 
12. On the body chart below, please shade the area or areas where you have pain. 
 
 
13. Please circle the area that hurts the most. 
14. How would you rate the pain you are experiencing today – on a scale from 0 to 10, where 0 is 
no pain and 10 is unbearable pain? 
0 1 2 3 4 5 6 7 8 9 10 
No pain Unbearable pain 
15. How would you rate the pain you have experienced on average during the past three 
months – on a scale of 0 to 10, where 0 is no pain and 10 is unbearable pain? 
0 1 2 3 4 5 6 7 8 9 10 
No pain Unbearable pain 
16. How would you rate the worst pain you have experienced in the past three months – on a 
scale of 0 to 10, where 0 is no pain and 10 is unbearable pain? 
0 1 2 3 4 5 6 7 8 9 10 
No pain Unbearable pain 
17. How would you rate the least amount of pain you have experienced in the past three months 
– on a scale of 0 to 10, where 0 is no pain and 10 is unbearable pain? 
0 1 2 3 4 5 6 7 8 9 10 
No pain Unbearable pain 
18. Since when have you been experiencing the pain?   ______________________________  
19. Have you received a diagnosis or explanation for your pain? 
Yes  No   
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20. If some-one did tell you, what is the name of your condition? 
  __________________________________________________________________________  
21. Which of the following chronic conditions do you have, if any? 
a) Hypertension/high blood 
pressure 
  i) Heart disease  
b) Tuberculosis (TB)   j) Asthma  
c) Osteoarthritis   k) Rheumatoid arthritis  
d) Fibromyalgia   l) Systemic lupus  
e) Scleroderma   m) Epilepsy  
f) Stroke   n) Diabetes (Sugar)  
g) Peptic ulcer   o) Depression  
h) Anxiety   p) Post-traumatic stress  
Other (please specify):  ___________________________________________________________  
22. Which of the following health carers have treated you for your pain? 
a) Biokineticist   k) Acupuncturist  
b) Chiropractor  l) Reflexologist   
c) Homeopath  m) Traditional healer   
d) Nurse  n) Anaesthetist   
e) Naturopath  o) General medical doctor (GP)  
f) Occupational therapist  p) Neurologist  
g) Osteopath  q) Occupational health doctor  
h) Physiotherapist  r) Orthopaedic doctor  
i) Psychologist  s) Psychiatrist  
j) Pain clinic  t) Rheumatologist  
Other (please specify):  ___________________________________________________________  
23. What medication are you using for your pain? 
Name of medication: How much/many per day (dosage): 
 __________________________________   _____________________________________  
 __________________________________   _____________________________________  
 __________________________________   _____________________________________  
Thank you for participating! 
Development of the general information questionnaire for patient participants 
The test-re-test reliability of the NPRS is moderate to high (0.67 to 0.96) (Kahl & Cleland, 2005); it 
has a convergent validity of 0.79–0.95 to the VAS (visual analogue scale); the minimal detectable 
change is 3 points (Kahl & Cleland, 2005).   
  
Stellenbosch University  https://scholar.sun.ac.za
  163 
APPENDIX 8:  
K10 QUESTIONNAIRE FOR PSYCHOLOGICAL DISTRESS 
The aim of this questionnaire is to determine how you have been feeling during the last month. 
 
The following questions ask about how you have been feeling over the past 4 weeks. 
For each question, mark the block under the option that best describes the amount of time you felt 
that way. 
 
 None 
of the 
time 
A little 
of the 
time 
Some 
of the 
time 
Most 
of the 
time 
All of 
the 
time 
1. During the last 4 weeks, about how often did 
you feel tired out for no good reason? 
     
2. During the last 4 weeks, about how often did 
you feel nervous? 
     
3. During the last 4 weeks, about how often did 
you feel so nervous that nothing could calm you 
down? 
     
4. During the last 4 weeks, about how often did 
you feel hopeless? 
     
5. During the last 4 weeks, about how often did 
you feel restless or fidgety? 
     
6. During the last 4 weeks, about how often did 
you feel so restless you could not sit still? 
     
7. During the last 4 weeks, about how often did 
you feel depressed? 
     
8. During the last 4 weeks, about how often did 
you feel that everything was an effort? 
     
9. During the last 4 weeks, about how often did 
you feel so sad that nothing could cheer you up? 
     
10. During the last 4 weeks, about how often did 
you feel worthless? 
     
Thank you for participating! 
The use of the K10 questionnaire for psychological distress:  
Spies et al. (2009) evaluated the validity of the K10 in 129 healthy pregnant women in Cape Town, 
SA, using the Structured Clinical Interview for the DSM (SCID) as the gold standard for clinical 
validation.  A Receiver Operating Characteristics (ROC) curve analysis indicated that the K10 
showed agreeable sensitivity and specificity in detecting depression (0.66), post-traumatic stress 
disorder (0.69), panic disorder (0.71), and social phobia (0.76).  Additionally, Anderson et al. 
(2011) evaluated the performance of the K10 in screening for depression and anxiety in a multi-
cultural SA population, using the translated versions of the K10 in English, Afrikaans, isiZulu, 
isiXhosa, Northern Sotho and Setswana.  The K10 demonstrated moderate discriminatory ability in 
detecting depression and anxiety in the general population (ROC curve 0.73).  The K10 had lower 
discriminating abilities for depression and anxiety among the Black group (0.71) and Andersen et 
al. (2011) concluded that further cross-cultural investigations and additional validation studies are 
needed.   
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APPENDIX 9: THE PAIN DISABILITY INDEX 
This questionnaire helps us to see how much your pain influences your life.  We want to learn more 
about the influence that your pain has on your activities.  Please indicate the general impact of pain 
on your life, not just when the pain is at its worst. 
 
Please circle the number on the scale that describes how seriously pain typically influences 
your activities.  
A score of 0 means that pain has no influence on your activities at all, while 10 means that 
your pain prevents certain activities or affects them severely. 
1. Family/household responsibilities: 
How does pain influence your activities at home or in the family?  This includes chores or 
duties that you do around the house as well as errands or favours for other family members, for 
example working in the garden, taking children to school, making beds or sweeping. 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
2. Recreation: 
How does pain influence your hobbies, sports, exercise and other leisure activities? 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
3. Social activity: 
How does pain influence activities that involve social contact with friends and acquaintances 
other than family members, such as church activities, parties, concerts or going out and other 
social functions? 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
4. Occupation: 
How does pain influence activities that are part of or relate to your job?  This includes non-
paying jobs, such as being a volunteer or housewife. 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
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5. Sexual behaviour: 
How does pain influence the frequency and quality of your sex life? 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
6. Self-care: 
How does pain influence your personal appearance and independent daily living – for example, 
taking a bath or shower, getting dressed, grooming yourself or driving a car? 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
7. Life-support activities: 
How does pain influence the basic things you have to do to stay alive, such as eating, sleeping 
and breathing? 
0 1 2 3 4 5 6 7 8 9 10 
No influence Severely affected 
Thank you for participating! 
 
 
Pain Disability Index 
The construct validity of the PDI is sufﬁcient with signiﬁcant correlations with the Beck Depression 
Inventory and the State-Trait Anxiety Inventory (Tait, Chibnall & Krause, 1990; Tait & Chibnall, 
2005).  The internal consistency of the two subscales was sufﬁcient (for factor 1, Cronbach α = 
0.85; for factor 2, Cronbach α = 0.70) (Tait et al., 1990).  Mewes, Rief, Stenzel, Glaesmer, Martin 
and Brähler (2009) found a very good internal consistency as a measure of reliability (Cronbach 
alpha α = .93).  Soer et al. (2012) evaluated the PDI in a sample with chronic low back pain and 
found the ROC curve values for sensitivity and specificity to be 0.76 and 0.77.    
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APPENDIX 10: INFORMED CONSENT (PATIENTS) 
INFORMATION LEAFLET AND CONSENT FORM FOR TAKING PART IN A 
RESEARCH STUDY 
Title of the research project: 
Study1: The perspectives of patients with chronic musculoskeletal pain about patient-centred 
primary health care 
Reference number: S14/01/018 
Principal investigator: Dawn Ernstzen 
Address: Division of Physiotherapy, Faculty of Medicine and Health Sciences, Stellenbosch 
University, PO Box 19063, Tygerberg 7505 
Contact numbers: 021 938 9300 
I would like to invite you to participate in a research study.  Please take some time to read through 
the information, because it explains the study.  Please ask the study staff any questions about 
anything that you do not understand fully.  It is very important that you must be happy and that you 
understand clearly what this study is about and how you could participate. Please remember: 
 Whether you participate or not is entirely your choice.   
 If you say no, this will not affect you negatively in any way whatsoever.   
 You are free to withdraw from the study at any point, even if you did agree initially to take 
part. 
This study was approved by the Health Research Ethics Committee of Stellenbosch University and 
will be conducted according to ethical guidelines and principles (the guidelines of the International 
Declaration of Helsinki, South African Guidelines for Good Clinical Practice and the Medical 
Research Council (MRC) Ethical Guidelines for Research). 
What is this research study all about? 
The aim of this study is to determine what people who suffer from persistent joint and muscle pain 
think of the medical treatment they receive at their community health centres.  The research will 
focus on describing patients’ experiences and opinions, and will explore the care patients would like 
from healthcare personnel.  The information can help us to plan future treatments. 
About 20 patients who visit their community health centres will be invited to take part.  The study 
will take place at various community health centres in the Western Cape.  The researcher or 
assistant researcher will ask each patient some questions.  It will take 30 to 60 minutes.  Each 
conversation will be private.  It will take place at your home or in the library of the healthcare 
centre.  With your permission, I would like to record the interview.  The recording will be copied to 
paper and later studied by researchers at Stellenbosch University.   
In a later study, patients will be invited to participate in a follow-up study.  The follow-up study 
will be to hear your comments about the treatment path that was developed. 
Why have you been invited to participate? 
You have been invited because you experience persistent pain in your muscles and joints, and 
because you have been attending the community health centre to have your condition treated. You 
have experience of the factors that the researcher wants to examine, so you can make a valuable 
contribution to the study. 
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What will your responsibilities be? 
The researcher will ask you to share your experiences, feelings and expectations about your medical 
condition and the treatment that you have received for it. You will be asked to complete a short 
questionnaire with general information about you.  The researcher needs your permission to look at 
your medical records at the community health centre in order to see what treatment you have 
received. 
Will you benefit from taking part in this research? 
You will not benefit directly in the short term.  However, future patients (including you) may 
benefit once the study is completed.  The information gained from this research will help healthcare 
workers to understand the needs of patients with persistent pain better. 
Are there any risks involved in your taking part in this research? 
There are no direct risks, as the research consists of a conversation about your joint and muscle 
pain.  However, this may put you in a position where you share some sensitive information that may 
make you emotional.  If you experience such emotions, please tell the researcher and ask for a break 
from the interview if you need it.  The researcher can also refer you to a trained counsellor. 
If you do not agree to take part, what alternatives do you have? 
If you prefer not to participate, we respect your choice. 
Who will have access to your information? 
Only the research team will be able to see your information.  Approved external examiners or 
funders may also inspect the research records.  Your identity will remain private, even when we 
report on the research.  Your name will appear on none of the forms or on the recording, because 
we will use only numbering codes.  The interviews will be recorded with a voice recorder and later 
be written down by someone who does not know you personally.  No names will be used in the 
original recordings or in the written versions.  Only the research group will do the interviews and 
study the documents.  The voice recordings will be destroyed after the research has been completed.  
Your information will be treated as confidential and will be protected.   
What will happen in the unlikely event that some form of injury occurs as a direct result of 
your taking part in this research study? 
This research entails only an interview (conversation).  Therefore, we foresee no injuries that may 
result from the research process.   
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to participate.  However, you will receive a small gift to show our 
gratitude.  There will also be no costs involved for you. 
Is there anything else that you should know or do? 
If you have any further questions or problems, please call the main research investigator, Dawn 
Ernstzen, on 021 938 9300. The study is financially supported by the National Research Foundation 
and no conflict of interests has been reported. 
If you have any concerns or complaints that the research team has not adequately addressed, you 
can call the Health Research Ethics Committee on 021 938 9207. 
You will receive a copy of this information and consent form to keep. 
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Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled: The perspectives of patients with chronic musculoskeletal pain about patient-centred 
primary health care. 
 
I declare that: 
 I have read or had read to me this information and consent form and it is written in a 
language in which I am fluent and with which I am comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
 I may be asked to leave the study before it has finished, if the study doctor or researcher 
feels it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Informed consent for recording the interview  
The reason for recording the interview and later destroying the voice recordings has been explained 
to me.  I understand these procedures and agree that they may be performed. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Declaration by investigator 
I (name)  ..........................................................................................................................  declare that: 
 I explained the information in this document to  ................................................................  
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign 
the declaration below.) 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
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Declaration by interpreter 
I (name)  ..........................................................................................................................  declare that: 
 I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..……………………… using the language medium of Afrikaans/isiXhosa. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of interpreter Signature of witness 
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APPENDIX 11: CODEBOOK FOR PATIENT STUDY 
Code-Filter: All 
HU: Ernstzen Patient Interviews CPG 
File:  [C:\Users\acer i5\Documents\ATLAS docs\Ernstzen Patient Interviews CPG.hpr7] 
Edited by: Super 
Date/Time: 2015-10-01 10:22:35 
 
Acceptance 
ASSESS: Investigations 
COPING 
COPING: self-talk 
COPING: act strategy 
COPING: decision 
COPING: pass strategy 
COPING: locus control 
COPING: spiritual 
HEALTH 
Health: diagnosis 
Health: comorbidities 
EXPLAIN: cause 
FINANCE 
FINANCE: disability grant 
FINANCE: unemployment 
IMPACT 
IMP: hope 
IMP: emotions 
IMP: function 
IMP: move 
IMP: participation 
IMP: relationships 
IMP: sleep 
IMP: stress 
INJURY: Mechanism 
MANAGEMENT 
MAN: advice 
MAN: effectiveness 
MAN: herbs 
MAN: exercise 
MAN: group 
MAN: injection 
MAN: OT 
MAN: Physio 
MAN: Psycho 
MAN: refer 
MAN: rubefacients 
MAN: self 
MAN: self-meds 
MAN: side effects 
MAN: specialist 
MAN: surgery 
MAN: meds 
Migration 
OCCUPATION 
OCC: effect 
OCC: employer attitude 
OCC: type 
PATIENT 
Patient collaboration 
Patient communication 
Patient knowledge 
Patient pathway 
Patient education 
PERSON: 
PERSON: advocate 
PERSON: perseverance 
PERSON: Resilience 
PERSON: tenacity 
PERSPECTIVE 
PERSP: assessment 
PERSP: belief 
PERSP: practitioner 
PERSP: pain cause 
PERSP: treatment 
SATISFACTION 
SATISF: ambivalent 
SATISF: positive 
SATISF: negative 
SOCIAL 
SOCIAL: family 
SOCIAL: gangsterism 
SOCIAL: hardship 
SOCIAL: violence 
SUPPORT 
SUPPORT: family 
SUPPORT: practitioner 
HEALTH CARE SYSTEM 
SYSTEM: belief 
SYSTEM: continuity 
SYSTEM: gen 
SYSTEM: pathway 
SYSTEM: patient-centred 
SYSTEM: private health 
SYSTEM: refer 
SYSTEM: resources 
SYSTEM: understand 
SYSTEM: wait 
Transport 
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APPENDIX 12:  
EXAMPLES OF TRANSLATED QUOTES (PATIENT STUDY) 
Afrikaans English 
En die x-strale wys toe hier is sulke kussinkies agter 
by my rug, toe sê hulle my kussinkies was 
gedamage. Ek weet nie wat is dit wat op my nerve 
druk nie, sê hulle, dis hoekom die pyn so erg is. Ek 
weet van die kussinkies, daar het van die joints ook 
uitgehaak, nou hulle kan mos nie mens se rug joints 
weer terug dingese nie, en dis daai wat maak dat 
my rug so ernstig pyn. P18, 51y, LBP 
And the X-rays showed that there are cushions in 
my back.  They told me that those cushions were 
damaged.  I don’t know what is pressing on my 
nerve, so they say. That is why my back pain is so 
severe. I know about the cushions, and some of the 
joints were also displaced. Now they can’t fix that 
displacement, and that is why my back pain is so 
severe. P18, 51y, LBP  
Maar dan is ek baie moeg. So verskriklik moeg uit 
myself uit en dan is die pyn verskriklik, maar dan 
gaan ek net ŉ bietjie lê weer en dan relax en dan 
staan ek weer op en so aan. P14, 43y, Joint pain 
Then I am so tired. So terribly tired from inside 
myself and the pain is dreadful. But then I lie down 
and relax, and later I get up again. P14, 43y, Joint 
pain 
Nou baie keer vra hulle vir my hoe gebruik ek my 
pille. Ek sê suster nie gereeld nie; soos suster vir 
ons sê soos nodig. Wanneer ek voel daar is pyn en 
hy wil nie verdof of so nie. Dan sal ek ŉ pilletjie 
drink maar dis nie dat ek graag nie. Al wat ek 
gereeld gebruik is my hoë bloed pilletjie en die 
water pilletjie P6, 66y, LBP 
And many times they ask me how I use my pills. 
Then I say, not often, as you say, as needed. When I 
feel there is pain and it is not getting less. Then I 
will drink the pill, not that I really want to. The only 
pills I take regularly are my hypertension and water 
pills. P6, 66y, LBP 
As ek dit nou glad nie kan hanteer nie, dat ek voel 
nou wil ek moed opgee, dan maak ek ŉ afspraak by 
haar. Dan gaan ek so vir twee, drie keer en dan 
voel ek weer ŉ bietjie beter. Maar dan kom dit mos 
weer. Al haar pasiënte dink ek moet maar weer 
teruggaan. Dis nou maar ongelukkig so. P10, 69y, 
LBP leg pain 
If I can’t take it anymore, and I become despondent, 
I make an appointment with the physiotherapist. 
Then I go for two or three times, and then I feel 
better. But it comes back again. I think all her 
patients must go regularly, That is the unfortunate 
case.  P10, 69y, LBP, leg pain  
Ek was by 3 verskillende dokters gewees en die een 
dokter het vir my gesê dit kan moontlik wees. Maar 
vir 3 maande het ek Voltaren en inspuitings gekry 
en die 4de maand toe’s ek net mooi dik. Aanmekaar 
Voltaren pille, Voltaren inspuiting en die 4de 
maand toe sê ek vir die suster maar genoeg is 
genoeg. Ek kan nie aanmekaar inspuitings en pille 
en dan verwys julle nie vir my êrens na haar toe 
nie, toe vra ek vir haar watter kant toe kan ek gaan, 
want ek weet my sigselwers nie watter kant toe nie. 
P 1, 47y LBP, leg pain 
I went to three different doctors, and the one told 
me what this could be. But for three months I 
received Voltaren pills and injections, and by the 
fourth month I had enough. I told the sister, I can’t 
get injections and pills all the time and you don’t 
refer me. And I asked her; where I should go for 
this, because I also did not really know what to do. 
P 1, 47y LBP, leg pain 
Toe’t ek maar weer begin met fisio, maar uit die 
aard van my werk kan ek nou nie so baie gaan nie 
want ek wil nie so baie af vra by die werk nie. So as 
ek dit nou regtig, as ek tande kners, dan gaan ek 
maar weer vir ŉ bietjie fisio. P11, 53F, Neck, 
shoulder pain 
I started with physiotherapy, but due to the nature 
of my job, I can’t come regularly. I can’t take off so 
much time from work. So if I can’t take it anymore 
and I gnash on my teeth, then I go for some more 
physiotherapy. P11, 53F, Neck, shoulder pain 
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APPENDIX 13:  
INTERVIEW SCHEDULE FOR HEALTHCARE PRACTITIONERS 
Introduction: aim, informed consent, rights of the participant 
Thank you for being willing to participate in the interview. 
Opening question: 
1. Please tell me about your experiences when treating patients for chronic musculoskeletal pain 
(CMSP). 
A typical story  
Emotions (e.g. satisfaction, frustration) 
Typical problems when treating patients with CMSP 
2. In your experience, what are the aspects that cause musculoskeletal pain to become chronic? 
Prompt: physical, personal, environmental or social, or organisational factors 
3. What management route or method do you usually use in the case of patients with CMSP? 
Prompt: How do you manage them – possible reasons? 
Evidence-based practice or clinical guidelines in your practice? 
Discharge plan? 
4. In your opinion, what are the factors that hamper patients in gaining control of their pain? 
5. To which healthcare practitioner do you refer CMSP patients? 
Rehabilitation (e.g. physiotherapist or occupational therapist) 
Specialist (e.g. neurologist, rheumatologist or orthopaedic surgeon) 
Pain clinic (Tygerberg or Groote Schuur) 
Psychologist or social worker 
Your reason for referring to that specific practitioner? 
6. Which factors in your current working situation hamper you in applying evidence-based 
practice in the case of patients with CMSP? 
Prompts: factors on personal, organisational, patient and family, or systemic level 
7. Which factors in your current working situation help you to apply evidence-based practice in 
the case of patients with CMSP? 
Prompts: factors on personal, organisational, patient and family, or systemic level 
8. What aspects in your current working situation need to change to enable you to manage people 
with CMSP conditions optimally? 
Thank you for your contribution. 
Explain what will happen next. 
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APPENDIX 14:  
HEALTHCARE PRACTITIONER GENERAL QUESTIONNAIRE 
The aim of the questions in this section is to obtain general information about you.  
The information will be kept confidential. 
 
Please respond to each question by ticking the appropriate box with an X or , 
OR by supplying the missing information. 
 
1. Age: ___ years 
2. Gender:    
Male  Female  
3. Home language:  
Afrikaans English isiXhosa Other (please specify): 
4. Ethnic group:   
Asian Black African Coloured White Other (please specify): 
5. Please indicate your profession: 
Community health centre manager  
Community health worker  
Dietician  
Medical doctor  
Nurse  
Occupational therapist  
Physiotherapist  
Psychologist  
Social worker  
Other (please specify): ______________________________ 
6. Please state your qualification(s) Year in which qualification(s) was/were obtained 
 ........................................................   ....................................... 
 ........................................................   ....................................... 
 ........................................................   ....................................... 
7. How many years have you been practising your current occupation? _____ years 
8. How many years have you worked at the community health centre? _______years  
9. Approximately what percentage of your patients or clients per week has chronic pain? 
____ % 
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10. In your context, approximately what percentage of your patients or clients has chronic 
pain that is musculoskeletal in origin? 
____% 
11. Please rate your satisfaction with treating patients with chronic musculoskeletal pain.  
Very satisfied Satisfied Slightly satisfied Not at all satisfied 
12. Do you currently use clinical practice guidelines for managing chronic musculoskeletal 
pain?  
Yes Sometimes No 
13. Approximately how often do you treat the following chronic conditions per month? 
 Not at all Occasionally Very often 
Carpal tunnel syndrome    
Chronic widespread or generalised pain     
Complex regional pain syndrome     
Fibromyalgia     
Migraine    
Myofascial pain    
Osteoarthritis    
Rheumatoid arthritis    
Rheumatic pain    
Sciatica    
Tendonitis    
Overuse injuries    
Regional pain 
Head    
Neck     
Thoracic     
Shoulder     
Arm    
Elbow    
Wrist and hand    
Abdominal    
Pelvic    
Lower back    
Leg    
Hip    
Knee    
Ankle    
Other (please state):    
Thank you for participating! 
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APPENDIX 15:  
INFORMED CONSENT (PRACTITIONERS) 
INFORMATION LEAFLET AND CONSENT FORM FOR PARTICIPATION IN A 
RESEARCH STUDY 
Title of the research project: 
Study 2: Healthcare providers’ perspectives about the primary healthcare management of patients 
with chronic musculoskeletal pain regarding their management pathway 
Reference number: S14/01/018 
Principal investigator: Dawn Ernstzen 
Address: Division of Physiotherapy, Faculty of Medicine and Health Sciences, PO Box 19063, 
Tygerberg 7505 
Contact numbers: 021 938 9300 
I would like to invite you to participate in a research project. Please take some time to read the 
information presented here, because it explains the details of the study. Please ask the study staff 
anything about this study that you do not understand fully. It is very important that you must be 
completely satisfied that you understand clearly what this research is about and how you could be 
involved. Please remember: 
 Participation is entirely voluntary, so you are free to say that you do not want to 
participate. 
 If you say no, this will have no negative effect on you in any way whatsoever. 
 You are free to withdraw from the study at any point, even if you did agree initially to take 
part. 
This study has been approved by the Health Research Ethics Committee of Stellenbosch University 
and will be conducted according to the ethical guidelines and principles of the International 
Declaration of Helsinki, South African Guidelines for Good Clinical Practice and the Medical 
Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
The main aim of this phase of the study is to determine what different healthcare providers 
experience and think regarding the management of patients with chronic musculoskeletal pain in the 
context of primary health care. Therefore, the research will focus on describing the experiences and 
views of healthcare providers. The information will be used to inform the overall study which will 
focus on the development of clinical guidelines and a care pathway for chronic musculoskeletal 
pain in the Western Cape. About 20 healthcare providers in 4 purposefully selected community 
healthcare centres will be invited to participate (e.g. medical doctors, nursing practitioners, 
physiotherapists, occupational therapists, social workers and psychologists).   
Individual interviews will be conducted at the healthcare centre where you work and each interview 
will last 30 to 45 minutes. With your permission, I would like to record the interview for it to be 
transcribed and later analysed by researchers at Stellenbosch University. A follow-up session will 
be arranged to share the results of the study. 
Why have you been invited to participate? 
You have been invited because you work at a healthcare centre and provide care to patients with 
chronic musculoskeletal pain; therefore, you can contribute valuable information to the study. 
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What will your responsibilities be? 
You are requested to share your experiences and views regarding the provision of care to patients 
with chronic musculoskeletal pain. You will also be required to complete a short questionnaire with 
general information about yourself, which will help me to describe the research context. 
Will you benefit from taking part in this research? 
You will not benefit directly from this research in the short term. However, future benefit lies in the 
fact that the information gained from this research may inform healthcare practitioners about issues 
and strategies for treating chronic musculoskeletal pain in the local context.  
Are there any risks involved in your taking part in this research? 
There are no direct risks; only interviews will be conducted. However, you may be put in a position 
of sharing sensitive information that may evoke emotional responses. Please inform the researcher 
should you be experiencing such emotions, and if you need a break from the interview. 
If you do not agree to take part, what alternatives do you have? 
If you prefer not to participate, we respect your choice. 
Who will have access to your medical records? 
Only the research team will have access to your records. Approved external auditors or funders may 
also inspect the research records. The information collected will be kept confidential. Your name 
will not appear on any records, as only numbering codes will be used. Your identity will remain 
confidential throughout the conducting and reporting of the research. 
The interviews will be recorded with a digital voice recorder and will be documented by a 
professional, independent transcriber. The recordings will be password protected. No names will be 
used in the transcriptions. Once the transcriptions are completed, the voice recordings will be 
destroyed. Only the research group will conduct the interviews and analyse the transcriptions.  
If the information obtained is published (e.g. in a report or journal article), the participants’ 
identities or the names of the community health centres will not be disclosed.   
What will happen in the unlikely event of some form of injury occurring as a direct result of 
your taking part in this research study? 
This part of the research project consists of interviews. Therefore, no injuries resulting from the 
research process are anticipated.  
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be compensated for participating, but you will receive a small gift of appreciation. 
Also, you will incur no costs if you do take part. 
Is there anything else that you should know or do? 
Should you have any further queries or encounter any problems, please call the principal 
investigator, Dawn Ernstzen, on 021 938 9300. The study is financially supported by the National 
Research Foundation and no conflict of interests has been reported. 
Should you have any concerns or complaints that the research team has not addressed adequately, 
you may call the Health Research Ethics Committee on 021 938 9207. 
You will receive a copy of this information and consent form for your own records. 
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Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled: Health care providers’ perspectives about the primary health care management of 
patients with chronic musculoskeletal pain regarding their management pathway. 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written in a 
language in which I am fluent and with which I am comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
 I may be asked to leave the study before it has finished, if the study doctor or researcher 
feels it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Informed consent for recording of the interview  
The reason for recording the interview and later destroying the voice recordings has been explained 
to me. I understand these procedures and agree that they may be performed. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above. 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign 
the declaration below.) 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
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Declaration by interpreter 
I (name)  ..........................................................................................................................  declare that: 
 I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..……………………… using the language medium of Afrikaans/isiXhosa. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of interpreter Signature of witness 
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APPENDIX 16: CODEBOOK FOR PRACTITIONER STUDY 
Code-Filter: All 
HU: Ernstzen HCP Interviews CPG 
File:  [C:\Users\acer i5\Documents\Scientific Software\ATLASti\TextBank\Ernstzen HCP Interviews CPG.hpr7] 
Edited by: Super                                             Date/Time: 2016-08-17 16:53:53 
 
BARRIER 
Barrier: continuity of care 
Barrier: meds available 
CPG: Use and Need 
Culture 
Diagnosis 
EBP 
EBP: barrier facilitator 
EBP: use 
Employer 
HEALTHCARE PRACTITIONER 
HCP: education development 
HCP: feeling 
HCP: roles 
HPC beliefs 
Language 
MAN: efficacy 
OCCUPATIONAL 
Occupational: barrier 
Occupational: facilitator 
Occupational: employer 
Pathway 
PATIENT 
PATIENT: education needs 
PATIENT: empowerment 
PATIENT: expectations 
PATIENT: health literacy 
PATIENT: psychosocial 
PATIENT: role 
PERSPECTIVE 
PERSP: care 
PERSP: causes chronicity 
PERSP: causes pain 
PERSP: change 
PERSP: community 
PERSP: Compliance 
PERSP: patient 
PERSP: pt beliefs meds 
PERSP: pt beliefs physio 
Trauma 
Typical patient 
PRACTICE 
PRACTICE: Ass devices 
PRACTICE: assessment 
PRACTICE: CBT 
PRACTICE: Coping 
PRACTICE: Diet 
PRACTICE: discharge 
PRACTICE: education 
PRACTICE: electro-physical 
PRACTICE: exercise 
PRACTICE: group therapy 
PRACTICE: meds 
PRACTICE: interdisciplinary  
PRACTICE: physio 
PRACTICE: psycho 
PRACTICE: psychiatry 
PRACTICE: refer 
PRACTICE: self-management 
PRACTICE: social worker 
PRACTICE: support 
PRACTICE: work assessment 
Satisfaction 
SOCIAL 
SOCIAL: disability grant 
SOCIAL: drugs 
SOCIAL: environment 
SOCIAL: finances 
SOCIAL: lifestyle 
SOCIAL: psychosocial 
SOCIAL: relationships 
SOCIAL: transport 
SOCIAL: violence 
SYSTEM 
SYSTEM: access 
SYSTEM: continuity 
SYSTEM: health care system 
SYSTEM: Interdisciplinary care 
SYSTEM: load 
SYSTEM: management 
SYSTEM: meds available 
SYSTEM: refer 
SYSTEM: resources 
SYSTEM: time 
SYSTEM: wait 
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APPENDIX 17:  
EXAMPLES OF TRANSLATED QUOTES  
(PRACTITIONER STUDY) 
Afrikaans English 
P 3, Doctor: En mens moet meer dink ek meer 
ŉ holistiese benadering ten opsigte van 
kroniese pyn hê. Ek bedoel aan die artritis, die 
eindstadium van artritis kan ons dalk iets doen. 
Ons moet ŉ diagnose kan hê, wat die rede vir 
die pyn is dat ons die regte diagnose het. Ons 
het regtig ŉ multidissiplinêre span nodig om 
die pyn te hanteer. Want daar is verskeie redes 
vir pyn. So ek dink nie daar word genoeg, daar 
is genoeg altyd tyd en aandag wat daaraan 
spandeer word nie.   
P 3, Doctor: I think we need a more holistic 
approach for chronic pain. We can do 
something for arthritis, the end-stage also. But 
we must have a diagnosis; we must know the 
reason for the pain to make the right diagnosis. 
We definitely need a multi-disciplinary team to 
manage pain. Because there are different 
reasons for the pain. So I don’t think that 
enough time and attention is spent on it.   
P 4, Doctor: Dit sisteem is nie perfek nie, maar 
ons probeer so ver moontlik accommodating te 
wees. Die IDL maak ŉ huge difference in ons 
werk. Ek kan nie vir jou genoeg sê nie. En toe 
ek in XXX gewerk het, jy moet ŉ afspraak maak 
om die physio te sien, die physio reis rond. Dis 
ŉ moeilike, moeilike, moeilike konsep. 
P 4, Doctor: The system is not perfect, but we 
try to be accommodating. The interdisciplinary 
approach makes a huge difference in our work. 
I can’t tell you enough. When I worked at XXX, 
you needed to make an appointment to see the 
physiotherapist, because she travels to other 
clinics. That is a very difficult concept.    
P 5, Occupational therapist: Ek dink definitief 
pasiënte moet vinniger by ons uitkom, want ŉ 
pasiënt loop dalk baie lank met ŉ arm of ŉ 
hand wat seer is, of selfs ŉ rug, dan kom hulle 
hier by XXX, dan sê hulle oe, ek loop nou al vir 
drie weke met my rug, maar ek het nou maar 
uitgehou. Waar as ons weereens gaan oor 
opvoeding, dat die pasiënte kan leer as jy pyn 
het, kom. As dit vir twee of drie dae seer is, 
kom dadelik in en kom vra dadelik vir hulp, 
want hoe vinniger jy dit stop, hoe beter. 
P 5, Occupational therapist: I really think 
patients need to get to us sooner. Because a 
patient will have pain for some period of time; 
a hand or an arm or a back; they present to 
XXX after three weeks of having pain; and say 
they have endured the back pain for three 
weeks. Once again, it is about education, so 
that the patient knows, if I have pain, I need to 
seek help. If it is painful for two or three days, 
come immediately and ask for help, because the 
sooner you stop it, the better.   
P 7, Physiotherapist: Ek en die sielkundige, 
ons het saamgegaan, ons het verduidelik die 
hele anatomie rondom pyn, die fisiologie, ons 
het alles gedoen en dit het baie goed gewerk, 
die mense het fantasties gereageer en gereeld 
gekom en saam met dit, die oefengroepie. Die 
pasiënte het nooit weer teruggekom kliniek toe 
nie. Glad nie. Hulle het nooit weer gekom vir ŉ 
gewone behandeling nie. 
P 7, Physiotherapist: The psychologist and I, 
we went together and explained 
comprehensively to patients the anatomy and 
physiology of pain. We did that and it worked 
very well, the people reacted very well to it. 
They came regularly and with that to the 
exercise group. Afterwards, the patients did not 
attend the clinic again, not at all. They did not 
return for the usual treatment. 
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APPENDIX 18:  
CONVERSION OF THE LEVELS OF EVIDENCE TO A SINGLE 
SYSTEM  
Single system: Level of evidence As described in various guidelines 
High level of evidence Level 1 
Levels I or II 
Levels A or B 
Good 
Moderate level of evidence Level 2 
Levels II 
Levels B or C 
Fair 
Low level of evidence Level 3 
Levels III  
Levels C  
Poor 
Expert consensus Level 4 
Level IV (in some CPG also III) 
Levels D 
Good practice point 
High levels of evidence can be variously described as Levels I or II, A or B.  
Moderate levels of evidence can be variously described as Levels II or III, B or C.  
Low levels of evidence can be variously described as Levels III or IV, C or D.  Expert consensus 
was also taken as low level.  
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APPENDIX 19:  ADAPTED PARM GUIDE FOR ENDORSEMENTS  
Phrase for strength of 
evidence 
Description of type level of evidence 
Guide for writing 
endorsements 
There is strong evidence Consistent grades of high-quality evidence with uniform thought
a
, and at least a moderate volume 
of references to support the recommendation 
We strongly recommend 
There is evidence A mix of moderate- and high-quality evidence with uniform thought and at least a low volume of 
references, 
A mix of high- and low-quality evidence with uniform thought and high volume of references, 
High-quality evidence coupled with GPPs, and at least moderate volume of references,  
Consistent grades of high-quality evidence with uniform thought, and at least a low volume of 
references,  
One level I paper (SR) and at least a moderate volume of references 
We recommend 
There is some evidence Single level II paper (RCT),   
Inconsistent grades of high and low evidence with uniform thought and a moderate volume of 
references,  
Inconsistent grades of moderate and low evidence with uniform thought and a moderate volume of 
references, 
Consistent grades of moderate level evidence and GPP with uniform thought and at least a 
moderate volume of references,  
Consistent grades of low-level evidence with uniform thought and at least a moderate volume of 
references 
There is conflicting evidence A mix of levels of evidence with non-uniform thought, irrespective of the volume of references 
b
We suggest that 
clinicians consider There is limited evidence A mix of levels of evidence with non-uniform thought, irrespective of the volume of references 
with or without GPPs,  
Consistent grades of moderate level evidence with uniform thought and a low volume of 
references 
There is expert consensus that 
it is good practice 
GPP only (no evidence): based on expert consensus 
There is  insufficient/no 
evidence 
Low or inconsistent levels of evidence with a low volume of references with or without GPPs, OR 
Absence of evidence 
We do not endorse
 
a 
Where only one recommendation is present, the criterion of uniformity of thought cannot be adhered to and therefore does not apply. 
b 
In the absence of a strong 
evidence base, but where plausible hypotheses exist for a particular recommendation (such as theoretical explanations, physiological rationale, expert consensus or 
other forms of such data), the clinician should use his/her own discretion by applying clinical reasoning to make a decision.   
(Adapted from Gonzalez-Suarez et al., 2012) 
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APPENDIX 20:  
EXAMPLES OF MERGING RECOMMENDATIONS  
Table 20.1. Example of recommendation on pharmacological management: NSAIDs 
 
Recommendation  Source 
guideline 
Quality 
level of 
evidence 
Strength of 
recommendation 
References 
(2) 
NSAIDs should be considered in 
the treatment of patients with 
chronic non-specific low back 
pain. 
SIGN, 
p10  
 
High 
quality 
B (moderate) 1 
NSAIDs should be used for 
periodic flare-ups of mild to 
moderate inflammatory or non-
neuropathic pain. NSAIDs should 
be used for periodic flair-ups 
rather than for long-term chronic 
use. 
ICSI, p35  
 
High 
quality  
- 1  
Criteria: Uniform thought – Consistent level of evidence – Low volume references – Non-current  
Merged level of evidence: There is evidence. 
Merged endorsement statement: We recommend that NSAIDs can be effective in the short 
term for chronic musculoskeletal pain such as chronic non-specific low back pain and arthritis 
pain. 
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Table 20.2. Example of recommendation on self-management 
 
Recommendation  Source 
guideline 
Quality 
level of 
evidence 
Strength of 
recommendation 
References 
(8) 
Self-management resources 
should be considered to 
complement other therapies in the 
treatment of patients with chronic 
pain. 
SIGN, p8 High 
quality x6 
 
 
C 6  
Self-management insures active 
patient participation in the care 
plan is essential. 
ICSI, p23 Low quality  - 1 
Healthcare professionals should 
signpost patients to self-help 
resources, identified and 
recommended by local pain 
services, as a useful aide at any 
point throughout the patient 
journey. Self-management may be 
used from an early stage of a pain 
condition through to use as part of 
a long term management strategy. 
SIGN, p5 High 
quality  
GPP 1  
Criteria: Uniformity of thought – Inconsistent level of evidence – High volume –Current  
Merged level of evidence: There is evidence. 
Merged endorsement statement: We recommend self-management resources to complement 
other therapies in the treatment of patients with chronic pain to ensure active patient participation 
during early management as well as part of long-term management. 
 
 
Comment:  
 
As can be seen in Table 19.1, SIGN (2013) assigns a B (moderate) rating, which is also displayed in 
the phrasing of the recommendations, amidst a high quality of evidence, indicating that factors 
other than the quality of evidence played a role in this recommendation.  ICSI (2013) did not use 
strength of the recommendation grading, and the wording suggests a strong recommendation.  A 
similar finding is presented in Table 19.2.  The reason for the B and C strength of recommendation 
ratings in the examples are indistinct.  However, SIGN (2013) mentions that the evidence indicates 
small improvements in outcomes for the intervention, and that the long-term effectiveness is 
unclear.  The latter two reasons could explain the strength of the recommendation rating. 
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APPENDIX 21:  
GUIDELINE CONTRIBUTORS 
Thank you to the expert panel who evaluated and validated the recommendations, and the expert 
panel who produced relevant context and practice points:   
Dr Debbie Alexander Principal Clinical Psychologist, Senior Lecturer, Department of 
Psychiatry, Stellenbosch University 
Ms Jacqui Armstrong Physiotherapist, Government sector 
Dr Sean Chetty Anaesthesiologist, Senior Lecturer, School of Clinical Medicine, 
University of the Witwatersrand and Rahima Moosa Mother and Child 
Hospital 
Prof Hoffie Conradie Former Director, Ukwanda Centre for Rural Health 
Ms Caroline de Wet Physiotherapist, Manager, Government sector 
Dr Janine Dizon Centre for Evidence-based Health Care, Stellenbosch University and 
Centre for Health Research and Movement Science, University of 
Santo Tomas, Manila, Philippines 
Ms Magda du Preez Physiotherapist, Government sector 
Ms Christa du Toit Medical Scientific Liaison: Pain 
Ms Marlie Enright Clinical lecturer, Physiotherapist, Stellenbosch University 
Ms Dawn Ernstzen Physiotherapist, Senior Lecturer, PhD candidate, Stellenbosch 
University 
Ms Charlyn Goliath Occupational therapist, Manager, Government sector 
Ms Danine Kitshoff Lecturer in Nursing, Stellenbosch University 
Ms Jacqui Koep Physiotherapist, Private practice 
Prof Quinette Louw Professor in Physiotherapy, Stellenbosch University 
Prof Helgard Meyer Professor, Department of Family Medicine, University of Pretoria 
Ms Hameedah Parker Medical Anthropologist, Research Intern, Stellenbosch University 
Prof Romy Parker Associate Professor in Physiotherapy, University of Cape Town 
Ms Hilary Rhode Lecturer, Family Medicine and Primary Care, Stellenbosch University 
Ms Michelle Smith-Venter Occupational therapist, Certified hand therapist (USA), Private 
practice 
Ms Herculene van Staden Occupational therapist, Private practice 
Ms Erica Venter Former Consultant Clinical Psychologist in Pain Management, NHS 
UK & PMC Jersey 
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Dr Klaus von Pressentin Family Physician, Senior Lecturer, Family Medicine and Primary 
Care, Stellenbosch University 
Thank you to Prof Marc Blockman, Division of Clinical Pharmacology, Department of Medicine, 
Faculty of Health Sciences, University of Cape Town, for his valuable feedback on the 
recommendations for pharmacological management.   
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APPENDIX 22:  
INFORMED CONSENT (CONSENSUS STUDY) 
INFORMATION LEAFLET AND CONSENT FORM FOR PARTICIPATION IN A 
RESEARCH STUDY 
Title of the research project: 
Study 4: Contextualisation of evidence-based clinical guideline recommendations for the 
management of chronic musculoskeletal pain in a South African primary healthcare setting 
Ethics reference number: S14/01/018 
Principal investigator: Dawn Ernstzen 
Address: P O Box 241, Cape Town, 8000 , South Africa 
Physiotherapy Division, Faculty of Medicine and Health Sciences, Stellenbosch University 
Contact number: 021 938 9300 
I would like to invite you to participate in a research project.  Please take some time to read the 
information presented here, which will explain the details of the study.  Please ask me any questions 
about any part of the study that you do not fully understand.  It is very important that you are fully 
satisfied that you clearly understand what this research is about and how you could be involved.  
Please remember: 
 Your participation is entirely voluntary and you are free to decline to participate.   
 If you say no, this will not affect you negatively in any way whatsoever.   
 You are free to withdraw from the study at any point, even if you did agree to take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch University 
and will be conducted according to the ethical guidelines and principles of the international 
Declaration of Helsinki, South African Guidelines for Good Clinical Practice and the Medical 
Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
The study focuses on chronic musculoskeletal pain AND primary/community health care 
The main aim of this research is to contextualise evidence-based clinical guideline 
recommendations that were identified through a systematic review on user-friendly 
recommendations for clinical practice that are applicable to the local, South African context.   
This part of the study will take the form of a consensus study, during which a group of experts will 
provide feedback about evidence-based practice recommendations and their applicability to a South 
African context. This will be done as follows: 
 firstly, by rating their agreement with each evidence-based recommendation through a 
survey, and 
 secondly, by attending a consensus meeting to discuss SA contextual factors that might 
have an impact on the implementation of the recommendations. 
A multi-disciplinary group across government health sectors and academic institutions will be 
invited to participate in a study.  The consensus group will meet once, for between one and two 
hours at the Faculty of Medicine and Health Sciences, Stellenbosch University.  Using a specific 
agenda, the group will discuss the guideline recommendations and provide suggestions on how to 
contextualise and use it in the local context.  The principal investigator will chair the meeting and 
document the decisions made.   
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Why have you been invited to participate? 
You have been invited to participate because you have distinctive experience in 
 health care management and/or  
 pain management and/or  
 guideline development   
in the South African context.  Sharing your experiences and views about the providing care to 
patients with chronic musculoskeletal pain in your unique context will be vital in sketching a 
management pathway for these patients. 
What will be expected of you?  And how long will it take? 
The table below outlines each step of the process: 
Step  When? How long will it 
take you? 
Step 1 You will receive an e-mail with the 
baseline information to orientate you: 
 A “writing guide” that was 
developed to guide decision-
making 
 3 sample clinical 
recommendations 
September 2015 15 to 20 minutes 
Step 2 You will receive an e-mail link to 
complete a Delphi survey that 
contains all clinical practice 
recommendations. 
 You need to indicate your 
agreement with each 
recommendation, and  
 Provide comments if you like. 
October 2015 30 minutes 
Step 3 Consensus conference 
 
The group meets to discuss: 
 Any disagreements in evidence-
based recommendations as 
identified in step 4, and 
 South African contextual factors 
that might impact implementation. 
Proposed date: 
Wednesday, 11 
November.   
Time: 10:00–12:30 
Lunch: 12:30–13:30  
Venue: Faculty of 
Medicine and Health 
Sciences, Stellenbosch 
University 
2½ hours 
Step 4 Delphi survey Round 2 December 2015 10–20 minutes 
Will you benefit from taking part in this research? 
You will not benefit directly from this research in the short term.  However, future healthcare 
providers and patients may benefit once the research has been concluded.  The benefit lies therein 
that the information gained from this research may inform healthcare practice about a relevant 
management pathway and clinical guideline recommendations for the treatment of chronic 
musculoskeletal pain in the Western Cape. 
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Are there in risks involved in your taking part in this research? 
There are no direct risks involved in the study.  A conflict of interest form will be provided to 
identify any conflict of interest.  Should there be any voting about decisions, your vote will remain 
confidential.  You will also have the opportunity to change your vote, should this be necessary. 
If you do not agree to take part, what alternatives do you have? 
If you prefer not to participate, we respect your choice, and it will not disadvantage you. 
Who will have access to the records? 
 Your responses to the survey responses will be kept anonymous, as an electronic survey 
system will be used. 
 During the consensus conference, your opinion will be shared in the group.  However, only 
the consensus decision will be communicated in the outcome of the study and individual 
comments will thus not be identifiable.  The conference will be recorded with a digital voice 
recorder to aid in the documentation and motivation for decisions.  When the study is 
completed, the voice recordings will be destroyed.   
 Should there be voting, your vote will remain confidential, and you will have an opportunity 
to change your vote.   
 If you give permission, your name will appear as a contributor in the documentation of the 
study results.  If you do not give permission for you name to appear, a general non-
identifying description of your career profile will be given. 
Only the research team will have access to the study records.  Approved external examiners or 
funders may also inspect the research records.   
What will happen in the unlikely event of some form of injury occurring as a direct result of 
your taking part in this research study? 
The research involves a survey and a discussion group.  No injuries resulting from the research 
process are thus anticipated.   
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be compensated to take part in the study but you will receive a small gift of 
gratitude.  There will be no costs involved for you, if you do take part. 
I would like to offer you the following: 
 A small honorarium OR CPD points will be applied for; 
 Your contribution will be acknowledged in the final product;  
 Authorship in the final product; 
 A copy of the final product (after external review); 
 Should a journal article result, you may also be listed as an author.   
Is there anything else that you should know or do? 
You can contact the principal investigator, Dawn Ernstzen, at telephone 021 938 9300 if you have 
any further queries or encounter any problems.  The study is financially supported by the National 
Research Foundation and no conflict of interest has been reported. 
You can contact the SU Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by the research team.  You will 
receive a copy of this information and consent form for your own records. 
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Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled: 
Contextualisation of evidence based clinical guideline recommendations for the management of 
chronic musculoskeletal pain in a South African primary healthcare setting 
 
I declare that: 
 I have read or had read to me this information and consent form and it is written in a 
language in which I am fluent and with which I am comfortable. 
 I have had a chance to ask questions and all my questions have been adequately answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in any 
way. 
 I may be asked to leave the study before it has finished, if the study doctor or researcher 
feels it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Informed consent for recording of the discussion:  
The reason for recording the interview, transcribing it and later destroying the voice recordings 
have been explained to me.  I understand these procedures and give consent for them to take place. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of participant Signature of witness 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as discussed 
above. 
 I did/did not use an interpreter.  (If an interpreter was used then the interpreter must sign the 
declaration below. 
Signed at (place) .............................................................  on (date)  .................................................. 
 ................................................................................  ................................................................. 
Signature of investigator Signature of witness 
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APPENDIX 23:  
CONFLICT OF INTEREST 
Contextualising clinical practice guidelines for chronic musculoskeletal pain 
Disclosure of conflict of interest 
We would like to ensure balance, independence, impartiality and scientific rigour in the 
contextualising of the guideline by experts from across the Western Cape. 
You are asked to declare any real or potential conflicts of interest that may have a direct influence 
on the content of the guidelines.  This includes relationships with pharmaceutical companies who 
may manufacture or distribute pharmaceutical products mentioned in this guideline; or relationships 
with insurance companies or workers’ compensation agencies. 
The intent of this disclosure is not to prevent any reviewer from participating, but rather to be 
transparent about possible conflicts, and to identify potential bias. 
The final guideline will include all the names of the advisory group as well as the named conflicts 
of interest. 
Name:  
Address/Affiliation:  
 
Please choose the appropriate option: 
 I have no actual or potential conflicts of interest. 
 I have/had financial interests, arrangements, affiliation with the following 
organisations:  
Affiliation/financial interest Name of organisation 
Grant or research support  
Shareholder  
Other   
Other  
 
Publication interest 
I am interested in participating in a publication that might result from this contextualisation 
(Delphi) process. 
Please circle your choice: YES  NO 
 
Signature: _______________ 
Date: __________________ 
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APPENDIX 24:  
CONTEXTUALISATION CRITERIA 
We endorse performing a complete and holistic patient evaluation which includes history, 
physical examination, functional status, psychosocial risk factors and contextual factors in the 
evaluation, diagnosis and management of patients with CMSP. 
Evidence base: There is evidence  
PHC Contextual factors: contextual factors that may affect the implementation of this 
recommendation 
 See framework 
What is needed to implement this intervention?  
What is needed? Minimum standards Additional standards 
Organisational  
 
  
Practice method 
(how) 
 
 
 
 
Staff (who)  
 
 
Resources  
 
 
Training  
 
 
Timing (when)  
 
 
Re-assessment  
 
 
Referral   
 
 
Consumer/patient 
/family 
 
 
 
Policy 
 
  
Other?  
 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
  193 
APPENDIX 25:  
FRAMEWORK OF CONTEXTUAL FACTORS 
Patient-specific (personal) factors Social and environmental factors 
Beliefs about chronic musculoskeletal pain 
 Knowledge and understanding of pain 
 Biomedical or biopsychosocial beliefs 
Impact of chronic pain  
 Movement and function 
 Emotions 
 Relationships  
 Participation  
Coping with chronic pain  
 Active or passive coping strategy 
 Spirituality 
 Resilience  
 Acceptance  
Adherence to management 
Treatment goals 
Family 
 Family support 
 Concerns about family 
Financial circumstances 
Disability insurance 
Occupational influences 
Personal loss 
Physical environment  
Community influence 
 Community support groups  
 E.g. drug abuse, violence, 
gangsterism 
 
Healthcare management/interventions 
factors 
Healthcare system factors 
Practitioner beliefs 
Practitioner attributes 
Access to interdisciplinary care 
Pharmacological management 
 Effectiveness of analgesia 
 Beliefs about analgesia 
 Adherence to prescribed medication 
Self-medication/use of traditional medicines 
Non-pharmacological management 
 Effectiveness of exercise/other therapies  
 Beliefs about exercise and other therapies 
The need for advice and education 
Treatment goals 
Pathway of care (patient journey) 
 Private and/or public healthcare 
sector usage 
 Referral 
Waiting time/waiting lists 
Continuity of care 
Regularity of care 
Patient interaction with healthcare system 
 Satisfaction with care  
 Understanding the system 
Access to care/access to rehabilitation 
Staff capacity 
Consultation time 
System load 
Analgesics available 
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APPENDIX 26: TABLE OF COMMENTS ABOUT 
RECOMMENDATIONS DURING THE DELPHI ROUND 1 & 2  
Recommendation Comment 
Approach  A patient-centred approach is good, but ‘compassionate’ can be 
interpreted as ‘sympathetic’ which can enhance the fear-avoidance 
behaviour.  A ‘pro-active’ approach used by all members or the multi-
disciplinary team has a better outcome. 
Collaborative 
decision-making 
Which also considers the behavioural, cognitive and emotional status of 
the patient 
Inter-professional 
collaboration 
Unfortunately, there is no time to develop a thorough individual plan for 
every patient.  But that is the ideal!! 
Holistic assessment Without a proper holistic evaluation, you cannot plan and treat 
appropriately. 
Must also include quality of life and level of participation/participation 
restrictions. 
Tools It makes it easier to compare your results and for evidence-based 
treatment regimes.   
As an adjunct to a thorough clinical evaluation. 
It is also important to get a clinical sense of the person, as well as using 
instruments to measure distress. 
Classification Classification is important relating to educating client on underlying 
pathology/reason for pain, but it is uncertain how it will influence 
further management strategies of chronic pain.   
Will need extra training in terminology. 
Would you include pain of psychological origin? 
Special investigations We would have to clarify the standardised process/guidelines of defining 
and choosing appropriate information investigated/shared as each client 
has individual interpretation/understanding/needs in regards to their 
health status. This can also become an ethical dilemma as we withhold 
access to certain special investigations or information. 
Consider patient right to information. 
Brief education It would depend on the patient whether this will be brief or elaborate, 
depending on his/her beliefs, past experiences of pain, secondary gain, 
early referrals and working conditions. 
I am not sure what ‘to continue to work’ means. Does it mean to 
continue with daily activities and working towards being more active? If 
so I agree. I would include the family in this brief education. 
Therapeutic 
neuroscience 
education 
Xhosa and other African translations needed. 
 
Education about 
analgesia 
I would like to know more about the side effects of medications. 
Analgesic review These patients should preferably be seen every 4–6 months and the aim 
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Recommendation Comment 
remains to reduce pharmacological therapies whenever possible. 
Reviewed more often, on step 3 at least monthly. 
Antidepressant 
therapy fibromyalgia 
But most important lifestyle adaptation programme 
Most FMS patients respond to 10-25 mg at night and can't tolerate 
higher doses. Tramadol is the primary drug of choice. 
Anti-convulsants 
(Pregabalin) 
This is also very effective for patients post lumbar surgery with residual 
radiculopathy.  
Most patients respond to lower dosages such 50-75 mg. 
Not available in primary care therefore not an option in state practice. 
SNRI (Duloxetine) Yet again as co-analgesia but patient needs to improve lifestyle to 
decrease the use of these drugs. 
Evidence base for OA is much smaller than in FMS and neuropathic 
pain. 
Not available in primary care therefore not an option in state practice. 
Not available at hospital. 
Knowledge can be made known to patients who can afford to source 
internationally. 
Opioids consent The doctors don’t do informed consent – it is used a lot. 
Opioid therapy Criteria for long-term opioid therapy should emphasise appropriate 
patient selection for e.g. risk of abuse, etc. more emphatically. 
Exercise Patient subjective 
Acupuncture Limited evidence 
TENS Evidence is limited and clinical experience often disappoints. 
Psychological 
comorbidities 
I am not sure which clinicians you have in mind to do this. 
Cognitive 
behavioural therapy 
Indications for cognitive behavioural therapy should be better described. 
Depending on the person’s ability to be aware of their cognitions and to 
challenge them. 
Refer to psychologist A psychologist and I had a chronic pain group for a couple of weeks.  It 
delivered fantastic results, but the psychologist was transferred to a 
different region before we could complete the programme.   
Psychologists do not always understand the physical components of pain 
and if not trained psychologists can enhance fear-avoidance behaviour. 
Antidepressant 
therapy 
Start low go slow not optimised. 
Not all patients with pain will be clinically depressed. 
No antidepressant 
therapy CLBP 
Tricyclic antidepressants are in particular beneficial in chronic LBP 
patients with sleep disturbances and also with underlying fibromyalgia.  
Some medication, like Trepiline in small dosages, can be beneficial in 
chronic low back pain, when combined with pain management 
techniques. 
SSRI (Fluoxetine) If an assessment of the psychosomatic factors is conducted with patients 
with low back pain and shows that the person is ‘at risk’, the use of 
Depramil has shown to be effective. 
Only until lifestyle adaptation programme can be more effective. 
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Recommendation Comment 
The treatment of Fluoxetine for fibromyalgia has been discontinued.  
Unlike to benefit the primary pain complaint but very valuable for 
comorbid depression. 
Multi-disciplinary 
pain management 
programme 
Such programmes are very limited in our country and a general 
statement like this is not only inappropriate but also impractical, most 
chronic pain patients are managed by primary care doctors and nurses. 
Pain management 
specialist 
 
Early referrals can address misbeliefs, prevents fear-avoidance 
behaviour and start with pain management from the start. With late 
referrals as recommended, a pain syndrome could have established 
itself, and this will prolong treatment. 
There are no pain specialists in SA. Most doctors who call themselves 
‘pain specialists’ do not work from a biopsychic-social framework and 
are often procedural orientated which has the potential to lead to 
unnecessary procedures which often worsens the prognosis. 
If there is a collaborative approach would this be necessary? 
Muscle relaxants Anxiolytics have their place to get the patient to be more cooperative for 
other treatment plans. 
There is a small subset of patients who respond to muscle relaxants such 
as cyclobenzaprine and this may limit the use of more toxic alternatives 
such as NSAIDs. 
Short-term use. 
Laser Safety is really an issue regarding adverse events. 
No Laser available. 
Can be done in private but not applicable for the government setting 
because of limited results and being time-consuming. 
Not enough experience with this modality. 
We don’t have Laser. 
Rubefacients Topical rubefacients are sometimes effective as first-line therapy and the 
rubbing action has been shown to be beneficial by stimulating the 
thicker Beta fibres. It is unlikely to be beneficial if used as a ‘last resort’.  
If people can afford it, it must be made known to them. 
Topical NSAIDs The absorption ability through the skin is little and it can cause skin 
irritation if the patient is sensitive to NSAIDs. Perhaps oral plus 
paracetamol, then NSAID & NSAID. Then topical application could be 
another option specifically in chronic pain. You need to have various 
options in a longer time frame. 
It is not absorbed in the same manner through the intestinal tract.   
If a topical NSAID is going to facilitate rubbing the area of chronic pain. 
It may be more beneficial and can be used instead than normal NSAIDS. 
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APPENDIX 27:  
EXAMPLE – CONTEXT POINTS FOR APPROACH TO CARE 
Criterion  Context point 
Organisational  
 
To enable this approach, more time per patient and an 
interdisciplinary team is required.  A solution of the system overload 
is imperative. 
Practice method (how) 
 
Applying patient-centredness is very important at the first visit to 
build rapport and gain patient’s trust. 
Communication skills are important to identify the real main problem 
and contributing factors (e.g. social). 
Cultural appropriateness will enhance approach. 
Important to take cognisance of language influences. 
Staff (who) All clinicians 
The interdisciplinary team should have regular meetings (monthly) to 
enhance communication, collaboration, contact and early referral. 
Resources Use patient decision aids/educational material.  An electronic 
communication system is essential to provide feedback to the team. 
A care plan for each patient with chronic pain is essential. 
Training Skills training may be required to use the approach, for example 
communication skills training and chronic pain management training. 
Timing (when) Very important at first visit, but needs to be ongoing.   
Re-assessment Patient should be re-assessed at follow-up by the same treating 
clinician, to enhance continuity of care. 
Check for change in social environment/physical symptoms. 
Referral  Within the interdisciplinary team 
Patient/family Patient should be empowered to take part in decision-making. 
Policy 
 
As part of CAIRR (Healthcare 2030). 
This approach needs to be emphasised in the undergraduate 
curriculum. 
Curriculum needs to focus more on cultural sensitivity and social 
determinants of health. 
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APPENDIX 28:  
EXAMPLE – CONTEXT POINTS FOR ASSESSMENT  
Criterion  Context point 
Organisational  To enable holistic assessment, more time per patient is required.  
An outcome-orientated approach is needed – outcomes should be 
measured. 
Practice method (how) 
 
Conduct a thorough interview. 
Simple, short and validated screening tools and outcome measures 
will ease holistic assessment and interdisciplinary communication.  
One holistic tool relevant for the context would be ideal.  Risk 
stratification is important. Important to identify type of pain – may 
also use a diagnostic tool. 
Staff (who) An interdisciplinary approach is essential.  However, holistic 
assessment is important at the first contact clinician which can be the 
nurse, medical doctor or in some cases the physiotherapist.   
Resources Printed copy in the folder 
Electronic information system, available to all clinicians 
Training Staff may initially need training to use assessment tools.  Additional 
training in a chronic pain management may be required.   
Timing (when) Important at first visit 
Re-assessment On follow-up visit or at the end of a 6-week intervention programme, 
using the same outcome measure. 
For stabilised patients, a chronic pain club, once a month is advisable. 
Referral  Clinicians may need guidelines for referral. 
Within the interdisciplinary team, depending on findings of the 
holistic assessment.  A social worker and psychologist should be 
included. 
For special tests if needed 
To specialist centres if needed  
Patient/family Explain findings to the patient using appropriate language.  Patient 
education is important to foster adherence to treatment. 
Family education may enhance support. 
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APPENDIX 29:  
CLINICAL PRACTICE GUIDELINE RECOMMENDATIONS 
RECOMMENDATIONS (with practice/context points*) 
TOPIC 
LEVEL OF 
EVIDENCE 
RECOMMENDATION STATEMENT 
APPROACH 
Patient-centred 
 
We recommend the use of a compassionate, patient-centred 
approach for the assessment and management of chronic 
musculoskeletal pain.  This includes the exploration of the 
patient’s beliefs, knowledge and understanding of pain and 
pain management to positively influence outcomes. 
* Enhanced continuity of care if the same clinician is involved 
in follow-up. 
Shared 
decision-
making 
 
We recommend collaborative decision-making which 
includes identifying patient goals; developing a 
comprehensive and patient–specific pain management 
strategy that considers the age, gender, ethnic and cultural 
background; and spirituality of the patient. 
Inter-
professional 
collaboration 
 
We recommend inter-professional collaboration and the 
development of an individualised and comprehensive plan of 
care based on the biopsychosocial model for the effective 
assessment and management of chronic musculoskeletal pain. 
*Early referral for rehabilitation therapy is important. 
ASSESSMENT 
Holistic 
assessment  
We recommend performing a holistic patient evaluation, 
which includes history, physical examination, functional 
status, psychosocial risk factors and contextual factors in the 
evaluation, diagnosis and management of patients with 
chronic musculoskeletal pain.   
Assessment 
tools  
We recommend the use of appropriate, validated assessment 
tools to establish functional and psychological status and 
quality of life. 
*Where available, use the tools in appropriate languages. 
CLASSIFICATION 
Classification of 
pain  
We recommend the classification of chronic pain according to 
the type of pain as neuropathic, inflammatory, mechanical, 
nociceptive (or mixed picture), to guide management. 
*Also consider central sensitisation. 
SPECIAL INVESTIGATIONS 
Special 
investigations  
We recommend that clinicians be cautious in ordering various 
imaging and other evaluations; and provide relevant and 
appropriate information about imaging to the patient.   
This information may play a role in avoiding increased fear, 
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TOPIC 
LEVEL OF 
EVIDENCE 
RECOMMENDATION STATEMENT 
activity restriction, maladaptive behaviours and requests for 
increased opioids. 
*Consider red flags and refer when appropriate. Ensure that 
the patient has had the necessary investigations done. Do not 
withhold basic, required investigations. 
ADVISE AND EDUCATE 
Address 
concerns  
We recommend that clinicians address the patient’s concerns 
and misbeliefs and teach the person, their family and 
caregivers about pain management strategies. 
*Involve the family in education to enhance support. Use 
patient education material. 
Brief education 
 
We recommend that brief education be given to patients with 
chronic musculoskeletal pain to enable patients to continue to 
work. 
*Brief education is described as: examination, information, 
reassurance and advice to stay active. 
Advice to stay 
active  
We recommend advice to stay active in addition to exercise 
therapy for patients with chronic low back pain to improve 
disability in the long term. Advice alone is insufficient. 
*Encourage occupational activities where indicated. 
Therapeutic 
neuroscience 
education 
 
We suggest that the clinician consider pain neuroscience 
education to assist the patient in understanding their 
condition, change their conception about pain and improve 
their ability to cope with pain. 
* Use narratives and language that are applicable to the local 
context and culturally appropriate.   
PHARMACOLOGICAL MANAGEMENT 
Education 
about analgesia  
We recommend that the clinician: 
- educate patients about the risks and benefits of all 
medications and 
- monitor and manage side-effects. 
*Use patient educational material. Consider advice about 
concomitant use of over-the-counter medicines and herbal 
remedies. 
Analgesic 
review  
We suggest that the clinician consider reviewing a patient 
with chronic musculoskeletal pain using analgesics at least 
annually. More frequent review is necessary if medication is 
changed, or if the pain and/or underlying comorbidities alter. 
Paracetamol 
 
We recommend Paracetamol (alone and in combination with 
NSAIDs); and in combination with non-pharmacological 
treatments in the management of chronic musculoskeletal 
pain, such as hip or knee osteoarthritis. 
NSAIDs 
 
We recommend NSAIDs in the short term for chronic 
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TOPIC 
LEVEL OF 
EVIDENCE 
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musculoskeletal pain such as chronic non-specific low back 
pain and arthritis pain. 
* Consider individual risk profile; avoid the simultaneous use 
of oral and topical NSAIDs due to cumulative effects. 
Topical NSAIDs 
 
We suggest that the clinician consider topical NSAIDs for 
the treatment of inflammatory pain in patients with chronic 
musculoskeletal pain. 
* Avoid the simultaneous use of oral and topical NSAIDs due 
to cumulative effects. Consider side-effects (skin irritation). 
NSAIDs risks 
 
We recommend that clinicians consider cardiovascular, 
gastrointestinal and renal risk when prescribing NSAIDs, 
especially for older adults. 
Opioid consent  
 
We recommend that clinicians obtain informed consent 
before starting opioid therapy by advising the patient about 
potential benefits and risks. 
*The opioid Tramadol is listed in the EML for chronic non-
cancer pain. 
Opioid therapy  
 
We recommend opioid therapy for patients with moderate to 
severe chronic musculoskeletal pain (such as chronic low 
back pain or arthritis). Careful patient selection and regular 
review is required. Therapeutic benefits need to outweigh 
potential harms. 
*The opioid Tramadol is listed in the EML for chronic non-
cancer pain. 
PHYSICAL THERAPY 
Manual therapy 
 
We recommend manual therapy, integrated with other 
interdisciplinary treatments for the short-term relief of chronic 
pain. 
Manual therapy 
(neck)  
We recommend manual therapy in combination with exercise 
for the treatment of patients with chronic neck pain. 
Exercise 
 
We recommend exercise and exercise therapies, regardless of 
their form, in the management of patients with chronic pain. 
Exercise 
adherence  
We recommend the following approaches to improve 
adherence to exercise:  
 supervised exercise sessions  
 individualised exercises in group settings  
 provision of a combined group and home exercise 
programme with the addition of supplementary material 
TENS 
 
We recommend transcutaneous electrical nerve stimulation 
(TENS) for the relief of chronic pain. Low or high frequency 
TENS can be used. 
PSYCHOLOGICAL SUPPORT 
Psychological 
 
We recommend that clinicians identify, manage and monitor 
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comorbidities comorbid psychological conditions such as depression in 
patients with chronic pain. 
Operant 
Behavioural 
conditioning 
 
We recommend that clinicians be aware that the clinical 
environment and their own behaviour influence their 
responses to, and interaction with the patient.  These aspects 
may reinforce patients’ behaviour negatively or positively. 
Cognitive 
behavioural 
therapy 
 
We recommend cognitive behavioural therapy for functional 
restoration and reduction of pain in patients with chronic pain. 
Respondent 
Behavioural 
therapy  
 
We recommend progressive relaxation or electro-myographic 
biofeedback for the treatment of patients with chronic pain.   
*Described as the reduction on muscle tension to modify the 
physiological response to pain. Can be used as a self-
regulatory strategy. 
PSYCHOLOGICAL TREATMENT 
Refer to 
psychologist  
We suggest that clinicians consider assessing and addressing 
any concerns the patient may have about referral for 
psychological assessment by indicating that the approach to 
pain management is a holistic one and therefore the 
management includes the involvement of a psychologist to 
enhance coping skills. 
*Psychologists are not readily available in this context; may 
need to seek alternatives. 
Antidepressant 
therapy  
We recommend optimised antidepressant therapy for the 
treatment of patients with chronic pain and moderate 
depression. 
*Pharmacological and non-pharmacological management is 
needed for optimised treatment. 
Antidepressant 
therapy chronic 
lower back pain 
 
We suggest that the clinician consider tricyclic 
antidepressants for the management of chronic low back pain 
and concomitant depression. 
* A thorough evaluation of health status is warranted. The 
dosage is dependent on numerous factors. Refer to the EML. 
Antidepressant 
therapy 
fibromyalgia 
 
We recommend the tricyclic antidepressant Amitriptyline for 
the treatment of patients with fibromyalgia. 
* Amitriptyline is recommended as an adjuvant for the 
management of chronic non-cancer pain in the EML (2014).   
Antidepressant 
therapy review  
We suggest that the clinician consider reviewing patients 
with chronic musculoskeletal pain using antidepressants 
regularly to assess the on-going need for antidepressants and 
to ensure that the benefits outweigh the risks. 
SSRI: 
Selective  
We recommend Fluoxetine for the treatment of patients with 
fibromyalgia. 
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serotonin re-
uptake inhibitor 
*Fluoxetine is included in the EML for the treatment of major 
depression. 
RE-ASSESSMENT 
Re-assessment 
 
We recommend regular re-assessment of the physical, 
psychological and social domains of the patient to determine 
the person’s response to pain management interventions. 
MULTI-DISCIPLINARY PAIN MANAGEMENT 
Multi-
disciplinary 
pain 
management 
programme 
 
We recommend referral to a multi-disciplinary pain 
management programme for patients with chronic pain. 
*Few multi-disciplinary pain management programmes are 
available in SA. Interdisciplinary collaboration and a good 
referral system in primary health care are advocated. 
PAIN MANAGEMENT SPECIALIST 
Pain 
management 
specialist 
 
We recommend referral to a pain management specialist 
when: There is failure to achieve treatment goals; chronic 
pain is poorly controlled; intolerance of therapies; there is 
significant distress; there is a need for multi-disciplinary 
treatment or a need for interventional management. 
*Access to pain clinics at tertiary centres is limited in the 
context. 
SUPPORTED SELF-MANAGEMENT 
Self-
management  
We recommend self-management resources to complement 
other therapies in the treatment of patients with chronic pain 
to ensure active patient participation during early 
management as well as part of a long-term management. 
*A community-based support group is advocated.   
DO NOT OFFER 
Rubefacients 
 
  
We do not recommend topical rubefacients for the treatment 
of pain in patients with chronic musculoskeletal conditions. 
* Salicylate creams are available in SA, though their use are 
not supported by evidence. The research base supports the 
use of Capsaicin creams, however these expensive creams are 
not readily available in SA. 
Muscle 
relaxants  
We do not recommend the chronic use of muscle relaxants. 
*EML: Please refer to the Standard Treatment Guidelines and Essential Medicines List for Primary Health Care in SA 
(National Department of Health, 2014) for recommended dosages. 
**Off-label use should be used within ethical and legal guidelines or safety regulations.  (Please see SIGN 2013, pp. 3-
4 for guiding principles.) 
 
Other options not readily available in SA PHC. 
Anti-
convulsants**  
We recommend the use of Pregabalin for pain management in 
fibromyalgia. 
* The cost of these medicines limits its use in SA. Research 
focused on Pregabalin and Gabapentin. This medication is 
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not listed in the EML (2014). 
SNRI ** 
antidepressants
Serotonin 
norepinephrine 
re-uptake 
inhibitors 
 
We strongly recommend Duloxetine (where available) for the 
treatment of patients with fibromyalgia or osteoarthritis.  
* Research studies about SNRI’s for pain focused on 
Duloxetine.  Cost and availability in SA limits its use. 
Duloxetine is not included in the EML (2014).   
Acupuncture 
 
We recommend acupuncture for the short-term relief of pain 
in patients with certain pain conditions, such as chronic low 
back pain or osteoarthritis. 
* Consider safety with application and training required; not 
readily available in the context.  
LASER 
 
We suggest that the clinician consider low-level Laser 
therapy as a treatment option for patients with chronic low 
back pain.  
* Consider the cost of apparatus, safety with application and 
training required; Laser is not readily available in primary 
health care. 
 
UPDATING THIS GUIDELINE 
This guideline will be updated in 2018.  The procedure for updating will involve forming a 
guideline development team, updating the evidence and re-writing recommendations where 
indicated. 
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APPENDIX 30:  
INFORMED CONSENT (EXTERNAL REVIEW) 
Dear Healthcare practitioner 
 
Invitation to participate in a research study 
I would like to invite you to participate in a survey about the appropriateness of a newly developed 
clinical practice guideline for the Primary Health Care Management of Chronic Musculoskeletal 
Pain in the Western Cape of South Africa. 
I am a PhD student at Stellenbosch University (SU), and this survey forms part of the research 
project entitled:  The development of a contextualised evidence-based clinical practice guideline 
for the management of chronic musculoskeletal pain in primary health care centres in the Western 
Cape, South Africa. 
(SU Health research ethics approval number: S14/01/018) 
(Western Cape Provincial Research Health Committee permission number: RP038/2014). 
The main aim of this study is to determine if the clinical guideline recommendations that were 
developed, are applicable and acceptable to use in the primary health care of patients with chronic 
musculoskeletal pain in the Western Cape (community health care centres).  Feedback from 
different stakeholders will be obtained.  The information will be used to inform the revision of the 
clinical guideline recommendations.  The detail of the study is provided in the accompanying 
documents. 
The feedback is gathered through an electronic survey to ensure confidentiality.  It will take about 
20 minutes to read guideline (short form) and 5-10 minutes to answer the survey.  Please read the 
accompanying short form of the proposed CPG.  There-after, please answer the survey using 
the following link: https://sunsurveys.sun.ac.za/External-review-Clinical-guideline.aspx  
Please contact me, should you have any questions about the study or the clinical guideline. 
Your feedback about the clinical practice guideline is highly appreciated! 
 
Kind regards 
 
Principal investigator: Dawn Ernstzen 
Research supervisors: Prof Quinette Louw; Prof Susan Hillier 
Address: Division Physiotherapy, P O box 241, Cape Town 8000 
Contact number: 021 938 9300  
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APPENDIX 31:  
EXTERNAL REVIEW SURVEY  
Clinical practice guideline recommendations for the management of 
Chronic Musculoskeletal pain in Primary Health Care in the Western Cape 
 
AIM of this questionnaire:  
To obtain your views about appropriateness of the proposed clinical guideline recommendations for 
management of Chronic Musculoskeletal pain in Primary Health Care in the Western Cape, South 
Africa. 
Thank you for participating in this survey.  We value your feedback. Please read the accompanying 
short form of the proposed CPG.  There-after, please answer the following questions by circling or 
ticking [√] your response. 
 
Do you provide informed consent to participate in the study?      YES ___  NO __ 
 
GENERAL INFORMATION: 
What is your main role/s in the care of patients with musculoskeletal pain?  (Multiple options 
possible) 
 Evaluation/Assessment  Diagnosis  Referral 
 Rehabilitation  Physical therapy  Mental health 
 Patient Education  Student Education  Follow up 
 Continuing Professional Education 
 Pharmacological management 
 Other (please provide details):  
 
WORK SETTING: (You may tick more than one option) 
Do you work at a: 
 Community Clinic  Community Health Centre 
 Central/Tertiary Hospital  District Hospital 
 Private Practice  Regional Hospital 
 University  Organisation/Professional Body 
 Other (please provide details): 
 
PROFESSION: 
Please state your profession __________________ 
How long have you been practising this profession?  ______ Years 
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FEEDBACK:   
Please tick the box that most closely reflects your opinion about the guideline 
recommendations: 
1 = strongly agree 2 = agree 3 = undecided  4 = disagree 5 = strongly disagree 
The patient 1 2 3 4 5 
The recommendations in the guideline will address the needs and 
expectations of most patients in the primary healthcare setting. 
     
The patients will benefit from the recommendations in the guideline.      
The recommendations in this guideline allows for clinical decision-
making for individualised management. 
     
The guideline recommendations will be culturally/socially acceptable to 
patients. 
     
Primary health care  1 2 3 4 5 
There is a need for a guideline on chronic musculoskeletal pain.      
The recommendations in this guideline are suitable for the primary health 
care context.    
     
It will be easy to apply the recommendations.      
Little reorganisation of services/systems will be required to implement 
this guideline.  
     
The recommendations will improve the use of resources.       
Primary care practitioners are adequately skilled to implement this 
guideline. 
     
The patient journey (pathway of care) is relevant to primary health care.      
My practice 1 2 3 4 5 
I agree with most of the recommendations in the guideline.      
I already implement some of these recommendations.      
I think that the recommendations will improve patient outcomes.       
I recommend that this guideline should be approved for use in primary 
care. 
     
Format 1 2 3 4 5 
The recommendations in this guideline are specific and unambiguous.        
The recommendations in this guideline are easy to understand.         
The patient pathway is a useful visual tool.      
(Based on the ADAPTE II Collaboration, 2009; Gonzalez-Suarez et al., 2012) 
 
Please indicate any aspect of the guideline that you think should be revised or changed? 
 
 
 
 
 
Do you have any other comments about the guideline? 
 
 
 
 
 
Thank you for participating! 
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